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Members of the serpin (serine protease inhibitor) superfamily of proteins regulate key 
physiological processes through their ability to undergo major conformational 
transitions. In conformational diseases, native protein conformers convert to 
pathological species that polymerise. Structural characterization of these key 
transitions is challenging. Mechanistic intermediates are unstable and minimally 
populated in dynamic equilibria that may be perturbed by many analytical techniques. 
I use Nuclear Magnetic Resonance (NMR), and Circular Dichroism (CD) 
spectroscopy, to investigate the interrelated processes of serpin folding, misfolding 
and polymerisation in solution using the 45kDa prototypic serpin α1-antitrypsin, the 
recent assignment of the backbone resonances of α1-antitrypsin by our group, allows 
us to ask more sophisticated questions by a range of NMR techniques to study its 
structure and dynamics. In this study, I analysed early unfolding behaviour of α1-
antitrypsin across a urea titration within what is apparently the largest two-states 
system yet characterised. In order to assess the dynamics of the native state, I have 
used hydrogen/deuterium exchange nuclear magnetic resonance spectroscopy 
(HDXNMR) to characterise motions on the slow (ms) timescale. I have conducted a 
detailed analysis of residue-specific changes in protection from exchange across a pH 
titration using SOFAST-HMQC. This is complemented by a detailed a preliminary 
analysis of fast motions (ps-ns) using NMR relaxation experiments. Moreover, a 
forme fruste deficiency variant of α1-antitrypsin (Lys154Asn) that forms polymers 
recapitulating the conformer-specific neo-epitope observed in polymers that form in 
vivo was characterized in this study. Lys154Asn α1-antitrypsin populates an 
intermediate ensemble along the polymerisation pathway at physiological 
temperatures. Together, this study shows how the use of powerful but minimally 
perturbing techniques, mild disease mutants, and physiological conditions, provides 
novel insights into pathological conformational behaviour. 
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1.1.	  Protein	  folding	  	   Protein	   folding	   is	   the	  process	  by	  which	  a	  protein	  assumes	   its	   functional	  conformation	   in	   health.	   However	   neurodegenerative	   and	   other	   diseases	   are	  believed	   to	   result	   from	   an	   accumulation	   of	   protein	   aggregates	   formed	   by	  misfolded	  proteins.	  What	  factors	  determine	  the	  conformation	  of	  a	  protein?	  How	  does	  conformational	  change	  occur	  and	  how	  does	  this	  affect	  a	  protein’s	  function	  and	   dysfunction?	   Can	   an	   understanding	   of	   structural	   biology	   help	   unveil	   the	  mechanisms	  of	  neurodegenerative	  diseases	  such	  as	  Alzheimer’s	  and	  Parkinson’s	  disease?	  	  	   The	  number	  of	  different	  types	  of	  proteins	  in	  the	  human	  body	  approaches	  100	  0001,	  which	  are	  engaged	   in	  promoting	  or	   controlling	  virtually	  every	  event	  upon	   which	   our	   lives	   depend.	   Despite	   the	   numerous	   studies	   carried	   out	   on	  protein	  folding	  and	  misfolding,	  the	  mechanism	  by	  which	  a	  protein	  folds	  remains	  an	   ongoing	  question.	  A	   key	  principle	   is	   that	   the	   reversible	   in	   vitro	   folding	   of	   a	  protein	  in	  a	  cell	  free	  system	  to	  a	  thermodynamically	  stable	  native	  state	  indicates	  that	   this	   state	   has	   the	   global	   minimum	   free	   energy	   of	   all	   kinetically	   stable	  structures2.	   Christian	   Anfinsen	   and	   colleagues’	   work	   on	   ribonuclease	   showed	  that	  the	  native	  structure	  of	  a	  protein	  is	  determined	  by	  its	  amino	  acid	  sequence3,	  a	  finding	  for	  which	  Anfinsen	  received	  the	  Nobel	  Prize	  in	  Chemistry	  in	  19724.	  They	  proposed	   that	   under	   the	   environmental	   conditions	   (temperature,	   solvent	  concentration,	  composition)	  in	  which	  folding	  occurs,	  the	  native	  conformation	  is	  the	  unique,	  stable,	  and	  kinetically	  accessible	  minimum	  free	  energy	  state.	  	  Protein	  folding	   within	   a	   specific	   environment	   is	   therefore	   dependent	   upon	  thermodynamic	  and	  kinetic	  considerations.	  	  
1.1.1.	  Physical	  forces	  and	  principle	  underlying	  protein	  folding	  	  	  A	   linear	   polypeptide	   chain	   is	   autonomously	   organized	   in	   a	  well-­‐defined	  three-­‐dimensional	  structure.	  In	  the	  case	  of	  a	  globular	  protein,	  the	  internal	  core	  is	  mostly	   formed	  by	  hydrophobic	   residues5.	  Together,	   it	   is	   compacted	  by	  van	  der	  Waals	  forces,	  and	  the	  globule	  surface	  is	  mostly	  formed	  by	  charged	  and	  polar	  side	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chains6.	   The	   conformation	   of	   this	   state	   of	   condensed	   matter	   is	   largely	  determined	   by	   the	   flexibility	   of	   the	   polypeptide	   backbone	   and	   by	   the	   specific,	  consistent	  intermolecular	  interactions	  of	  the	  side	  chains.	  	  	  
1.1.1.1 Thermodynamics	  	   From	   a	   thermodynamic	   point	   of	   view,	   the	   free	   energy	   of	   a	   protein	  molecule	  is	  influenced	  by:	  (i)	  the	  hydrophobic	  effect,	  (ii)	  the	  energy	  of	  hydrogen	  bonds,	  (iii)	  the	  energy	  of	  electrostatic	  interactions,	  and	  (iiii)	  the	  conformational	  entropy	  due	  to	  the	  restricted	  motion	  of	  the	  main	  chain	  and	  the	  side	  chains7.	  	  	  	   Thermodynamic	   stability	   is	   defined	  by	   the	  Gibbs	   free	   energy	   (∆G),	  which	  reflects	  the	  difference	  in	  energy	  between	  the	  folded	  native	  conformation	  (N)	  and	  the	  unfolded	  (U)	  state(s)	  of	  a	  protein.	  The	  stability	  of	  the	  folded	  conformer	  is	  a	  function	   of	   the	   fragile	   balance	   between	   compensating	   forces,	   being	   favorable	  hydrophobic,	   van	   der	   Waals,	   hydrogen-­‐bonding	   interactions;	   and	   unfavorable	  conformational	  entropy.	  The	  folding	  free	  energy	  ∆FG	  (of	  the	  Folded	  <-­‐>	  Unfolded	  reaction)	   is	   typically	   small,	   it	   is	   of	   the	   range	  5-­‐15	  kcal.mol−1	   for	  most	   globular	  proteins8	  (in	  comparison	  with	  approximately	  30	  to	  100	  kcal.mol-­‐1	  for	  a	  covalent	  bond).	  It	  reflects	  the	  balance	  between	  enthalpy	  and	  entropy	  by	  the	  relation:	  	  	  
∆G	  	  =	  	  ∆H	  −	  T∆S	  	  	   	   	   	   	   Equation	  1.1	  
Where	   ∆H	   is	   the	   difference	   in	   enthalpy,	   T	   is	   the	   temperature	   and	   ∆S	   is	   the	  
difference	  in	  entropy.	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Figure	  1.1.	  	   Illustration	  of	  the	  process	  of	  protein	  folding.	  It	  is	  the	  process	  by	  which	  a	  protein	   structure	   assumes	   its	   functional	   shape	   or	   conformation	   from	   an	  unfolded	  (U)	  to	  a	  fully	  functioning	  folded	  state	  (N),	  via	  an	  equilibrium	  constant	  of	   unfolding	   (ku),	   illustrated	   using	   protein	   folding	   model	   ubiquitin	   (PDB:	   1	  UBQ).	  	  	   In	   the	   unfolded	   state	   of	   a	   protein,	   there	   is	   high	   configurational	   entropy.	  Protein	   folding	   will	   occur	   when	   entropy	   loss	   is	   offset	   by	   a	   gain	   in	   enthalpy,	  resulting	   from	   main	   and	   side-­‐chain	   packing	   interactions.	   	   This	   results	   in	   a	  negative	   ∆G,	   and	   hence	   a	   favorable	   reaction.	   For	   any	   reversible	   reaction,	   from	  unfolded	   to	   folded,	   ∆FG	   under	   standard	   conditions	   can	   be	   expressed	   as	   the	  relation:	  	  
	   ∆	  F	  G	  	  =	  	  −	  RTlnK	   	   	   	   	   	   	   	   Equation	  1.2	  
Where	  ∆	  F	  G	  is	  the	  free	  energy	  of	  folding,	  R	  is	  the	  gas	  constant,	  T	  the	  temperature	  in	  
Kelvin	  and	  Keq	   the	  equilibrium	  constant	  of	   folding	  where	  K	  =	   [N]/[U]n,	  where	   [N]	  
and	  [U]	  are	  the	  molar	  concentrations	  of	  folded	  and	  unfolded	  protein,	  respectively	  n	  
denotes	  how	  many	  chains	  associate	  when	  the	  protein	  is	  folded	  (Fig.1.1.).	  	  
	   ∆	  F	  G	  	  =	  	  	  GN	  –	  GU	  	   	   	   	   	   	   	   	   Equation	  1.3	  
The	  Gibbs	  free	  energy,	  G,	   is	  made	  up	  the	  two	  terms	  enthalpy	  (H)	  and	  entropy	  (S),	  
where	  G	  =	  H	  –	  TS.	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1.1.1.2.	  Kinetics	  	  	   	   The	   kinetics	   of	   folding	   within	   the	   polypeptide	   chain	   are	   defined	   by	  reversibility	   and	   the	   time	   needed	   for	   a	   protein	   to	   reach	   a	   native	   state	   from	   a	  given	  starting	  state.	  	  	  	  	  	   The	  rate	  of	  folding	  at	  a	  given	  temperature	  equals	  to	  k1[U]n	  and	  the	  rate	  of	  unfolding	  equals	  to	  k-­‐1[N],	  where	  k1	  and	  k-­‐1	  are	  the	  rate	  constants	  for	  folding	  and	  unfolding,	   respectively.	   At	   equilibrium	   the	   rates	   of	   folding	   and	   unfolding	   are	  equal,	  i.e.,	  k1[U]n	  =	  k-­‐1[N],	  	  where	  the	  rate	  of	  folding	  is	  also	  defined	  as:	  
	   kF	  	  =	  	  k1	  /	  k-­1	   	   	   	   	   	   	   Equation	  1.4	  The	   kinetics	   of	   folding	   within	   a	   polypeptide	   chain	   are	   particularly	  important	  as	  they	  limit	  the	  range	  of	  conformational	  space	  that	  it	  can	  explore.	  For	  most	   proteins	   this	   does	   not	   ultimately	   prevent	   folding	   to	   the	   most	   stable	  physiological	  state,	  and	  may	  assist	  in	  solving	  the	  Levinthal	  paradox9.	  This	  points	  out	   that	  number	  of	  possible	   conformations	  available	   to	   a	   given	  protein	   is	   vast.	  	  Thus,	   even	  a	  protein	  of	  a	  100	  residues	   size,	  would	   require	  more	   time	   than	   the	  universe	  has	  existed	  to	  explore	  all	  possible	  conformations	  (1010	  years)	  in	  order	  to	   adopt	   the	   appropriate	   fold.	   The	   paradox	   rests	   on	   the	   assumption	   that	   all	  conformations	  are	  equally	  likely	  to	  be	  populated	  in	  the	  path	  from	  the	  unfolded	  to	  the	  folded	  states.	  Folding	  kinetics,	  together	  with	  thermodynamic	  considerations,	  mean	  this	  is	  not	  the	  case.	   	  Moreover,	  such	  kinetics	  can	  also	  cause	  a	  polypeptide	  to	   become	   trapped	   within	   local	   energy	   minima.	   However,	   intracellular	  environments	  are	  rich	   in	  chaperone	  molecules	  and	  degradative	  machinery	   that	  respectively	   facilitate	   escape	   from,	   or	   proteolysis	   of,	   these	   states10.	   Thus	   the	  most	  stable	  physiological	  state	  is	  generally	  favoured.	  	  
1.1.1.3.	  Models	  of	  protein	  folding	  	   	   The	   concept	   of	   folding	   pathways	   motivated	   a	   vast	   number	   of	  experimental	  research	  aimed	  at	   finding	  the	  specific	   ‘folding	   intermediates’,	  and	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also	   give	   rise	   to	   a	   number	   of	   models	   describing	   the	   folding	   process.	   The	  nucleation/growth	  model11	  addresses	  Levinthal’s	  paradox	  by	  assuming	  that	  the	  rate-­‐limiting	   step	   of	   the	   folding	   process	   is	   an	   initial	   nucleation	   event	   of	  hydrophobic	  collapse.	  Once	   the	  nucleation	   takes	  place	   the	  nuclei	  grow	  fast	  and	  the	   folding	   process	   rapidly	   completes;	   the	   secondary	   structure	   is	   formed,	   and	  finally	   these	   secondary	   structures	   are	   collided	   together	   and	   pack	   tightly	  together.	   However	   many	   systems	   appear	   to	   proceed	   via	   folding	   intermediate	  ensemble(s).	  In	  contrast,	  the	  ‘jigsaw	  puzzle’	  or	  framework	  model12	  proposes	  that	  folding	  pathways	  are	  not	  necessarily	  unique	  and	  directed.	   Instead	  each	  protein	  molecule	  may	  follow	  a	  different	  route	  to	  the	  native	  structure.	  These	  two	  models	  of	  protein	  folding	  may	  be	  reconciled	  in	  the	  ‘nucleation-­‐condensation’	  model13;	  14	  in	  which	  native	  hydrophobic	  interactions	  stabilize	  otherwise	  variable	  secondary	  structure	   features	   to	   give	   a	   transition	   state15.	   The	   ‘framework	  model’	   presents	  the	  folding	  process	  as	  hierarchical	   in	  which	  secondary	  structure	   is	  proposed	  to	  fold	   first,	   followed	   by	   docking	   of	   the	   pre-­‐formed	   secondary	   structural	   units	   to	  yield	  the	  native,	  folded	  protein15.	  	   	   Folding	   studies	   on	   a	   range	   of	   globular	   proteins	   16;	   17;	   18;	   19	   have	   probed	  intermediate	   formation	   along	   the	   folding	   pathways.	   Equilibrium	   states	   are	   not	  necessarily	   identical	   to	   intermediates	   populated	   along	   the	   folding	   pathways.	  	  However,	  it	  was	  of	  interest	  that	  such	  studies	  indicated	  equilibrium	  intermediates	  possessed	   native-­‐like	   secondary	   structure,	   which	   was	   found	   to	   form	   later	  tertiary	   structure,	   suggesting	   a	   hierarchic	   process.20.	   	   Such	   intermediates	   are	  trapped	  within	  a	   local	  minima,	  and	  models	   involving	  one	  or	  more	  intermediate	  states	   have	   been	   generated	   to	   explain	   complex	   protein	   folding	   kinetics.	   These	  models	  distinguish	  between	  two	  intermediates:	  “on-­‐pathway”	  and	  “off-­‐pathway”.	  The	  former	  are	  those	  considered	  present	  in	  the	  direct	  sequence	  of	  folding	  steps	  between	   the	   unfolded	   and	   the	   fully	   folded	   native	   state20.	   Off-­‐pathway	  intermediates	   are	   considered	   to	   represent	   states	   populated	  when	   the	   adopted	  conformation	  is	  alternative	  to	  this.	  	  They	  may	  therefore	  correspond	  to	  misfolded	  protein	  that	  must	  partially	  or	  completely	  unfold	  to	  allow	  correct	  refolding	  to	  the	  native	  conformer.	  In	  the	  energy	  landscape	  view	  described	  later	  in	  1.1.1.4,	  there	  is	  no	  clear	  distinction	  between	  on-­‐	  and	  off-­‐pathway	  intermediates21;	  22.	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  The	   ‘molten	   globule’	   state	  was	   proposed	   for	   the	   first	   time	   in	   1983	   on	   the	  cytochrome	   c	   model	   23,	   describing	   for	   the	   first	   time	   the	   existence	   of	   a	   third	  (intermediate)	   equilibrium	   state	   by	   Ohgushi	   and	   Wada.	   	   However	   it	   was	   not	  clear	  whether	  this	  was	  related	  to	  the	  specific	  folding	  intermediates.	  Nonetheless,	  the	   equilibrium	   intermediates	  were	   demonstrated	   to	   be	   remarkably	   similar	   to	  each	  other.	  This	  was	  defined	  as	  a	  thermodynamic	  state	  that	  conserves	  a	  native-­‐like	   secondary	   structure	   content	   without	   the	   tightly	   packed	   protein	   interior	  (lacked	   a	   specific	   tertiary	   structure).	   In	   the	   case	   of	   α-­‐lactalbumin	   the	   molten	  globule	   state	   appears	   identical	   to	   its	   transient	   folding	   intermediate24.	   Molten	  globule	   states	   could	   be	   generated	   using	   mild	   denaturing	   conditions	   (such	   as	  moderate	  concentrations	  of	  denaturant,	   low	  pH,	  high	   temperature,	  and	  various	  salts)25.	  	  	  
1.1.1.4.	  Polypeptide	  chain	  behaviour	  and	  energy	  landscapes	  	   These	   findings	   together	   sparked	  off	   the	  need	   to	  define	   the	   relationships	  between	   free	   energy	   and	   protein	   conformation	   resulting	   in	   the	   concept	   of	   an	  energy	  landscape26.	  For	  a	  folding	  system	  this	  may	  be	  defined	  as	  a	  mapping	  of	  the	  chain	   conformation	   to	   its	   internal	   energy,	   along	   with	   rules	   defining	   what	  configurations	  are	  accessible	  from	  a	  given	  conformation	  and	  how	  the	  protein	  can	  move	  between	  them,	  as	  illustrated	  in	  figure	  1.2.	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Figure	  1.2.	  	   Schematic	   representation	   of	   the	   protein	   folding	   landscape.	   The	  protein	   energy	   landscape	   is	   multi-­‐dimensional	   and	   corresponds	   to	   the	  interrelationships	  between	   the	  various	  configurational	   states	  of	  a	  protein.	  The	  depth	   represents	   the	   free	  energy	  of	   a	  given	  conformational	   state;	   the	  width	   is	  typically	   taken	  to	  be	  a	  measure	  of	   the	  configurational	  entropy.	  Different	  states	  have	   different	   energies.	   Each	   state	   has	   a	   transition	   ratio	   related	   to	  configurations	  locally	  connected	  to	  it.	  The	  set	  of	  states	  along	  with	  their	  energies	  and	  transition	  matrices	  fully	  determine	  the	  folding	  dynamics	  for	  the	  system.	  	  	   Thus,	  the	  free	  energy	  of	  a	  conformational	  state	  is	  illustrated	  by	  the	  depth,	  while	  the	  width	  is	  typically	  taken	  to	  be	  a	  measure	  of	  the	  configurational	  entropy.	  Entropy	  can	  be	  defined	  as	  a	  measure	  of	  the	  number	  of	  specific	  ways	  in	  which	  a	  system	  may	  be	  arranged,	  often	   taken	   to	  be	  a	  measure	  of	  disorder,	  progressing	  towards	   a	   thermodynamic	   equilibrium.	   The	   enthalpy	   on	   the	   other	   hand,	  represents	   a	   measure	   of	   the	   total	   energy	   of	   a	   thermodynamic	   system,	   which	  takes	  in	  consideration	  the	  internal	  energy,	  as	  well	  as	  the	  volume	  and	  pressure	  of	  a	   given	   system.	   Recent	   theories	   of	   protein	   folding	   suggest	   that	   individual	  proteins	  within	  a	  large	  ensemble	  may	  follow	  a	  stochastic	  search	  in	  conformation	  space	  from	  the	  high	  free	  energy	  level	  unfolded	  state	  toward	  the	  functional	  fully	  folded	  native	  state,	   corresponding	   to	   the	   local	   free	  energy	  minima	   in	   their	   free	  energy	  surfaces,	  and	  vice	  versa27;	  28.	  The	  use	  of	  structural	  biology	  techniques	  such	  as	  Nuclear	  Magnetic	   Resonance	   (NMR)	   spectroscopy	   has	   increasingly	   played	   a	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significant	   role	   in	   obtaining	   atomic-­‐level	   resolution	   of	   the	   protein	   folding	   in	  solution29.	  Indeed,	  NMR	  spectroscopy	  can	  provide	  detailed	  understanding	  of	  the	  nature	  and	  extent	  of	  protein	  dynamics	  on	  physiologically	   important	  timescales,	  and	  conditions,	  which	  can	  allow	  detailed	  mapping	  of	  the	  protein	  conformational	  energy	  landscape.	  	  	  
1.1.1.5.	  Tools	  for	  the	  study	  of	  protein	  folding.	  	  	   In	  the	  last	  decade,	  a	  wide	  range	  of	  biochemical	  and	  biophysical	  methods	  complemented	   the	   fundamental	   techniques	   to	   study	   protein	   folding.	   Protein	  folding	  can	  be	  studied	  by	   two	  distinct	  approaches.	  Equilibrium	  studies	  provide	  information	  about	  potential	  folding	  intermediate	  states	  by	  characterizing	  stably	  populated	  ensembles	  across	  a	  range	  of	  folding	  environments.	  On	  the	  other	  hand,	  the	  relaxation	  approach	  probes	  the	  dynamics	  of	  a	  system	  as	  it	  evolves	  towards	  a	  new	   equilibrium,	   following	   rapid	   perturbation	   of	   the	   condition	   of	   its	  environment	  (pH,	  pressure,	  temperature,	  or	  solvent	  conditions)30.	  Folding	  rates	  vary	  greatly	  amongst	  systems,	  with	  timescales	  between	  milliseconds	  to	  minutes.	  Classic	   experimental	   techniques	   to	   study	   folding	   kinetics	   are	   stopped-­‐flow	  fluorescence	   spectroscopy	  and	  stopped-­‐flow	  circular	  dichroism,	   that	   can	  probe	  the	   formation	   of	   secondary	   and	   tertiary	   structure	   at	   a	   millisecond	   timescale.	  Continuous-­‐flow	   techniques	   extend	   the	   resolution	   time	   to	   the	   millisecond	  timescale	  range31.	  Using	  the	  former,	  studies	  of	  the	  initial	  collapse	  and	  formation	  of	  intermediates	  in	  early	  folding,	  has	  become	  possible32.	  The	  structural	  dynamics	  of	  these	  processes	  can	  be	  modeled	  in	  silico	  33.	  	  
1.1.1.6.	  Relationship	  of	  polypeptide	  folding	  within	  cells	  and	  in	  isolation	  	   The	  energy	  landscape	  of	  protein	  folding	  and	  conformational	  behaviour	  is	  determined	  not	  only	  by	  its	  amino-­‐acid	  sequence	  but	  also	  by	  the	  physico-­‐chemical	  environment	   within	   which	   it	   exists10.	   The	   most	   physiologically	   relevant	  environments	   for	   protein	   folding	   are	   those	   of	   the	   intracellular	   folding	  compartments,	   meaning	   the	   cytoplasm	   or	   endoplasmic	   reticulum	   (ER).	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Furthermore,	   protein	   folding	   is	   intrinsically	   linked	   to	   the	   macro-­‐molecular	  complex	  named	  the	  ribosome	  that	  serves	  as	  a	  primary	  site	  of	  protein	  synthesis.	  The	   detailed	   mapping	   of	   its	   structure	   and	   function	   awarded	   Yonath	   and	  colleagues	   the	   Nobel	   Prize	   in	   Chemistry	   200934.	   It	   is	   responsible	   for	   the	  translation	  from	  mRNA	  into	  all	  proteins	  of	   living	  organisms.	  As	  all	  proteins	  are	  synthesized,	   the	   nascent	   chains	   emerge	   vectorially	   from	   the	   ribosomal	   exit	  tunnel	  and	  into	  the	  highly	  crowded	  cellular	  environment	  to	  fold,	  often	  with	  the	  aid	   of	   cell	   machinery	   such	   as	   chaperones35	   or	   co-­‐translational	   folding	   on	   the	  ribosome28.	   Taken	   together	   the	   complexity	   of	   intracellular	   co-­‐translational	  folding	   presents	   major	   challenges	   to	   understanding	   the	   various	   processes	   in	  detail.	   Encouraging	   recent	   progress	   has	   been	   made	   to	   this	   end	   by	   the	  Christodoulou	   group	   28;	   36;	   37;	   38;	   39	   and	   others40;	   41;	   42;	   43;	   44.	   Furthermore,	  characterizing	   the	   folding	   of	   isolated	   polypeptide	   chains	   in	   cell-­‐free	  environments	   in	   vitro,	   albeit	   as	   a	   simplification	   of	   the	   physiological	   state,	  constitutes	  a	  promising	  avenue	  to	  aid	  interpretation	  of	  complex	  data	  from	  in	  situ	  studies28.	  
1.1.1.7.	  Protein	  misfolding	  and	  conformational	  disease	  	   The	   failure	   of	   a	   protein	   to	   adopt	   or	   maintain	   its	   native	   functional	  conformation,	  may	  result	  in	  a	  wide	  range	  of	  pathological	  disorders,	  referred	  to	  as	  ‘protein	   misfolding	   diseases’	   or	   ‘conformational	   diseases’45;	   46;	   47;	   48.	  Conformational	  disease	  phenotypes	  are	  related	  to	  both	  a	  loss	  of	  normal	  function	  and	  a	  gain	  in	  toxic	  function.	  	  It	  is	  likely	  that	  many	  diseases	  are	  mediated	  to	  some	  degree	   by	   abnormal	   conformational	   behaviour.	   A	   recent	   example	   of	   the	  importance	   of	   such	   mechanisms	   comes	   from	   cystic	   fibrosis49	   where	   small	  molecule	  stabilizers	  of	  the	  functional	  state	  of	  the	  transmembrane	  CFTR	  protein	  have	   been	   a	   major	   breakthrough	   in	   treatment50;	   51.	   However,	   the	   best-­‐known	  group	   of	   conformational	   diseases	   are	   associated	   with	   protein	   deposition	  organized	  in	  fibrillar	  aggregates,	  e.g.	  amyloid	  fibrils	  47;	  52.	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Figure	  1.3.	  	   States	  accessible	  to	  a	  protein	  molecule.	  	  Represented	  here	  is	  an	  overview	  of	   the	  different	   states	   available	   to	   a	  molecule	   after	   it	  has	  been	   synthesized	  on	  the	   ribosome.	   The	   challenge	   now	   is	   to	   define	   the	   structures,	   energetic	   and	  kinetic	  properties	  of	   all	   the	   states	  of	   a	   given	  protein	  under	   certain	   conditions.	  (Figure	  adapted	  from	  the	  work	  of	  Dobson	  et	  al.53)	  	   The	   range	  of	   states	  available	   for	  a	  protein	   to	   fold	   is	   illustrated	   in	   figure	  1.3.	  Folding	  into	  a	  unique	  three-­‐dimensional	  native	  conformation	  is	  essential	  to	  their	   function,	   and	   a	   failure	   to	   fold	   into	   native	   structure	   generally	   produces	  inactive	   proteins,	   and	   in	   some	   instances,	  modified	   or	   toxic	   functionality,	   often	  characterized	  by	  the	  formation	  of	  aggregated	  proteins	  into	  amyloid	  fibrils.	  These	  misfolding	   principles	   are	   observed	   in	   a	  wide	   range	   of	   conformational	   diseases	  including	  Alzheimer's54,	  Parkinson’s55;	  56;	  57,	  and	  Huntington's58	  diseases,	  and	  the	  prion	   encephalopathies59.	   They	   are	   characterized	   by	   a	   ‘toxic	   gain	   of	   function’	  created	  by	  the	  presence	  of	  accumulated	  protein	  deposition,	  and	  ‘loss	  of	  function’	  as	   a	   result	   from	   the	   deficiency	   of	   activity	   required	   for	   their	   function.	  Conformational	  diseases	  can	  be	   inherited,	  usually	  as	  dominant	   traits,	  or	  can	  be	  induced,	   as	   in	   the	   case	  of	  prions.	  The	  vast	  majority	  of	   conformational	  diseases	  are,	  however,	  of	  unknown	  etiology.	  How	  cells	  respond	  to	  the	  production	  of	  these	  abnormal	   protein	   conformers	   and	   how	   these	   misfolded	   proteins	   cause	  cytotoxicity	  are	  central	  unanswered	  questions	  that	  are	  the	  subject	  of	  our	  study.	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1.2.	  Serpins	  and	  serpinopathies	  	  	  	   An	  archetypal	  model	  of	  conformational	  disease	  comes	   from	  a	  superfamily	  of	  proteins	  known	  as	  the	  serpins	  (serine	  protease	  inhibitors)60,	  where	  disorders	  caused	   by	   serpin	   polymerisation	   have	   been	   termed	   the	   serpinopathies46.	   	   The	  formation	   of	   polymers	   underlies	   the	   retention	   of	   α1-­‐antitrypsin	   within	   the	  hepatocytes	  and	  neuroserpins	  within	  neurons	   to	  cause	  cirrhosis	  and	  dementia,	  respectively	  (Fig.1.4.).	  Similar	  conformational	  transitions	  were	  observed	  in	  other	  serpins	  (α1-­‐antichymotrypsin,	  C1-­‐inhibitor)54.	  	  	  	  
	  	  
Figure	  1.4.	  	   Conformational	   disease:	   Z	   α1-­antitrypsin	   is	   retained	   within	  
hepatocytes	   as	   intracellular	   inclusions.	   	   A-­‐	   Intracellular	   inclusions	   are	  PAS	  positive	   and	  diastase	   resistant	   and	   are	   associated	  with	  neonatal	   hepatitis	  and	  hepatocellular	  carcinoma.	  B-­‐	  These	  inclusions	  are	  composed	  of	  chains	  of	  α1-­‐antitrypsin	   polymers	   shown	  here	   from	   the	  plasma	  of	   a	   Siiyama	  α1-­‐antitrypsin	  homozygote.	  Figure	  adapted	  from54.	  	  	   Serpins	   are	   defined	   by	   at	   least	   30	  %	   sequence	   identity	   to	   the	   archetypal	  member	   α1-­‐antitrypsin,	   and	   a	   common	  native	   fold,	   consisting	   of	   β-­‐sheets	   A,	   B,	  and	  C	  and	  at	  least	  7	  (typically	  9)	  α-­‐helices	  (Fig1.5.).	  This	  conformation	  is	  not	  the	  most	   energetically	   preferred	   state	   but	   is	   instead	   metastable61.	   This	   property	  underlies	   diverse	   serpin	   functions	   (protease	   inhibition,	   hormone	   precursors,	  hormone	  carriers	  and	  chaperones)	  but	  also	  predisposes	  to	  alternative	  stabilizing	  (and	  hence	  inactivating)	  conformational	  change.	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   Most	   typical	   serpin	   structures	   contains	   9	   α-­‐helices,	   as	   in	   the	   structure	   of	  native	  α1-­‐antitrypsin	  represented	  below,	  which	  comprises	  394	  amino	  acids.	  The	  reactive	  centre	  loop	  (RCL),	  which	  contains	  the	  proteinase	  recognition	  site,	  is	  an	  exposed,	  flexible	  stretch	  of	  ~20-­‐25	  residues	  tethered	  between	  β-­‐sheets	  A	  and	  C.	  The	   β-­‐sheet	   A	   and	   the	   RCL	   domains	   have	   been	   highlighted	   in	   blue	   and	   red	  respectively,	   as	   focusing	   on	   these	   features	   indicates	   global	   changes	   that	   occur	  during	  conformational	  transitions.	  
	  	  
Figure	  1.5.	  	   Ribbon	   diagram	   of	   the	   native	   state	   wild	   type	   α1-­antitrypsin.	   	   The	  structure	   of	   α1-­‐antitrypsin	   is	   composed	   of	   a	   lower	   N-­‐terminal	   helical	   domain	  and	   an	   upper	   C-­‐terminal	   β-­‐barrel	   domain	   (when	   in	   this	   “classic”	   orientation).	  The	  main	  features	  are	  the	  RCL	  in	  red	  and	  β-­‐sheet	  A	  in	  blue	  which	  are	  believed	  to	  undergo	  major	  conformational	  changes	  upon	  polymerisation,	  β-­‐sheets	  B,	  and	  C,	  and	  9	  α-­‐helices	  (A	  to	  I).	  (PDB:	  NE4)	  	  
1.2.1.	  α	  1-­antitrypsin	  deficiency	  	   α1-­‐antitrypsin	   is	   the	   best-­‐characterized	   (archetypal)	   member	   of	   the	  serpin	   family.	   Its	  main	   function	   is	   to	   inhibit	   neutrophil	   elastase	   present	   in	   the	  lungs	  and	  it	   is	  synthesized	  in	  the	  liver	  and	  circulates	  in	  the	  bloodstream.	  In	  the	  context	  of	  disease	  mutations,	   such	  as	   in	   the	  Z	   (Glu342Lys)	  variant,	   abnormally	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folded	   proteins	   accumulate	   linked	   within	   polymeric	   chains	   in	   the	   ER	   of	  hepatocytes.	   Polymerisation	   is	   associated	   with	   gain-­‐of-­‐function	   toxicity	   that	  causes	   α1-­‐antitrypsin	   deficiency	   associated	   liver	   disease.	   The	   accumulation	   of	  abnormally	   folded	   protein	   within	   ER	   causes	   ER	   stress,	   perturbing	   normal	   ER	  function.	  Once	  normal	  ER	  quality	  control	  mechanisms	  of	  autophagy62;	  63	  and	  ER-­‐associated	  degradation	  (ERAD)	  are	  overwhelmed,	  the	  accumulation	  of	  abnormal	  proteins	   triggers	   the	   ER	   Overload	   Response	   (EOR).	   This	   is	   characterised	   by	  calcium-­‐dependant	   NF-­‐kappa	   B	   activation.	   On	   the	   other	   hand,	   the	   loss-­‐of-­‐function	   is	   the	   product	   of	   a	   lack	   of	   active	   circulating	   functional	   α1-­‐antitrypsin	  mainly	   due	   to	   polymerisation,	   reduced	   anti-­‐protease	   activity,	   and	   secretion.	  Together	  with	  proposed	  gain	  of	  function	  due	  to	  extracellular	  polymers	  found	  in	  lungs	   these	   effects	   give	   rise	   to	   panacinar	   emphysema;	   the	   hallmark	   of	   α1-­‐antitrypsin	   deficiency-­‐related	   lung	   disease.	   Polymerisation	   therefore	   seems	  central	   to	   disease	   mechanisms	   in	   α1-­‐antitrypsin	   deficiency	   and	   the	  serpinopathies.	  	  
1.2.2.	  Metastability	  and	  inhibitory	  mechanism	  	   The	   intrinsic	   dynamic	   potential	   of	   serpins	   arises	   because	   the	   native	  conformation	   into	   which	   they	   fold	   in	   vivo	   and	   in	   vitro	   is	   not	   the	   most	  energetically	   preferred	   state	   but	   is	   instead	   typically	   metastable61.	   From	   the	  native	  state	  the	  molecule	  can	  continue	  to	  adopt	  more	  stable	  conformations.	  	  This	  is	   utilized	   in	   the	   characteristic	   serpin	  mechanism	  of	   serine	   protease	   inhibition	  (Fig.1.6.).	   Unlike	   other	   protease	   inhibitors,	   serpins	   do	   not	   interact	   with	  corresponding	  proteases	   in	  a	  reversible	   ‘lock-­‐and-­‐key’	   fashion,	  but	   function	  via	  an	   irreversible	   ‘suicide-­‐substrate’	   inhibitory	  mechanism	   (Fig.1.6.).	   The	   apex	   of	  the	  RCL	  of	  inhibitory	  serpins,	  centred	  on	  the	  P1-­‐P1’	  scissile	  bond64,	  represents	  an	  ideal	  substrate	  for	  the	  target	  protease	  in	  its	  sequence	  and	  conformation.	  	  	  The	  initial	  non-­‐covalent	  docking	  interaction	  (Michaelis	  complex)	  develops	  by	  the	  first	  steps	  of	  a	  classical	  serine	  protease	  mechanism.	  	  This	  means	  that	  P1-­‐P1’	   peptide	   bond	   cleavage	   is	   accompanied	   by	   formation	   of	   a	   covalent	   bond	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between	   the	   enzyme	   active	   site	   and	   the	   substrate.	   However	   this	   step	   also	  releases	   the	   native	   strain	   distributed	   around	   the	   molecule	   by	   freeing	   the	   N-­‐terminal	   portion	   of	   the	   RCL	   to	   insert	   as	   a	   central	   antiparallel	   β-­‐strand	   in	   the	  centre	   of	   β-­‐sheet	   A	   (s4A).	   	   Rapid	   RCL	   insertion	   traps	   the	   covalently	   bound	  protease	  by	  distorting	   its	   catalytic	  machinery	   such	   that	   it	   cannot	   complete	   the	  overall	  hydrolysis	   reaction	   that	  would	   release	  a	   cleaved	  substrate65.	   	  This	   final	  serpin-­‐enzyme	  inhibitory	  complex	  is	  therefore	  physiologically	  irreversible.	  	  RCL	  insertion	   at	   the	   s4A	   site	   is	   associated	   with	   a	   large	   drop	   in	   free	   energy	   of	   the	  serpin	  fold	  and	  hence	  it	  is	  also	  hyperstable.	  	  	  
	  
Figure	  1.6.	  	   Ribbon	   diagram	   of	   α1-­antitrypsin	   structural	   forms	   and	   inhibitory	  
mechanism	  Inhibitory	  mechanism	  illustration	  from	  the	  native	  state	  
can	  be	  considered	  as	  a	  mousetrap.	  A-­‐	  Crystal	  structure	  of	  the	  native	  state	  of	   α1-­‐antitrypsin	   where	   the	   P1	   position	   is	   represented	   by	   a	   red	   circle	   (PDB:	  3NE4);	   B-­‐	   Reversible	   Michaelis	   complex	   (PDB:	   1OPH).	   Which	   represents	   the	  RCL/protease	  interactions	  prior	  to	  cleavage	  of	  the	  P1–P1’	  bond	  and	  formation	  of	  the	  acyl-­‐enzyme	  intermediate.	  C-­‐	  Irreversible	  final	  covalent	  inhibitory	  complex	  (PDB:	  1EZX).	  	   The	  processes	  of	  serpin	  folding	  and	  function	  are	  therefore	  linked	  to	  such	  and	  extent	  that	  the	  inhibitory	  mechanism	  has	  been	  termed	  ‘functional	  folding’66.	  They	  can	  be	  therefore	  be	  related	  by	  a	  free	  energy	  landscape	  (Fig.1.7.),	  left).	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Figure	  1.7.	  	   Schematic	   energy	   landscape	   of	   serpin	   folding	   and	   conformational	  
change.	  Model	   of	   the	   serpin	   polypeptide	   chain	   folding	   and	   the	   relationship	  between	   folding	   and	   conformation.	   The	   surface	   ‘funnels’	   the	   multitude	   of	  unfolded	   species	   through	   intermediate	   ensembles	   to	   the	   unique	   but	   dynamic	  native	  structure.	  From	  this	  metastable	  native	  state	  the	  molecule	  can	  adopt	  more	  stable	   conformations,	   either	   by	   functional	   folding	   required	   for	   its	   inhibitory	  function	  or	  by	  dysfunctional	  conformational	  change/misfolding	  leading	  to	  latent	  or	  polymer	  conformations	  67.	  	  	  
1.2.3	  Alternative	  serpin	  conformations	  	  	   The	  potential	   for	  stabilizing	  conformational	  change	   is	  also	  what	  renders	  serpins	   highly	   susceptible	   to	   the	   effects	   of	   disease	   mutations	   predisposing	   to	  alternative	   conformations	   outside	   of	   the	   inhibitory	  mechanism	   (Fig.1.7,	   right).	  Firstly,	   in	   the	   presence	   of	   excess	   or	   non-­‐cognate	   proteases	   an	   irreversible	  complex	  may	  not	  result.	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Figure	  1.8.	   RCL	  P-­sites	  upon	  monomeric	  cleavage.	  	  The	  RCL	  is	  highlighted	  in	  red	  and	  numbered	  according	  to	  the	  P-­‐sites	  convention	  of	  Schechter	  and	  Berger,	  in	  which	  P1	  and	  P1’	  positions	  are	  either	  side	  of	  the	  site	  of	  cleavage	  by	  a	  protease.	  The	  β-­‐sheet	   A	   is	   coloured	   in	   blue,	   upon	   transition	   from	   the	   native	   metastable	  conformation	   (left)	   to	   the	   cleaved	   (right)	   conformer	   the	   RCL	   shifts	   from	   an	  exposed	  position	  to	  an	   inserted	  position	  and	  forms	  an	  additional	  strand	   in	  the	  centre	  of	  the	  β-­‐sheet	  A;	  represented	  for	  the	  native	  (PDB:	  3NE4)	  and	  the	  cleaved	  conformer	  (PDB:	  1EZX).	  	  	   In	  these	  cases,	  failure	  to	  trap	  the	  protease	  in	  a	  covalent	  complex,	  leaves	  a	  cleaved	  serpin	  monomer	  68.	  The	  cleaved	  conformation	  (Fig.1.8.	  illustrating	  the	  P-­‐sites	   upon	   cleavage)	   is	   inactive,	   and	   demonstrates	   the	   thermodynamic	  hyperstability	   characteristic	   of	   all	   conformers	   formed	   from	   an	   stressed	   (S)	   to	  relaxed	   (R)	   transition69,	   similarly	   to	   the	   hyperstable	   inhibitory	   complex	  illustrated	  in	  Fig1.7.	  The	  RCL	  can	  also	  insert	  into	  the	  β-­‐sheet	  A	  in	  the	  absence	  of	  cleavage.	  This	   is	   the	  case	  of	   the	   latent	  species	   (Fig.1.9.	  –	   left)	   in	  which	   the	  RCL	  fully	  inserts	  into	  the	  β-­‐sheet	  A70.	  This	  latent	  species	  occurs	  spontaneously	  in	  PAI-­‐1	   (Plasminogen	   Activator	   Inhibitor-­‐1),	   with	   inhibitory	   activity	   restored	   by	  denaturation	   and	   refolding,	   and	   in	   antithrombin71	  when	   not	   bound	   to	   heparin	  moieties.	  It	  has	  also	  been	  demonstrated	  for	  α1-­‐antitrypsin72;	  73;	  74,	  neuroserpin75,	  and	   α1-­‐antichymotrypsin76.	   	   The	   δ	   conformer	   (Fig.1.9.	   -­‐	   middle),	   involves	   the	  partial	   insertion	   of	   the	   RCL	   in	   the	   s4A	   site,	  with	   the	   lower	   part	   of	   this	   strand	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being	  formed	  through	  partial	  unwinding	  of	  the	  overlying	  F-­‐helix,	  mimicking	  full	  insertion77.	  Lastly,	  serpins	  can	  also	  accept	  an	  exogenous	  RCL	  analogue	  peptide	  to	  form	  protein:peptide	  (e.g.	  binary)	  complex,	  (Fig.	  1.9.	  -­‐	  right)78;	  79;	  80.	  	  
	  
Figure	  1.9.	  	   Alternative	   monomeric	   serpin	   conformers	   resulting	   from	  
stabilizing	   conformational	   change.	   The	   failure	   to	   trap	   a	   substrate	  protease	  as	  a	  complex	  results	  in	  cleavage	  of	  the	  RCL	  (red)	  and	  its	  insertion	  into	  
β-­‐sheet	   A	   (blue)	   to	   generate	   the	   cleaved	   conformer.	   Serpins	   can	   also	   form	   a	  latent	   species	   in	   which	   the	   intact	   RCL	   is	   fully	   inserted	   into	   β-­‐sheet	   A	   (left)	  Partial	  insertion	  of	  the	  RCL	  is	  seen	  in	  the	  δ	  conformation	  with	  the	  lower	  part	  of	  the	  strand	  (yellow)	  being	  formed	  by	  partial	  unwinding	  of	  the	  overlying	  F-­‐helix	  (middle).	  Furthermore,	  serpins	  can	  accept	  an	  exogenous	  RCL	  analogue	  peptide	  (yellow)	  to	  form	  a	  binary	  complex	  (right).	  	  
	  
1.2.4.	  Studies	  of	  serpin	  folding	  	   The	   thermodynamic	  metastability	   of	   the	   serpin	   native	   fold	   is	   relatively	  unusual	   in	   protein	   folding	   and	   explains	   the	   propensity	   of	   serpins	   to	   undergo	  conformational	  change	  that	  has	  both	  physiological	  and	  pathological	  importance.	  However	   the	   ability	   to	   probe	   the	   folding	   process	   (and	   indeed	   other	   structural	  and	  dynamic	  behaviour)	  for	  serpins	  in	  solution	  is	  not	  trivial.	  Specific	  difficulties	  arise	   due	   to	   the	   range	   of	   conformational	   pathways	   and	   dynamic	   equilibria	  accessible	   to	   the	   fold	   in	   cell	   free	   systems.	   	   Polymerisation,	   and	   subsequent	   or	  parallel	   aggregation	   events	   that	   are	   less	   specific,	   present	   a	   clear	   challenge	   for	  data	  analysis,	  particularly	  when	  partially	  denatured	  states	  are	  studied.	  Moreover	  exogenous	  labeling	  techniques	  may	  perturb	  the	  conformational	  dynamics	  of	  the	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polypeptide	  chain	   in	  solution.	  There	   is	   therefore	  a	  need	  to	  develop	  approaches	  that	  inform	  upon	  details	  of	  serpin	  solution	  behaviour	  without	  perturbing	  it,	  and	  where	   polymerisation	   events	   can	   be	   accounted	   for.	   In	   normal	   serpin	   folding,	  serpins	  are	  believed	  to	  rapidly	  move	  to	  a	  key	  folding	  intermediate	  to	  attain	  their	  native	   state81;	   82;	   83.	   A	   number	   of	   studies	   have	   indicated	   that	   serpin	   folding	  intermediates	   have	   the	   ability	   to	   aggregate84,	   it	   is	   therefore	   important	   for	   the	  polypeptide	  to	  rapidly	  transition	  to	  a	  native	  state.	  Bottomley	  et	  al.	  81;	   82;	   83	  have	  undertaken	  a	  number	  of	  serpin	  folding	  studies	  using	  increasing	  concentration	  of	  denaturant	  measured	   using	   far-­‐UV	   CD83	   81.	   These	   data	   indicate	   that	   there	   are	  three	  species	  present	  during	  unfolding:	  the	  native	  (N),	  the	  unfolded	  (U)	  as	  well	  as	   an	   intermediate	   species	   (I)85;	   86.	   Refolding	   experiments	   showed	   an	   almost-­‐fully	   reversible	   process	   (≤90%	   recovery)87.	   The	   percentage	   of	   recovery	   was	  dependant	   on	   the	   time	   of	   incubation	   in	   high	   denaturant	   conditions.	   Together,	  these	   studies	   indicate	   that	   for	   α1-­‐antitrypsin	   the	   intermediate	   ensemble	   is	  formed	   in	   approximately	   around	  1.5	  M	   guanidine	   hydrochloride83,	   and	   around	  4.0	  M	  urea81.	   Tryptophan	  mutagenesis	   and	   fluorescence	   studies	   indicated	   that,	  during	   urea-­‐induced	   unfolding,	   dynamic	   changes	   occurred	   around	   β-­‐sheet	   A	  consistent	  with	  its	  expansion	  in	  the	  intermediate	  state	  88.	  More	  limited	  structural	  change	  was	   observed	   from	   a	   typtophan	   residue	   reporting	   on	   the	   environment	  around	  β-­‐sheet	  B	  with	  evidence	  of	  some	  residual	  secondary	  structure	  even	  at	  8.0	  M	   urea.	   	   Kinetic	   studies	   of	   wild-­‐type	   α1-­‐antitrypsin	   in	   urea	   have	   further	  supported	   the	   involvement	  of	  2	  kinetic	   intermediates	  along	   the	  polymerisation	  pathway	  (I1	  and	  I2)89.	  I1	  corresponded	  to	  an	  intermediate	  identified	  by	  Bruch	  et	  al.	   85;	   86.	   However,	   since	   I2	  was	   identified	   on	   the	   basis	   of	   tryptophan	   emission	  maxima	  data,	  it	  is	  important	  to	  mention	  that	  this	  technique	  may	  not	  be	  a	  robust	  quantitative	  assay	  89.	  	  	   Mass	   Spectrometry	   (MS)-­‐based	  methods	  have	  been	  developed	   in	   recent	  years,	  providing	  useful	  insights	  into	  native	  solution	  state	  behaviour	  and	  folding	  of	   serpins	   90;	   91;	   92;	   93.	   One	   such	   method	   is	   Hydrogen	   Deuterium	   exchange	  (HDXMS).	  The	  resolution	  of	  HDXMS	  data	  is	  limited	  by	  the	  lengths	  of	  the	  peptide	  products	   of	   enzymatic	   treatment	   that	   can	   be	   analysed.	  However,	   these	   studies	  have	   provided	   useful	   insights	   into	   folding	   and	   native	   state	   behaviour	   of	   α1-­‐
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antitrypsin	  in	  solution.	  HDXMS	  was	  used	  to	  monitor	  region-­‐specific	  folding	  of	  α1-­‐antitrypsin94.	  Where	  a	  key	  region	  in	  metastable	  to	  stable	  transition,	  β-­‐sheet	  5	  A,	  shows	  protection	  upon	  folding,	  in	  contrast	  to	  the	  B-­‐C	  barrel	  remains	  unchanged.	  The	   incorporation	   of	   the	   C-­‐terminal	   residues	   into	   β-­‐sheets	   B	   and	   C	   is	   largely	  complete	   before	   the	   center	   of	   β-­‐sheet	   A	   begins	   to	   fold.	   Furthermore,	   findings	  from	   HDXMS	   of	   native	   α1-­‐antitrypsin	   showed	   a	   highly	   dynamic	   F-­‐helix,	  particularly	  at	  its	  C-­‐terminal	  end92.	  In	  contrast,	  strands	  3	  and	  5	  of	  the	  β-­‐sheet	  A,	  which	  must	  separate	   to	  allow	   insertion	  of	   the	  RCL,	  during	  both	  polymerisation	  and	  enzyme	   inhibition,	  were	  highly	   stable.	   Strand	  1C	   (s1C),	  which	  anchors	   the	  distal	   end	  of	   the	  RCL	   is	   also	   stable,	  while	   strand	  6	  of	   the	  β-­‐sheet	  A	  was	  highly	  flexible.	  Overall,	  data	  from	  HDXMS	  experiments	  on	  the	  folding	  of	  the	  native	  state	  demonstrated	  differences	  in	  the	  folding	  kinetics	  of	  different	  regions,	  particularly	  in	  key	  regions	  in	  the	  metastable	  to	  stable	  transition,	  β-­‐sheet	  A,	  with	  a	  lag	  phase	  of	   350s.	   The	   ‘B-­‐C	   barrel’	   regions	   shows	   no	   lag	   phase,	   and	   data	   shows	   the	  incorporation	   of	   the	   C-­‐terminal	   residues	   into	   the	   β-­‐sheet	   C	   and	   C	   is	   achieved	  before	   strands	   3	   and	   5	   of	   β-­‐sheet	   A	   begins	   to	   fold.	   This	   was	   proposed	   as	   the	  mechanism	   that	   holds	   α1-­‐antitrypsin	   in	   its	  metastable	   state,	   by	   avoiding	  more	  stable	  polymeric	  conformations.	  	  
1.2.5.	  Serpin	  polymerisation	  	   In	   1992,	   Lomas	   and	   colleagues	   made	   the	   crucial	   discovery	   that	   serpin	  polymerisation	  in	  the	  endoplasmic	  reticulum	  of	  liver	  cells	  most	  likely	  formed	  the	  basis	   of	   α1-­‐antitrypsin	   deficiency95.	   Stabilising	   conformational	   change	   can	   also	  result	   in	   the	   formation	   of	   serpin	   polymers.	   Polymerisation	   appears	   to	   be	   a	  central	  event	  in	  the	  disease	  mechanisms	  of	  the	  serpinopathies54;	  96.	  A	  key	  goal	  of	  research	   into	   these	   conditions	   is	   therefore	   to	   understand	   its	   structural	   basis,	  since	  this	  will	  imply	  a	  range	  of	  potential	  therapeutic	  targets.	  However,	  although	  many	  insights	  have	  been	  gained,	  the	  precise	  mechanism	  of	  serpin	  polymerisation	  that	  causes	  disease	  remains	  contentious	  with	  a	  variety	  of	  intermolecular	  linkage	  mechanisms	  proposed	  77;	  97;	  98;	  99.	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   Even	   though	   a	   lot	   of	   controversy	   remains	   around	   the	   polymerisation	  mechanism,	   a	   number	   of	   physical	   characteristics	   were	   specific	   to	   serpin	  polymerisation.	   An	   S-­‐R	   transition	   is	   observed	   from	   the	   native	   state	   with	  concomitant	   loss	   of	   functional	   activity100.	   Serpin	   polymers	   are	   generally	  analyzed	   using	   non-­‐denaturing	   gel	   electrophoresis,	   and	   are	   characterized	   by	  ladders	  of	  oligomeric	  bands101.	  Using	  electron	  microscopy,	  polymers	  have	  been	  observed	   as	   ‘bead-­‐like’	   morphology,	   with	   substantial	   flexibility	   between	  subunits102.	   Polymerisation	   is	   concentration-­‐dependent,	   and	   can	   be	   induced	   in	  
vitro	   from	   the	   native	   state	   by	   heat,	   and	   chemical	   dentaurants	   (e.g.	   urea,	  guanidine,	  low	  pH)	  and	  RCL	  cleavage	  between	  residues	  preceding	  the	  RCL103.	  	  
1.2.5.1.	  Polymerisation	  induced	  by	  loop	  cleavage	  or	  peptide	  insertion	  	   The	  ability	  of	  inhibitory	  serpins	  to	  polymerise	  upon	  RCL	  cleavage	  by	  non-­‐cognate	  proteases	  N-­‐terminal	  to	  the	  P1-­‐P1’	  bond	  (e.g.	  near	  P8)	  was	  first	  observed	  over	   two	   decades	   ago104.	   Subsequently,	   crystal	   structures	   of	   such	   so-­‐called	  cleaved	  polymers	  were	  solved	  105;	   106.	   Intramolecular	   insertion	  of	   the	  truncated	  s4A	   β-­‐strand	   was	   complemented	   at	   the	   lower	   s4A	   site	   by	   insertion	   of	   the	  corresponding	   residues	   extending	   from	   the	   N-­‐terminal	   end	   of	   strand	   s1C	   in	   a	  neighbouring	  molecule	  (Fig.1.10.).	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Figure	  1.10.	  	   Cleaved	   α1-­antitrypsin	   polymers	   at	   atomic	   resolution.	   A	   wealth	   of	  biochemical	   and	   biophysical	   data	   suggests	   that	   α1-­‐antitrypsin	   polymers	   form	  via	   insertion	   of	   residues	   from	   the	   RCL	   of	   one	  molecule	   into	   the	   beta-­‐sheet	   of	  another.	   However,	   this	   long-­‐standing	   hypothesis	   has	   not	   been	   confirmed	   by	  direct	  structural	  evidence.	  Here	  is	  illustrated	  the	  first	  crystallographic	  evidence	  of	   a	   β-­‐strand	   linked	   polymer	   form	  of	   α1-­‐antitrypsin:	   the	   crystal	   structure	   of	   a	  cleaved	  α1-­‐antitrypsin	  polymer	  (PDB:	  1	  QMB).	  
	   These	   data	   were	   further	   supported	   by	   experiments	   with	   RCL	   analogue	  peptides	  of	  different	  lengths107.	  Fitton	  et	  al.	  demonstrated	  that	  incubation	  of	  the	  serpin	   antithrombin	   with	   large	   excess	   of	   P14-­‐P9	   exogenous	   peptide	   induced	  polymerisation.	  Conversely	  when	  peptides	  containing	  sequences	  corresponding	  to	  P8-­‐P3	  residues	  were	  used	  instead,	  polymerisation	  was	  blocked.	  This	  led	  to	  the	  first	   hypothesis	   that	   intact	   loop-­‐sheet	   polymers	   could	   form	   through	  intermolecular	   insertion	   of	   the	   P8-­‐P3	   site	   into	   the	   β-­‐sheet	   A95.	   Subsequently	   a	  crystal	   structure	   of	   the	   ternary	   complex	   of	   antithrombin	  with	   polymerisation-­‐inducing	  and	  blocking	  peptides	  was	  solved	  (PDB:	  1	  JVQ).	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Together	  these	  data	  were	  therefore	  interpreted	  to	  support	  the	  hypothesis	  that	  partial	  intramolecular	  RCL	  insertion	  can	  also	  promote	  polymerisation	  when	  induced	   by	   disease	   mutations	   rather	   than	   protease	   activity	   or	   equivalent	  peptides104;95.	  
1.2.5.2.	  Three	  models	  of	  polymerisation	  proposed	   for	  disease	  mechanism	  
and	  intermediate	  formation	  	  	   Developments	   over	   the	   time	   of	   these	   PhD	   studies	   mean	   that	   currently	  three	  models	  of	  serpin	  polymerisation	  are	  supported	  in	  the	  literature,	  based	  on	  high	   resolution	   snapshots	   obtained	  using	  X-­‐ray	   crystallography	   108;109;110;111;112.	  The	  longest	  established	  model	  (Fig.1.11.)	  can	  be	  termed	  the	  classical,	  loop-­‐sheet,	  or	  single-­‐strand	  model.	  It	  arises	  from	  the	  studies	  of	  cleaved	  and	  peptide-­‐induced	  polymers.	  It	  is	  apparently	  strongly	  supported	  by	  the	  structure	  of	  the	  δ	  conformer	  of	   α1-­‐antichymotrypsin	   since	   this	   was	   identified	   in	   a	   deficiency	   variant	  (Leu55Pro)	  that	  simultaneously	  favoured	  latent	  and	  polymeric	  states.	   	  Here,	  an	  unstable	   intermediate	   species	   is	   populated	   that	   is	   characterised	   by	   β-­‐sheet	   A	  expansion	   and	   partial	   intramolecular	   RCL	   insertion.	   Intermolecular	   linkage	  between	  subunits	  therefore	  occurs	  via	  the	  insertion	  of	  the	  RCL	  of	  one	  constituent	  subunit	  as	  a	  central	  strand	  within	  the	  β-­‐sheet	  A	  of	  its	  neighbour	  in	  the	  polymer	  chain.	   This	   model	   was	   most	   recently	   supported	   by	   studies	   of	   the	   effects	   of	  substitution	  of	  Asp	  residues	  into	  the	  reactive	  loop	  upon	  the	  polymerisation	  of	  α1-­‐antitrypsin113.	  These	  showed	  that	  the	  presence	  of	  the	  charged	  Asp	  residues	  at	  P4	  and	  P6	   impeded	  polymerisation	  at	   the	   intermolecular	   linkage	  step.	   	   In	  contrast,	  mutation	  at	  P8	  and	  P10	  instead	  impaired	  intermediate	  formation.	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Figure	  1.11.	  	   Ribbon	  diagram	  of	   first	  model	  of	  polymerisation	  of	  α1-­antitrypsin.	  Model	   of	   polymerisation	   in	   which	   conformational	   change	   from	   the	   native	  conformation	  (A)	  involves	  the	  insertion	  of	  the	  RCL	  of	  the	  target	  proteinase	  as	  an	  extra	  strand	  into	  β-­‐sheet	  A	  (blue)	  similar	  to	  what	   is	  observed	  in	  the	   inhibition	  mechanism,	   and	   inactivation	   of	   the	   catalytic	   triad	   of	   the	   protease.	   Point	  mutations	   subvert	   this	   mechanism	   and	   cause	   aberrant	   conformational	  transitions	  (B)	  and	  the	  formation	  of	  polymers	  (C	  and	  D).	  96	  
	   A	   second	  model	  was	   proposed	   in	   2008,	   based	   on	   the	   study	   on	   a	   closed	  dimer	  of	  antithrombin	  under	  low	  pH	  and	  low	  salt	  conditions	  114.	  This	  new	  model	  demonstrated	  an	  intermolecular	  β-­‐hairpin	  swap	  involving	  the	  RCL	  and	  strand	  5	  of	  β-­‐sheet	  A	  (s5A)	  comprising	  50	  residues,	  rather	  than	  single	  β-­‐strand	  insertion.	  This	  polymerisation	  mechanism	  caused	  expansion	  of	  β-­‐sheet	  A	  to	  allow	  insertion	  of	  the	  β-­‐hairpin	  of	  a	  neighbouring	  molecule	  (Fig.1.12.).	  This	  study	  suggested	  that	  if	  considerably	  more	  structure	  is	  unfolded	  relative	  to	  the	  native	  fold	  (helix	  I	  and	  linker	  to	  s5A),	  an	  extended	  polymer	  could	  be	  propagated.	  This	  crystal	  structure	  of	  an	  intact	  serpin	  dimer	  put	  forward	  the	  idea	  that	  much	  larger	  “domain	  swaps”	  are	   possible	   and	   would	   also	   lead	   to	   hyperstable	   linkage	   between	   serpins	  monomers.	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Figure	  1.12.	  	   Ribbon	   diagram	   of	   second	   model	   of	   polymerisation	   of	   α1-­antitrypsin.	  Model	   of	   polymerisation	   in	   which	   conformational	   change	   from	   the	   native	  conformation	   involve	   the	   insertion	  of	   the	  RCL	  of	   the	   target	  proteinase	  and	  the	  strand	  3	  of	  the	  β-­‐sheet	  A	  as	  a	  β-­‐hairpin	  on	  a	  closed	  dimer	  of	  antithrombin114.	  
	   More	   recently	   still	   a	   third	   model	   of	   polymerisation	   has	   been	   proposed	  (Fig.1.13).	  This	  is	  based	  on	  the	  crystal	  structure	  of	  a	  closed	  trimeric	  form	  of	  α1-­‐antitrypsin.	   	   This	   is	   recognized	   by	   the	   2C1	  monoclonal	   antibody	   that	   has	   high	  conformational	   specificity	   for	   and	   between	   α1-­‐antitrypsin	   polymers.	   	   This	  recognizes	   polymers	   observed	   in	   disease	   or	   when	   formed	   by	   heating,	   but	   not	  those	   formed	  under	   the	   conditions	   in	  which	   the	   data	   supporting	   the	  β-­‐hairpin	  model	  were	  collected.	  The	  new	  structure	  revealed	  a	  polymeric	  linkage	  mediated	  by	  domain	  swapping	  of	  the	  C-­‐terminal	  34	  residues	  spanning	  β-­‐strands	  s1C,	  s4B	  and	   s5B115.	   	   In	   this	   mechanism,	   the	   stabilized	   expansion	   of	   β-­‐sheet	   A	   that	  characterizes	  S-­‐R	  transitions	  occurs	  by	  full	  intramolecular	  insertion	  of	  the	  RCL.	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Figure	  1.13.	  	   Ribbon	   diagram	   of	   the	   third	   model	   of	   polymerisation	   of	   α1-­
antitrypsin.	  The	  unfolded	   state	   (U)	  misfolds	   to	   an	   intermediate	   (I)	   in	  which	  the	   RCL	   (red)	   is	   fully	   inserted	   as	   the	   fourth	   strand	   of	   β-­‐sheet	   A,	   and	   the	   C-­‐terminal	  elements	  strands	  1C	  and	  4	  and	  5B,	  (green).	  This	  can	  attain	  the	  global	  free-­‐energy	  minimum	  by	   forming	   polymers	   (P)	   via	   a	   C-­‐terminal	   domain-­‐swap	  mechanism	  as	  seen	   in	   the	  crystal	  structure	  of	  a	  self-­‐terminating	  α1-­‐antitrypsin	  trimer.	  	  
	   The	   different	   polymerisation	   models	   share	   some	   conceptual	   and	  structural	   features,	   but	   must	   proceed	   through	   distinct	   intermediate	   states.	  Moreover,	  since	  all	  the	  models	  of	  polymerisation	  involve	  formation	  of	  relatively	  unfolded	   intermediate	   states,	   it	   is	   crucial	   to	   understand	   the	   structure	   of	   those	  folding	  transitions	  to	  elucidate	  the	  polymerisation	  process.	  It	  becomes	  clear	   that	  despite	   their	  potential	   importance	   to	  develop	  new	  therapeutic	  strategies,	  data	  available	  about	  the	  structure	  and	  the	  dynamics	  of	  the	  one	   or	   more	   intermediate	   state(s)	   along	   the	   folding	   pathway	   is	   limited,	   and	  unclear.	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1.3.	  NMR	  spectroscopy	  in	  studying	  protein	  folding	  
1.3.1.	  General	  principles	  of	  NMR	  	   Nuclear	  Magnetic	  Resonance	  or	  NMR	  was	  first	  described	  and	  measured	  in	  molecular	   beams	   by	   Isidor	   Rabi	   in	   1938	   (awarded	   Nobel	   Prize	   in	   Physics	  1944)116.	  	  Over	  the	  next	  50	  years,	  NMR	  has	  developed	  into	  a	  powerful	  technique	  providing	  detailed	  atomic	  information	  in	  solution	  and	  is	  now	  a	  major	  method	  for	  studying	  biomacromolecules	  in	  solution.	  Providing	  high-­‐resolution	  structure	  and	  dynamics.	  The	  application	  of	  NMR	  to	  biomolecules	  was	  pioneered	  by	  Wüthrich	  et	  
al.	  117;	  118	  (awarded	  a	  Nobel	  Prize	  in	  Chemistry	  2002).	  The	   phenomenon	   of	   NMR	   occurs	   when	   nuclei	   of	   specific	   atoms	   are	  immersed	   into	   a	   static	   magnetic	   field	   and	   exposed	   to	   a	   second	   oscillating	  magnetic	   field.	   Nuclei	   that	   possess	   that	   property	   termed	   ‘spin’	  will	   experience	  respond	  by	  demonstrating	  a	  phenomenon	  known	  as	  the	  Larmor	  precession.	  The	  general	   term	   of	   precession	   can	   be	   defined	   as	   a	   change	   of	   orientation	   of	   the	  rotating	  axis	  of	  the	  rotating	  body.	  It	  can	  be	  defined	  as	  a	  change	  in	  the	  first	  Euler	  angle,	  leading	  to	  the	  rotation	  of	  a	  body	  that	  rotates	  itself	  around	  another	  axis.	  In	  physics,	   there	   are	   two	   types	   of	   precession:	   torque-­‐free	   and	   torque-­‐induced.	  Using	  NMR,	  the	  Larmor	  precession	  of	  the	  nuclear	  spins	  occurs	  under	  a	  magnetic	  field	  that	  exerts	  a	  torque	  on	  the	  magnetic	  moment.	  	  	   	   	   	   	   	   Equation	  1.5.	  
Where	   	   is	  the	  torque,	   is	  the	  magnetic	  dipole	  moment,	   is	  the	  angular	  
momentum	   vector,	   	   is	   the	   external	   magnetic	   field,	   symbolises	   the	   cross	  
product,	  and	  γ	  is	  the	  gyromagnetic	  moment.	  	  
	  The	   magnetic	   property	   specific	   to	   each	   spin	   can	   be	   utilized	   to	   yield	  chemical	   information.	   In	   quantum	  mechanical	   terms,	   the	   Larmor	   frequency	   or	  the	  precession	  rate	  (ω)	  of	  the	  nuclear	  magnetic	  moment	  of	  a	  nucleus	  is	  aligned	  with	   or	   against	   an	   externally	   applied	   magnetic	   field	   of	   magnitude	   B,	   and	   is	  function	  of	  the	  gyromagnetic	  ratio:	  γ,	  by	  the	  relation:	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  ω	  =	  	  -­‐	  γ	  B	   	   	   	   	   	   Equation	  1.6.	  Each	  nucleus	  has	  a	  characteristic	  γ	  value	  that	   is	  defined	  as	  a	  constant	  of	  proportionality	  between	  the	  nuclear	  angular	  momentum	  and	  magnetic	  moment.	  Precession	  of	  a	  spin	  generates	  an	  electric	  field	  with	  ω	  frequency.	  Since	  γ	  relates	  the	   magnetic	   moment	   μ	   and	   the	   spin	   number	   I	   for	   a	   specific	   nucleus,	   the	  rotational	  axis	  of	  the	  precessing	  spin	  is	  characterized	  by:	  	  	  γ	  =	  2πμ/ħI	  	   	   	   	   	   	   Equation	  1.7.	  
Where	  μ	  is	  the	  magnetic	  dipole	  moment,	  ħ	  is	  the	  reduced	  Planck	  constant	  or	  
Dirac	  constant	  and	  corresponds	  to	  ħ	  =	  h/2π,	  I	  is	  the	  spin	  number.	  	  The	  gyromagnetic	  ratio	  also	  corresponds	  to:	  	  	   γ	  =	  -­‐eg/2m	  	   	   	   	   	   	   Equation	  1.8.	  
Where	  e	  is	  the	  charge,	  g	  is	  the	  g-­factor,	  and	  m	  is	  the	  mass.	  	  	  Therefore	  the	  Larmor	  frequency	  becomes:	  	  	  	   ω	  =	  egB/2m	   	   	   	   	   	   Equation	  1.9.	  
Where	  ω	  is	  the	  Larmor	  frequency,	  m	  is	  the	  mass,	  e	  is	  the	  charge,	  and	  B	  is	  the	  
applied	  magnetic	  field.	  	  	  	  By	  irradiating	  the	  protein	  sample	  with	  radio	  waves	  (in	  the	  MHz	  frequency	  range),	   the	   proton	   will	   absorb	   the	   energy	   and	   progress	   to	   a	   less	   favourable	  energy	  state.	   	  Electromagnetic	   radiation	   is	   re-­‐emitted	  as	   it	   returns	   to	   the	  more	  favourable	  state.	  The	  observed	  resonance	  relates	  to	  the	  tendency	  of	  the	  nucleus	  to	   switch	   energy	   states,	   the	   frequencies	   of	   the	   applied	   radiation	   and	   the	  precession.	   The	   specific	   resonance	   frequency	   is	   therefore	   a	   function	   of	   the	  strength	  of	  the	  applied	  magnetic	  field	  and	  the	  magnetic	  proprieties	  of	  the	  isotope	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of	  the	  atoms	  being	  observed.	  In	  NMR	  experiments,	  the	  electromagnetic	  radiation	  applied	  must	   be	   of	   the	   correct	   frequency	   to	   allow	   resonant	   absorption	   by	   the	  nuclear	   spin,	   equal	   to	   the	   Larmor	   precession	   rate),	   to	   match	   the	   energy	  difference	   between	   nuclear	   spin	   level	   in	   a	   constant	   magnetic	   field	   of	   the	  appropriate	  strength.	  	  The	  absorbing	  photon	  has	  energy	  equal	  to:	  	  	  E	  =	  	  hν0	   	   	   	   	   	   Equation	  1.10.	  Where	   h	   is	   the	   Planck	   constant	   and	   ν0	   corresponds	   to	   the	   resonance	  radiofrequency	  (equivalent	  to	  Larmor	  precession	  frequency).	  	  	  Therefore,	  the	  magnetic	  resonance	  absorption	  will	  occur	  only	  when	  	  	  ΔE=	  	  hν0	  	   	   	   	   	   	   Equation	  1.11.	  
when	  ν0	  =	  γB0/(2π)	  	  	  The	  NMR	  properties	  of	  a	  nucleus,	  such	  as	  the	  energy	  difference	  between	  the	  orientations	  and	  therefore	  the	  frequency,	  at	  which	  a	  residue	  absorbs	  energy,	  also	   depends	   strongly	   upon	   its	   chemical	   environment.	   Therefore,	   different	  atomic	   nuclei	   within	   a	   molecule	   resonate	   at	   different	   frequencies	   for	   similar	  given	  magnetic	   field.	   Magnetic	   nuclei	   are	   also	   affected	   by	   each	   other,	   through	  chemical	   bonds	   or	   via	   their	   spatial	   distance.	   This	   scalar	   and	   dipolar	   coupling,	  respectively,	   can	   be	   used	   to	   assign	   resonances	   to	   a	   specific	   nuclei	   within	   the	  structure,	  and	  can	  be	  used	  to	  derive	  constraints	  for	  their	  separating	  distance	  and	  orientation.	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1.3.2.	  Study	  of	  protein	  structure	  and	  dynamics	  using	  NMR	  
spectroscopy	  	  	   NMR	   study	   can	   provide	   a	   detailed	   understanding	   of	   the	   structure	   of	  proteins	  in	  solution,	  permitting	  the	  study	  of	  intermediate	  species	  in	  solution119;	  120;	  121;	  122,	  it	  can	  also	  provide	  information	  about	  the	  folding	  of	  a	  protein119;	  123;	  124	  in	   a	   residue-­‐specific	   manner.	   Structural	   data	   describing	   intermediate	   state(s)	  along	   a	   folding	   pathway	   are	   limited	   through	   the	   intensive	   studies	   required	   to	  obtain	   relevant	   information	   but	   nonetheless	   several	   intermediate	   states	   have	  been	   reasonably	   well	   characterized125;	   126;	   127.	   Such	   understanding	   of	   the	  structural	  properties	  of	  key	  intermediates	  is	   likely	  to	  be	  increasingly	  important	  in	  the	  development	  of	  target	  structures	  for	  therapeutic	  interventions.	  Using	  NMR	  spectroscopy,	   three	   complementary	   strategies	   can	   be	   applicable	   for	   obtaining	  structural	   information	   about	   intermediate	   species.	   The	   first	   involves	  characterization	  of	   species	  generated	   transiently	  during	  refolding	  of	  denatured	  proteins,	  either	  in	  real	  time	  or	  by	  means	  of	  trapping	  experiments119.	  The	  second	  involves	   the	   study	   of	   those	   partially	   folded	   states,	   such	   as	   the	   increasingly	  recognized	   molten	   globule	   state29,	   which	   are	   stable	   under	   equilibrium	  conditions.	  The	  third	  strategy	  involves	  the	  design	  and	  study	  of	  models	  of	  folding	  intermediates.	   Important	   key	   NMR	   experiments	   in	   such	   studies128	   are	  	  measurements	  of	   dynamics	  parameters,	   in	  particular	   relaxation	  measurements	  and	  modern	  derivatives	   such	   as	  dispersion	  measurements,	   and	   also	  hydrogen-­‐deuterium	  exchange	  (HDXNMR)	  experiments.	  HDXNMR	  was	  a	  major	  part	  of	  the	  work	  undertaken	  in	  this	  study	  and	  is	  described	  further	  below.	  	  As	  for	  relaxation	  experiments,	  these	  are	  briefly	  introduced	  in	  the	  Appendix	  A.	  	  HDXNMR	   provides	   a	   key	   route	   to	   understanding	   protein	   stability,	  dynamics,	  global	  and	  sub-­‐global	  fluctuations,	  and	  towards	  the	  characterization	  of	  intermediate	   states.	   Lysozyme	   is	   probably	   the	   best	   studied	   example	   using	   this	  method	   and	   due	   to	   early	   knowledge	   of	   its	   amino-­‐acid	   sequence	   and	   three-­‐dimensional	  structure,	   it	  became	  a	  central	  model	  molecule	   for	   in	  vitro	   study	  of	  the	   folding	   of	   secondary	   and	   tertiary	   structural	   element.	   The	  work	   of	   Dobson	  and	  colleagues129	  on	   lysozyme	  using	  HDXNMR	  (details	  are	  explored	   in	  Chapter	  IV),	  was	   a	  major	   breakthrough	   for	   the	   structural	   study	   of	   intermediate	   states.	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The	  study	  allowed	  identification	  of	  hydrogen-­‐bonding	  patterns	  in	  early	  transient	  folding	   intermediates.	   The	   pattern	   of	   amide	   protection	   within	   the	   different	  helices	  of	  the	  lysozyme	  was	  found	  to	  vary	  significantly.	  These	  studies,	  combined	  with	  mass	   spectrometry	   studies,	   revealed	   the	   transient	   unfolding	   of	   the	   alpha	  domain	  of	  lysozyme	  as	  a	  key	  intermediate	  in	  the	  misfolding	  of	  lysozyme.	  	  
1.3.3.	  NMR	  studies	  of	  high	  molecular	  weight	  proteins	  	  	   Traditionally,	   NMR	   studies	  were	   restricted	   to	   those	   involving	   relatively	  small	  systems	  (ranging	  from	  10	  to	  30	  kDa	  in	  size).	  This	  range,	  is	  one	  where	  the	  majority	  of	   resonances	   can	  be	  observed	  by	  NMR	  and	   this	   ‘limitation’	   is	  mainly	  caused	  by	  the	  relaxation	  processes,	  which	  are	  mediated	  by	  bipolar	   interactions	  and	  chemical	  shift	  anisotropy130.	  These	  are	  highly	  dependent	  on	  the	  size	  of	   the	  proteins	   being	   under	   study;	   rates	   will	   increase	   accordingly	   to	   the	   size	   of	   the	  protein	  rendering	  the	  study	  of	  large	  molecular	  weight	  proteins	  using	  NMR	  highly	  challenging	   process.	   However,	   with	   recent	   developments	   in	   the	   NMR	  methodology,	   structure	   determination	   and	   dynamics	   studies	   have	   now	   been	  rendered	   feasible	   for	   molecules	   of	   large	   molecular	   weight.	   Indeed,	   the	  introduction	   of	   Transverse	   Relaxation-­‐Optimized	   Spectroscopy	   (TROSY)131,	  Residual	   Dipolar	   Coupling131	   (RDC)	   and	   labeling	   strategies132	   has	   opened	   new	  avenues	  for	  NMR	  of	  high	  molecular	  weight	  complexes.	  During	  NMR	  experiments,	  the	  relaxation	  of	  the	  magnetization	  is	  characterized	  by	  a	  loss	  of	  NMR	  signal,	  the	  main	   factor	   responsible	   for	   this	   is	   the	   transverse	   relaxation128.	   The	   rapid	  transverse	   relaxation	   rate	   (R2,	   characterized	   by	   the	   time	   constant	   T2)	   and	  consequent	  loss	  of	  signal	  induced	  with	  increasing	  molecular	  weight	  increases	  in	  proportion	   to	   the	   mass	   of	   the	   molecule.	   This	   is	   due	   to	   the	   increasingly	   slow	  tumbling	  time,	  characterized	  by	  the	  rotational	  correlation	  time	  (τc)	  of	   the	   large	  molecules132.	  The	  T2	  is	  inversely	  proportional	  to	  the	  molecular	  tumbling	  time:	  	  	  τc	  =	  1/T2	   	   	   	   	   	   Equation	  1.12.	  	  The	  slower	  the	  tumbling	  time	  the	  broader	  the	  linewidth	  characterized	  by	  a	   loss	   of	   signal	   lifetime.	   Therefore,	   improving	   the	   linewidth	   of	   the	   observed	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signal	   is	  crucial	  to	  obtaining	  the	  necessary	  improved	  sensitivity.	   	  The	  linewidth	  of	  the	  observed	  frequency	  is	  characterized	  by	  Δν1/2	  and	  depends	  on	  the	  ability	  of	  the	  excited	  spin	  to	  relax	  through	  T2	  mechanisms.	  The	  slower	  the	  relaxation,	  the	  sharper	  the	  linewidth	  of	  the	  observed	  frequency,	  characterized	  by	  the	  relation:	  	  	  Δν1/2	  =	  1/(π.T2).	  	   	   	   	   	   Equation	  1.13.	  	  As	  a	  result	  of	  fast	  relaxation	  induced	  by	  large	  molecular	  weight	  molecules,	  the	   Free	   Induction	   Decay	   (FID)	   loses	   in	   resolution	   of	   the	   observed	   frequency	  after	   Fourier	   transformation.	   	   This	   increase	   in	   linewidth	   has	   very	   important	  consequences	  for	  high	  resolution	  NMR.	  It	  can	  lead	  to	  insolvable	  overlap	  issues,	  a	  significant	   loss	   in	   the	   signal	   to	   noise	   ratio.	   Implementation	   of	   a	   relaxation	  optimized131	  element	   in	   the	  pulse	  sequence	  during	  the	  time	  course	  of	   the	  NMR	  experiment133	   has	   been	   developed	   to	   reduce	   the	   extent	   of	   loss	   of	   signal.	  Furthermore,	   labelling	   strategies	   also	   participate	   in	   alleviating	   the	   signal	   loss;	  using	   highly	   deuterated	   background	   and	   selective	   1H,	   15N	   and	   13C	   labelled	  residues	   in	  an	  otherwise	   14N,	   12C	  unlabeled	  background	  reduces	   the	  significant	  dipolar	   coupling	   arising	   from	   the	   high	   density	   of	   protonation	   within	   a	  polypeptide	   chain.	   This	   strategy	   therefore	   allows	   suppression	   of	   a	   significant	  contribution	   of	   the	   transverse	   relaxation	   from	   dipole-­‐dipole	   interactions	   and	  scalar	  coupling.	   	  These	  developments,	  termed	  Transverse	  Relaxation	  Optimized	  Spectroscopy	   (TROSY)	   131;	   134	   and	   the	   methyl	   analogue,	   the	   methyl-­‐TROSY	  HMQC135	  type	  of	  experiments	  have	  opened	  avenues	  to	  study	  biomolecules	  with	  large	  molecular	  masses.	  TROSY-­‐based	  spectroscopy	  is	  optimal	  for	  observation	  of	  the	   13C	  methyl	  groups	  because	  of	   the	   increase	   in	   the	   recorded	   intensity,	  which	  arises	  from	  three	  equivalent	  protons,	  and	  the	  higher	  mobility	  of	  the	  side-­‐chains	  compared	  to	  the	  backbone.	  Selective	  13C,	  1H	  labelling	  of	  methyl	  groups	  in	  a	  12C,2H	  background	   can	   be	   realized	   by	   using	   labeled-­‐leucine,	   isoleucine,	   and	   valine	  precursors.	   Astonishing	   examples	   of	   structural	   and	   dynamical	   NMR	   studies	   of	  high	   molecular	   weight	   biological	   system	   are	   studies	   of	   the	   670	   kDa	   20S	  proteasome	  of	  the	  GroEL-­‐ES	  and	  of	  the	  SecA	  machinery	  by	  Kay	  and	  colleagues136.	  This	   strategy,	   helped	   preserving	   the	   resulting	   NMR	   signal	   lifetime,	   revealing	  functionally	   important	   motions	   and	   interactions137.	   These	   studies	   provided	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detailed	   insight	   to	   the	   possible	   use	   of	   NMR	   to	   investigate	   aspects	   of	   supra-­‐molecular	   structures	   over	   an	   order	   of	   magnitude	   larger	   than	   those	   routinely	  studied	  using	  methodology	  that	  is	  generally	  applicable.	  	  	  
1.3.3.1.	  HSQC	  
	   Heteronuclear	   Single	   Quantum	   Coherence	   (HSQC)	   or	   Heteronuclear	  Single	   Quantum	   Correlation	   experiments	   are	   frequently	   used	   in	   NMR	  spectroscopy	   for	   the	   study	   of	   large	   molecular	   weight	   proteins.	   These	  experiments	   result	   in	   a	   two-­‐dimensional	   spectrum	   with	   one	   1H	   axis	   and	   the	  other	  heteronucleus	  axis	  corresponding	  to	  the	  isotope	  used	  for	  the	  experiments,	  generally	  13C	  or	  15N.	  It	  is	  designed	  to	  involve	  the	  transfer	  of	  magnetization	  on	  the	  proton	  to	  the	  second	  nucleus	  via	  an	  INEPT	  function	  (Insensitive	  Nuclei	  Enhanced	  by	  Polarization	  Transfer).	  A	  time	  delay	  (t1)	  is	  applied	  before	  the	  magnetization	  is	  transferred	   back	   to	   the	   proton,	   through	   a	   so-­‐called	   retro-­‐INEPT	   process.	  Following	   these	   steps	   the	   signal	   will	   be	   detected	   in	   the	   direct	   dimension	   for	  protons	  and	  indirect	  dimension	  for	  15N	  or	  13C.	  This	  technique	  increases	  the	  signal	  to	  noise	  ratio	  by	  the	  use	  of	  inverse	  NMR	  experiments	  in	  which	  the	  magnetization	  is	  transferred	  from	  protons	  to	  the	  hetero	  nucleus	  (Fig.1.14.).	  	  
	  
Figure	  1.14.	  	   Standard	  HSQC	  Heteronuclear	  Single	  Quantum	  Correlation	  pulse	  
sequence.	   The	   overall	   pulse	   sequence	   can	   be	   summarised	   as	   follows:	  INEPT	  +	   echo	  +	   INEPT.	  The	   first	   INEPT	   is	   to	   improve	   the	   sensitivity	   of	   the	  low	   magnetogyric	   ratio	   nuclei	   (15N,	   13C).	   During	   echo,	   t1,	   the	   coupling	   is	  refocused.	  The	  retro-­‐INEPT	  is	  to	  perform	  inverse	  detection.	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1.3.3.2.	  TROSY	  
	   TROSY	   or	   Transverse	   Relaxation	   Optimized	   spectroscopy	   has	   been	  designed	   to	   be	   particularly	   suitable	   to	   large	   molecular	   weight	   proteins.	   As	  described	  using	  the	  equation	  1.12,	  the	  transverse	  relaxation	  (t2)	  time	  is	  directly	  proportionate	  to	  the	  tumbling	  time	  itself	  directly	  proportionate	  to	  the	  size	  of	  the	  protein.	   Therefore	   the	   larger	   the	   protein	   the	   greater	   the	   decay	   of	   NMR	   signal	  leading	   to	   line	   broadening,	   and	   a	   poor	   resolution.	   Typically	   a	   1H-­‐15N-­‐HSQC	  experiment	  is	  run	  with	  decoupling,	  the	  splitting	  of	  the	  resonant	  peak	  is	  removed	  during	   the	   pulse	   sequence.	   This	   results	   in	   a	   single	   peak	   that	   is	   the	   average	  chemical	   shift	   of	   the	   four	   in	   the	   multiplet.	   Each	   of	   the	   different	   multiplet	  components	  have	  different	  width,	  due	  to	  various	  interactions	  between	  relaxation	  mechanisms,	   hence	   relaxing	   at	   different	   rates.	   The	   TROSY	   pulse	   sequence	   is	  designed	  to	  select	  the	  multiplet	  component	  for	  which	  the	  relaxation	  mechanisms	  have	  almost	  cancelled	  each	  other	  out,	  leading	  to	  a	  single,	  sharp	  peak.	  For	  a	  large	  molecular	   weight	   protein	   this	   has	   the	   advantage	   of	   both	   increasing	   the	  sensitivity	   (sharp	   peaks)	   and	   the	   resolution	   (allowing	   to	   alleviate	   overlapping	  peaks	   issues	   occurring	   with	   large	  molecular	   weight	   proteins).	   Compared	  with	  the	   HSQC	   sequence	   illustrated	   in	   Fig.1.14.	   TROSY	   pulse	   sequence	   is	   lacking	   a	  180°	   pulse	   applied	   to	   the	   proton	   during	   t1	   phase,	   furthermore,	   it	   lacks	   the	  decoupling	  of	  the	  15N	  nucleus.	  This	  leads	  to	  detection	  of	  a	  multiplet	  separated	  by	  JHN	  (J-­‐coupling).	  The	  spectra	  are	  subsequently	  simplified	  by	  suppression	  of	  all	  but	  the	  wanted	  peak.	  	  	  
1.3.3.3.	  SOFAST-­HMQC	  
	   Two-­‐dimensional	   1H-­‐15N	   band-­‐selective	   optimized-­‐flip-­‐angle	   short-­‐transient	  (SOFAST)-­‐heteronuclear	  multiple-­‐quantum	  (HMQC)	  NMR	  experiments	  are	  optimized	  to	  allow	  fast	  and	  sensitive	  data	  collection.	  Their	  main	  component	  is	  the	  use	  of	  a	  shaped	  1H	  pulse	  that	  manipulates	  only	  a	  subset	  of	  proton	  spins	  in	  order	  to	  enhance	  the	  spin-­‐lattice	  relaxation	  (T1)	  via	  dipolar	  interactions	  with	  the	  unperturbed	  proton	  spins	  (Fig.1.15).	   	  The	  second	  important	  feature	  of	  SOFAST-­‐HMQC	   experiments	   is	   the	   use	   of	   Ernst	   angle	   excitation	   to	   achieve	   maximal	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sensitivity	   allowing	   high	   repetition	   of	   the	   pulse	   sequence.	   The	   recycle	   delay	   is	  therefore	  generally	  reduced	  to	  a	  few	  milliseconds	  and	  the	  flip	  angle	  adjusted	  to	  allow	  the	  highest	  overall	  sensitivity.	  SOFAST-­‐HMQC	  experiments	  are	  particularly	  useful	  for	  real-­‐time	  experiments	  such	  as	  HDXNMR	  (described	  in	  Chapter	  IV)	  as	  it	  allows	  to	  significantly	  increase	  the	  sensitivity	  and	  fast	  repetition	  rates.	  	  
	  
	  
Figure	  1.15.	  	   Standard	   SOFAST-­HMQC	   pulse	   sequence.	   1H–X	   (X	   =	   13C	   or	   15N)	  correlation	   spectra.	   Filled	   and	   open	   pulse	   symbols	   indicate	   90"	   and	   180"	   rf	  pulses,	  except	  for	  the	  1H	  excitation	  pulse	  applied	  with	  flip	  angle	  α.	  The	  variable-­‐flip-­‐angle	  pulse	  has	  a	  polychromatic	  PC9	  shape	  and	  band-­‐selective	  1H	  refocusing	  is	   realized	   using	   either	   REBURP	   or	   r-­‐SNOB.	   The	   transfer	   delay	   Δ	   is	   set	   to	  1/(2JHX),	  and	  there	  is	  a	  recycle	  delay	  between	  scans.	  The	  delay	  d	  accounts	  for	  spin	   evolution	   during	   the	   PC9	   pulse,	   and	   has	   to	   be	   adjusted	   prior	   to	   data	  acquisition	  to	  yield	  pure-­‐phase	  spectra	  in	  the	  1H	  dimension.	  To	  avoid	  extensive	  first	   order	   phase	   corrections	   in	   the	   t1	   dimension	   of	   experiments,	   for	   t1	   delays	  shorter	   than	   the	  REBURP	  pulse	   length	   the	  90"–t1–90"	  pulse	   sequence	  element	  on	   the	   15N	   channel	   is	   applied	   simultaneously	   to	   the	   REBURP	   pulse	   on	   the	   1H	  channel.	  Figure	  adapted	  from	  the	  work	  of	  Schanda	  et	  al.138.	   	  
1.3.4.	  Introduction	  to	  NMR	  of	  α1-­antitrypsin	  	  	   While,	   as	   discussed	   the	   application	   of	   NMR	   to	   large	   systems	   is	   now	  becoming	  more	  widespread,	  it	  still	  remains	  challenging	  to	  apply	  NMR	  on	  an	  all-­‐residue	   basis	   to	   globular	   proteins	   as	   large	   as	   serpins	   (45	   kDa).	   However,	   the	  successful	   assignment	   of	   the	   NMR	   spectrum,	   when	   combined	   with	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complementary	   high-­‐resolution	   X-­‐ray	   crystallography	   data,	   has	   provided	   a	  powerful	  tool	  for	  structural	  and	  dynamical	  studies	  of	  serpins	  folding,	  misfolding,	  and	  polymerisation,	  as	  well	  as	  enabling	  drug	  binding	  studies.	  The	  first	  study	  of	  serpins	   using	  NMR	   spectroscopy	  was	   undertaken	   by	  Gettins	   and	   colleagues139.	  Using	   two-­‐dimensional	   heteronuclear	   single	   quantum	   correlation	   2D	   NMR	  spectra	  of	   serpins	   combined	  with	   specifically	   15N-­‐labelled	  alanine	   residues,	   the	  vastly	  simplified	  resulting	  2D	  spectrum	  showed	  low	  resonance	  overlapping,	  and	  led	   to	   the	   assignment	   of	   a	   few	   of	   the	   observed	   resonances139.	   	   Recently,	   the	  assignment	   of	   the	   backbone	   resonances	   of	   the	   full-­‐length	   wild-­‐type	   α1-­‐antitrypsin	  using	  multidimensional	   heteronuclear	  NMR	  methods,	  was	   achieved	  within	  our	  group140.	  This	  is	  one	  of	  the	  largest	  globular	  proteins	  assigned	  to	  date	  (Fig.1.16.).	  This	  (close	  to)	  complete	  backbone	  assignment	  provided	  the	  starting	  point	   for	   a	   detailed	   solution	   state	   characterization	   of	   α1-­‐antitrypsin	   under	   a	  range	   of	   conditions	   to	   explore	   structure,	   dynamics,	   aggregation	   and	   binding	  interactions	  of	  the	  protein.	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Figure	  1.16.	  	   1H,	   15N	  and	   13C	  backbone	  resonance	  assignments	  of	   the	  archetypal	  
serpin	  α1-­antitrypsin	  A-­‐	  15N-­‐TROSY-­‐HSQC	  spectrum	  of	  refolded	  [2H,15N,13C]	  α1-­‐antitrypsin	  at	  298K	  and	  800	  MHz,	  with	  the	  corresponding	  backbone	  chemical	  shifts	  assignment.	  The	  1H	  chemical	  shift	  (ppm)	  data	  are	  plotted	  on	  the	  x-­‐axis.	  15N	  chemical	  shift	  data	  (ppm)	  on	  the	  y-­‐axis;	  B-­‐	  Where	  the	  highly	  overlapped	  central	  region	  is	  enlarged140.	  	  
1.3.5.	  Multiple	  timescales	  allow	  structural	  and	  dynamical	  behaviour	  
to	  be	  characterized	  	   Using	   the	  power	  of	  NMR	   to	  provide	  dynamic	   information	  across	   a	  wide	  range	  of	  timescale	  enables	  the	  study	  of	  fundamental	  processes	  and	  has	  provided	  major	   insight	   into	  how	   living	   systems	  operate	   at	   the	   atomic	   level141;	   142;	   143.	  As	  described	   in	   1.3.1,	   a	   typical	   NMR	   experiment	   monitors	   signals	   from	   many	  reporters	  within	  a	  molecule,	  providing	  comprehensive	  view	  of	  internal	  motions	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with	   atomic	   resolution.	   These	   motions	   vary	   across	   various	   timescales	   as	  illustrated	   alongside	   the	   range	   of	   NMR	   techniques	   available	   to	   measure	   these	  motions.	  Indeed,	  all	  the	  nuclei	  within	  the	  molecule	  can	  act	  as	  hidden	  observers	  of	  the	   conformational	   fluctuation	   that	   accompany	  biological	   activity.	  A	  number	  of	  recent	   NMR	   techniques	   have	   been	   developed	   to	   quantify	   motions	   within	   a	  molecule.	  These	  can	  take	  place	  within	  a	  wide	  range	  of	  timescale	  from	  the	  ps,	  to	  days	  as	  illustrated	  in	  figure	  1.17.	  	  
	  
Figure	  1.17.	  	  	   NMR	  techniques	  to	  measure	  conformational	  fluctuations	  on	  a	  range	  
of	   timescales.	   A	   number	   of	   recent	  NMR	   techniques	   have	   been	  developed	   to	  quantify	  motions	  within	  a	  molecule.	  These,	  can	  take	  place	  within	  a	  wide	  range	  of	  timescale	   from	  the	  ps,	   to	  days,	  where	   the	   fast	  motions	  can	  be	  measured	  using	  Relaxation	  T1,	  T2,	  heteronuclear	  NOE	  (ps-­‐ns),	  and	  slower	  motions	  (ms-­‐s)	  can	  be	  measured	  by	  hydrogen	  deuterium	  exchange	  (HDXNMR)	  experiments.	  	  
	   Generally	  divided	  in	  two	  regimes,	  the	  slower	  timescale	  dynamics	  (μs-­‐ms),	  are	   particularly	   useful	   to	   characterise	   a	   two-­‐state	   process	   (e.g.	   open-­‐closed	  conformation	  of	  a	  protein,	  folded/unfolded).	  These	  NMR	  techniques	  can	  measure	  exchange	   rates	   (kinetics),	   populations	   (thermodynamics)	   and	   chemical	   shifts	  (structural	   information)	   as	   illustrated	   in	   figure	   1.18.	   To	   enumerate	   them,	  lineshape	   analysis,	   ZZ-­‐exchange	   (multidimensional	   NMR	   chemical	   shift	  correlation	   experiments	   used	   to	   measure	   the	   kinetics	   of	   interconversion	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between	   different	   molecular	   states.	   Its	   pulse	   sequence	   contains	   an	   additional	  mixing	   delay	   between	   the	   indirect	   and	   direct	   detection	   periods)	   and	   HD-­‐exchange	  methods	  are	  mostly	  used	  for	  monitoring	  slow	  timescale	  motions.	  The	  mechanisms	   underlying	   hydrogen-­‐deuterium	   exchange	   technique	   will	   be	  described	  in	  further	  detail	  in	  Chapter	  IV.	  
	  
Figure	  1.18.	  	  	   Slow	  timescale	  NMR	  dynamics	  experiments	  allow	  measurement	  of	  a	   two-­
state	   transition	   process	   The	   slower	   timescale	   dynamics	   (μs-­‐ms),	   requires	  chemical	  shift	  difference,	  and	  are	  particularly	  useful	  to	  characterize	  a	  two-­‐states	  process	   A	   and	   B	   (e.g.	   open-­‐closed	   conformation.	   These	   NMR	   techniques	   can	  measure	   exchange	   rates	   (kinetics)	   by	   the	   relation	   kex	   =	   kBA	   +	   kAB,	   populations	  (thermodynamics)	  by	  measure	  of	  the	  ∆G=‐RTlnKeq.	  
	   Exchange	   processes	  may	   result	   from	   conformational	   flexibility,	   chemical	  reactions,	   and	   formation	   of	   intermolecular	   complexes.	   It	   has	   important	  consequences	   for	   both	   the	   appearance	   of	   the	   spectra	   and	   consequently	   the	  information	  that	  can	  be	  derived	  from	  it.	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Figure	  1.19.	  	  	   NMR	   spectra	   for	   a	   pair	   of	   nuclei	   exchanging	   between	   two	   states	  
with	  equal	  population.	  For	  the	  simplest	  situation	  where	  A	  and	  B	  are	   inter-­‐converting	  forms	  of	  a	  molecule,	  the	  timescale	  of	  exchange	  (τ)	  can	  be	  measured	  using	   the	   equation	   illustrated.	   Δν	   represents	   the	   difference	   in	   frequency	   (Hz)	  between	  the	  two	  peaks.	  The	  exchange	  is	  fast	  when	  the	  rate	  of	  interconversion	  is	  slow	  (k1	  and	  k-­‐1	  are	  small	  compared	  to	  Δν),	  inversely	  it	  is	  fast	  when	  the	  rate	  of	  interconversion	   is	   fast.	   In	  between	  where	   the	   two	   limits	  overlap	   is	  considered	  an	  area	  of	  intermediate	  exchange.	  	  	   NMR	  spectral	  reports	  of	  exchange	  between	  two	  intermolecular	  complexes	  are	  a	  function	  of	  the	  timescale.	  	  This	  is	  characterised	  by	  the	  Δν	  (representing	  the	  difference	   in	   frequency	   (Hz)	   between	   the	   two	   states	   ν(A)	   and	   ν(B))	   and	   the	  timescale	  of	  exchange	  as	  illustrated	  in	  fig	  1.19.	  Slow	  exchange	  is	  characterised	  by	  kex	  <<	  ν(A)	  –	  ν(B)	  (where	  k1	  and	  k-­‐1	  are	  small	  compared	  to	  the	  frequency	  difference)	  and	   the	  presence	  of	   two	  sharp	  peaks	  on	   the	  NMR	  spectra,	   representative	  of	   the	  two	   states.	   Fast	   exchange	   is	   characterised	   by	   kex	   >>	   ν(A)	   –	   ν(B)	   as	   well	   as	   the	  presence	  of	  a	  single	  sharp	  peak	  equidistant	   from	  the	   two	  signals	  observed	   for	  a	  slow	  exchange	  defined	  as	  follow:	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δobs	  =	  αδA	  +	  (1	  -­‐	  α)	  δB	  	   	   	   	   Equation	  1.14.	  	  
Where	  the	  δobs	  is	  the	  chemical	  shift	  observed	  for	  fast	  exchange,	  δA	  and	  δB	  are	  
the	   chemical	   shifts	   of	   the	   two	   species	   inter-­converting	  observed	  at	   slow	  exchange,	  
and	  α is the fractional population of species A for the equilibrium.	  In	   between	   where	   the	   two	   limits	   overlap	   is	   an	   area	   of	   intermediate	  exchange	  characterised	  by	  line	  broadening	  where	  kex	  ~	  ν(A)	  –	  ν(B).	  	  In	   the	   absence	   of	   any	   coupling	   and	   at	   coalescence	   conditions	   (Fig.1.19.),	  the	  first-­‐order	  inter-­‐conversion	  rate	  constant	  can	  be	  calculated	  as	  followed:	  	  kTC=	  π	  (Δν/√2)	   	   	   	   	   Equation	  1.15.	  
Where	  kTC	   is	   the	  rate	  constant	   (in	   s-­1),	  Tc	   is	   the	  coalesence	   temperature	   (in	  
Kelvin),	  and	  Δν	  is	  the	  difference	  in	  chemical	  shift	  between	  (in	  Hz)	  of	  the	  two	  signals	  
without	  exchange.	  	  
	  
	  This	   thesis	   puts	   forward	   a	   strategy	   for	   the	   use	   of	   Nuclear	   Magnetic	  Resonance	  spectroscopy	   together	  with	  complementary	  biophysical	  methods,	   to	  unveil	   processes	   of	   folding,	  misfolding	   and	   polymerisation	   of	   α1-­‐antitrypsin	   in	  unprecedented	  detail.	  These	  processes	  underlie	  function	  and	  dysfunction	  in	  the	  serpin	  superfamily	  of	  proteins.	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2.1	  Materials	  	  
2.1.1	  Regents	  
	   All	   reagents	   were	   obtained	   from	   Sigma	   Chemical	   Company	   (St.	   Louis,	  USA),	   New	   England	   Biolabs	   (Ipswich,	   MA,	   USA),	   Fisher	   Scientific	   UK	   Ltd	   or	  Stratagene	   (California,	   USA),	   unless	   otherwise	   stated.	   BL-­‐21-­‐Gold	   (DE3)	  
Escherichia	   coli	   (E.	   coli)	   were	   obtained	   from	   Stratagene	   (California,	   USA).	  Primers	   for	   the	   mutagenesis	   experiments	   were	   synthesized	   by	   Operon	  (Huntsville,	  USA).	  Luria	  broth	  was	  made	  up	  from	  LB	  broth	  granules	  from	  Merck	  KGaA	  (Germany).	  Proteinase	  inhibitor	  tablets	  were	  obtained	  from	  Hoffmann-­‐La	  Roche	   ltd	   (Burgess	   Hill,	   UK).	   Snakeskin	   pleated	   dialysis	   membrane	   10	   kDa	  molecular	   weight	   cut-­‐off	   was	   obtained	   from	   Perbio	   Science	   UK	   Ltd.	  (Northumberland,	  UK),	  and	  5	  kDa	  molecular	  weight	  cut-­‐off	  Vivaspin	  filter	  units	  were	   from	   Viva	   Science	   (Stonehouse,	   UK).	   SDS-­‐PAGE	   pre-­‐casted	   gels	   were	  provided	   by	   Invitrogen	   (Paisley,	   UK).	   Benchmark	   protein	   molecular	   weight	  markers	  were	  obtained	  from	  Invitrogen	  (Paisley,	  UK).	  Plasmid	  purification	  was	  carried	  using	  a	  Qiagen	  Miniprep	  kit	  (Manchester,	  USA).	  Polyacrylamide	  gels	  were	  stained	   using	   InstantBlue	   Ultra	   fast	   protein	   stain	   (Paisley,	   UK)	   or	   Novexin	  InstantBlue	  Ultra	  fast	  protein	  stain	  (Cambridge,	  UK).	  D2O	  and	  DSS	  (4,4-­‐dimethyl-­‐4-­‐silapentane-­‐1-­‐sulfonic	  acid)	  were	  supplied	  from	  Sigma	  chemical	  company	  (St.	  Louis,	   USA).	   For	   mass	   spectrometry	   experiments,	   buffer	   exchange	   was	  performed	  using	  mini	  gel	  filtration	  columns	  (California,	  USA).	  	  	  
2.1.2	  Instruments	  	  
2.1.2.1.	  Cell	  purification	  and	  characterization	  
	   The	  sonicator	  was	  supplied	  by	  Sonic	  Vibracell	  (Newtown,	  USA).	  Cell	  lysis	  was	  performed	  using	  the	  Thermo	  Electron	  French	  Cell	  Press	   instrument	  model	  FA078,	   from	   Thermo	   Fisher	   Scientific	   Inc.	   (Asheville,	   USA).	   Chromatography	  columns	  and	  Akta	  Prime	  system	  were	  obtained	  from	  GE	  Healthcare	  Biosciences	  AB	   (Uppsala,	   Sweden).	   SDS-­‐PAGE	   running	   apparatus	   was	   obtained	   from	  Invitrogen	  (Paisley,	  UK).	  The	  Native-­‐PAGE	  running	  apparatus	  was	  obtained	  from	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Bio-­‐Rad	  Laboratories,	  Inc.	  (Hercules,	  CA,	  USA).	  The	  Transverse	  Urea	  Gel	  (TUG)-­‐PAGE	   were	   performed	   using	   a	   Bio-­‐Rad	   Mini-­‐protean	   II	   apparatus,	   Bio-­‐Rad	  Laboratories,	  Inc	  (Hercules,	  CA,	  USA).	  	  	  
2.1.2.2.	  Circular	  Dichroism	  
	   The	   62DS	   Circular	   Dichroism	   (CD)	   spectrometer	   was	   supplied	   by	   AVIV	  (Lakewood,	  USA).	  0.1	  mm	  pathlength	  quartz	  cuvette	  was	  supplied	  from	  Hellma	  UK	  Ltd	  (GB-­‐Southend-­‐on-­‐Sea,	  UK).	  Urea	  titration	  data	  were	  recorded	  on	  a	  JASCO	  J-­‐810	  Circular	  Dichroism	  (CD)	  spectropolarimeter,	  Jasco	  Inc.	  (Easton,	  MD,	  USA);	  Cambridge	  Institute	  for	  Medical	  Research	  facility	  (CIMR).	  	  	  
2.1.2.3.	  Nuclear	  Magnetic	  Resonance	  (NMR)	  Spectroscopy	  	  
	   NMR	   spectra	   for	   α1-­‐antitrypsin	   were	   recorded	   using	   spectrometers	  operating	   at	   1H	   frequencies	   of	   700MHz	   (Bruker	   Avance	   III	   equipped	   with	   4	  channels	   and	   deuterium	   decoupling	   and	   a	   5	   mm	   1H,13C,15N	   cryo-­‐probe	   with	  cooled	   1H	   and	   13C	   pre-­‐amplifiers;	   UCL	   Biomolecular	   NMR	   Centre	   and	   MRC	  biomedical	  NMR	  Centre,	  UK);	  600MHz	  (Varian	   Inova	  equipped	  with	  4	  channels	  and	   a	   5	   mm	   1H,13C,15N	   coldprobe	   with	   a	   cooled	   1H	   pre-­‐amplifier;	   UCL	  Biomolecular	  NMR	  Centre,	  UK);	  and	  900	  MHz	  (Bruker	  Avance	  III	  equipped	  with	  4	   channels	   and	   deuterium	   decoupling	   and	   a	   5	  mm	   1H,13C,15N	   cryo-­‐probe	  with	  cooled	  1H	  and	  13C	  pre-­‐amplifiers;	  Lille	  Pasteur	  Institute	  NMR	  centre,	  France).	  To	  minimize	   the	   sample	   requirements,	   Shigemi	   tubes	   were	   used	   (Optimized	  Shigemi	   Tube	   for	   D2O	   5mm)	   provided	   by	   Bruker	   (Coventry,	   UK).	   Data	   were	  processed	  using	  NMRpipe144,	  CCPN145	  and	  Sparky	  software146.	  	  
	  
2.1.2.4.	  Mass	  Spectrometry	  (MS)	  
	   Nanomate	   Robot	   Triversa	   for	   automated	   sample	   loading	   was	   obtained	  from	  Advion	   	   (New	  York,	  USA).	   Ions	  were	  generated	  by	  nanoflow	  electrospray	  ionization	   and	   spectra	   acquired	   on	   an	   LCT	   Premier	   XE	   mass	   Spectrometer	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Synapt	   HDMS	   by	  waters	   UK	   Ltd	   (Manchester,	   UK),	   quadrupole-­‐TWIMS-­‐oa-­‐ToF	  Mass	   Spectrometer,	  Wolfram	   Inc.	   (Oxfordshire,	   UK).	   	   The	  Mathematica	   scripts	  used	  in	  the	  analysis	  are	  available	  at: 	  http://people.cryst.bbk.ac.uk/~ubcg66a/software/MSDimer.	  	  Mass	   Spectrometry	   (MS)	   data	   were	   processed	   using	   Masslynx	   4.1	   software	  Waters	  Corporation	  (Milford,	  USA).	  
	  
2.2	  Methods	  
2.2.1	  Protein	  recombinant	  expression	  in	  Escherichia	  coli	  (E.	  coli)	  and	  
purification	  	  
	   The	  production	  of	  recombinant	  proteins	  is	  a	  critical	  avenue	  for	  the	  many	  structural	  biology	  research	  that	  require	  working	  with	  relatively	  large	  quantities	  of	   purified	   proteins.	   Escherichia	   coli	   represents	   the	   most	   commonly	   used	  prokaryotic	   organism	   for	   protein	   expression.	   It	   represents	   a	   powerful	   tool	   for	  affordable,	   rapid	   and	   abundant	   protein	   expression,	   for	   which	   genetics	   is	   well	  established	  and	  can	  be	  manipulated	  exhaustively.	  α1-­‐antitrypsin	  possesses	  very	  few	  basic	  post-­‐translational	  modifications,	  which	  makes	  them	  typically	  amenable	  to	   prokaryotic	   expression.	   It	   is	   glycosylated	   within	   the	   plasma,	   however	   its	  glycosylation	  has	  not	  been	  found	  to	  be	  critical	  to	  its	  function	  or	  structure87.	  The	  single	  cysteine	  residue	  in	  position	  232	  was	  found	  to	  form	  a	  disulfide	  bond	  with	  free	   cysteine147	   but	   isn’t	   involved	   in	   disulfide	   bonding	   within	   the	   protein.	  Therefore,	   producing	   recombinant	   proteins	   using	   E.	   coli,	   is	   a	   great	   tool	   for	  structural	   biology	   investigation,	   and	   furthermore,	   allows	   the	   incorporation	   of	  specifically	   selected	   isotope	   labels	   required	   for	   designed	   solution	   state	   NMR	  experiments.	  	  	  
2.2.1.1.	  Plasmid	  constructs	  	  
	   The	  pTermat	  expression	  vector	  system	  (pET)	  is	  the	  most	  powerful	  system	  yet	  developed	  for	  the	  cloning	  and	  expressions	  of	  recombinant	  proteins	  in	  E	  coli.	  Target	  genes	  are	  cloned	  in	  pET	  plasmids	  under	  control	  of	  strong	  bacteriophage	  
	   58	  
T7	  transcription	  and	  translation	  signals;	  the	  expression	  is	  induced	  by	  providing	  a	  source	   of	   T7	   RNA	   polymerase	   in	   the	   host	   cell.	   The	   T7	   RNA	   polymerase	   is	   so	  selective	   and	   active	   that	   once	   induced,	   almost	   all	   of	   the	   cells	   resources	   are	  dedicated	   to	   gene	   expression.	   For	   mutagenesis	   and	   recombinant	   protein	  expression	   purposes,	   a	   soluble	   pQE	   expression	   system:	   pQE-­‐31	   plasmid	   was	  used	   as	   the	   vector	   encoding	   hexahistidine-­‐tagged	   recombinant	   wild-­‐type	   α1-­‐antitrypsin	   cDNA.	   This	   plasmid	   contains	   both	   an	   antibiotic	   resistance	   to	  ampicillin	   (for	   selection	   of	   transfected	   cells)	   and	   a	   T7	   promoter.	   The	   latter	  enables	   induction	   of	   protein	   expression	   by	   Isopropyl	   β-­‐D-­‐1-­‐thiogalactopyranoside	   (IPTG).	   The	   α1-­‐antitrypsin	   cDNA	   constructs	   also	  contained	   an	  N-­‐terminal	   hexa-­‐histidine	   tag,	   to	   aid	   purification	   or	   recombinant	  protein	  using	  a	  Nickel	  (Ni)-­‐sepharose	  chromatography	  column.	  	  	  For	   Polymerase	   chain	   reaction	   (PCR)	   amplification	   purposes	   the	  following	  coding	  and	  reverse	  primers	  were	  used	  made	  to	  a	  stock	  solution	  of	  10	  
µM;	   	  Forward	  primer:	  
ATCTTCTTTAAAGGCAAATGAGAGAGACCCTTTGAAGTCAAGGACACC	  
	  Reverse	  primer:	  
GGTGTCCTTGACTTCAAAAGGGTCTCTCTCATTTGCCTTTAAAGAAGAT	  	  
	  PCR	  mixture	  were	  set	  up	  as	  follows	  1.25	  µl	  each	  of	   forward	  and	  reverse	  primer	  stocks,	  10x	  pfu	  buffer	  (2	  mM),	  dNTP	  mix	  (0.5	  mM),	  Pfu	  turbo	  (0.05	  U/µl),	  plasmid	  template	  pQE-­‐31	  (2	  ng/µl),	  dH20	  to	  a	  final	  volume	  50	  µl.	  	  The	  following	  PCR	  conditions	  were	  used:	  95	  °C	  for	  30	  s,	  then	  16	  cycles	  of	  melting	  (95	  °C	  for	  30	  s)	  annealing	  (55	  °C	  for	  1	  min)	  and	  elongation	  (68	  °C	  for	  10	  min).	  The	  bacterially	  derived	  methylated	  template	  DNA	  was	  then	  digested	  using	  1	   µl	   Dpn-­‐I	   (0.39	   U/µl),	   and	   Hind-­‐III	   and	   run	   onto	   agarose	   gel	   (1x)	   for	   size	  determination.	   Integrity	   of	   the	   α1-­‐antitrypsin	   cDNA	   was	   confirmed	   by	  sequencing.	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2.2.1.2	   Transformation	   of	   BL-­21-­Gold	   E.	   coli	   with	   plasmid	   pQE-­31	  
containing	  α1-­antitrypsin	  cDNA	  
	  BL-­‐21-­‐Gold	   (DE3)	   are	   the	   typical	   system	   used	   for	   over-­‐expression	   of	  serpins	  under	  a	  T7	  promoter	  and	  offer	  the	  advantage	  of	  bypassing	  recombinant	  expression	  issues	  due	  to	  toxicity,	  codon	  bias,	  and	  protease	  sensitivity.	  	  	  100	   µL	   BL-­‐21-­‐Gold	   (DE3)	   E.	   coli,	   pretreated	   by	   swirling	   on	   ice	   for	   10	  minutes	  with	  2	  µl	  of	  β-­‐MercaptoEthanol	  (βME)	  were	  transformed	  with	  2	  µl	  of	  α1-­‐antitrpspin	   cDNA	  contained	  within	  pQE-­‐31	  plasmid.	  The	  mixture	  was	   then	   left	  on	  ice	  for	  30	  minutes	  prior	  to	  delivering	  a	  heat	  shock	  at	  42	  °C	  for	  30	  s.	  Cells	  were	  then	  resuscitated	  for	  2	  minutes	  added	  500	  µl	  of	  LB	  media	  prewarmed	  to	  30	  °C.	  The	   sample	  was	   then	   incubated	   at	   37	   °C/225	   rpm	   for	   1	   hour,	   and	  100	  µl	  was	  plated	  onto	  an	  LB/ampicillin	  plate	  using	  aseptic	   technique.	  The	  remainder	  was	  spun	  at	  6000	  rpm.	  All	  the	  supernatant	  was	  discarded	  apart	  from	  the	  final	  ~100	  µl,	   into	   which	   the	   pellet	   was	   resuspended	   before	   plating	   onto	   a	   second	  LB/ampicillin	  plate.	  Since	  the	  pQE-­‐31	  plasmid	  contains	  an	  ampicillin-­‐resistance	  gene,	   the	   plates	   were	   then	   incubated	   at	   37	   °C	   overnight,	   allowing	   colonies	   of	  successfully	  transformed	  cells	  to	  grow.	  	  	  
2.2.1.3	  Unlabelled	  recombinant	  α1-­antitrypsin	  protein	  production	  	  
	  A	   colony	   of	   BL-­‐21-­‐Gold	   E.	   coli	   containing	   plasmid	   coding	   for	   α1-­‐antitrypsin	  was	  picked	  from	  an	  agar/ampicillin	  plate	  and	  grown	  in	  50	  ml	  starter	  culture	  of	  2xTY	  (15	  g	  casein	  peptone,	  10	  g	  yeast	  extract	  and	  5	  g	  sodium	  chloride,	  per	  liter)	  and	  100	  µg/ml	  ampicillin	  at	  37	  °C	  /	  225	  rpm	  overnight.	  10	  ml	  of	  this	  culture	  was	  inoculated	  into	  750	  ml	  of	  2xTY	  and	  100	  µg/ml	  ampicillin	  at	  37	  °C	  /	  225	   rpm	   for	   3	   hours.	   The	   cells	   growth	  was	  measured	   by	   photometric	   Optical	  Density	  (OD)	  at	  600	  nm	  wavelength	  (OD600).	  When	  the	  OD600	  reached	  the	  range	  0.6-­‐0.7	   nm,	   the	   protein	   expression	   was	   induced	   by	   adding	   IPTG	   to	   a	   final	  concentration	  of	  1	  mM.	  The	  incubation	  was	  continued	  for	  another	  4	  hours	  at	  30	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°C.	   Then	   the	   cells	   were	   pelleted	   at	   6,000	   rpm	   for	   15	  minutes.	   The	   pellet	   was	  snap-­‐frozen	   in	   liquid	   nitrogen	   and	   stored	   at	   -­‐80	   °C	   until	   required	   for	   protein	  purification.	  	  
2.2.1.4	  Uniform	   incorporation	  of	   15N-­	  and	   13C-­15N-­2H-­	   isotopic	   labeling	   for	  
NMR	  	  
	  For	   the	   production	   of	   uniformly	   isotopically	   labeled	   α1-­‐antitrypsin,	   the	  protein	  was	  produced	  in	  conditions	  where	  the	  only	  source	  of	  nitrogen	  +/-­‐	  carbon	  contained	  them	  exclusively	  in	  those	  isotopic	  forms.	  This	  is	  achieved	  by	  growing	  cells	   in	   1x	  M9	  minimal	  media	   (12.8	   g/l	   of	   Na2HPO4,	   3	   g/l	   of	   KH2PO4,	   0.5	   g	   of	  NaCl),	  1	  xM9	  salts	  (1	  mM	  MgSO4,	  50	  µM	  CaCl2),	  1x	  Basal	  Medium	  Eagle	  Vitamin	  Solution	  (Gibco),	  14NH4Cl	  Ammonium	  chloride	  (1	  g/l),	  0.4%	  (w/v)	  D-­‐glucose	  (2	  g/l)	  in	  glass	  distilled,	  autoclaved	  H2O,	  and	  all	  buffers	  were	  0.2	  µ	  filter	  sterilized.	  For	  15N-­‐labeling,	  15NH4Cl	  was	  used;	  while	  for	  15N-­‐13C-­‐2H-­‐	  labeling,	  13C-­‐D7-­‐Glucose	  was	  used	  as	  well,	  and	  all	  growth	  buffers	  were	  made	  up	  in	  100	  %	  D2O.	  A	  colony	  of	  BL-­‐21-­‐Gold	  E.	  coli,	  containing	  plasmid	  coding	  for	  α1-­‐antitrypsin,	  was	  picked	  from	  an	   LB	   agar/ampicillin	   plate,	   and	   grown	   in	   50	   ml	   of	   2xTY	   and	   100	   µg/ml	  ampicillin,	  at	  37	  °C/225	  rpm	  overnight.	  4	  ml	  of	  this	  culture	  was	  inoculated	  into	  200	  ml	  of	  unlabelled	  M9	  Minimal	  Media	  to	  allow	  adaptation	  of	  E.coli	  to	  isotopes	  incorporation.	   After	   6	   hours	   growth,	   each	   15	   ml	   of	   overnight	   growth,	   was	  inoculated	   into	   2	   litres	   flasks	   containing	   500	  ml	   of	   M9	  Minimal	  Media.	   Flasks	  were	  incubated	  at	  37	  °C/225	  rpm.	  The	  cells	  growth	  was	  measured	  at	  OD600	  and	  protein	  expression	  was	  induced	  and	  harvested	  as	  described	  in	  2.2.1.3.	  	  	  
2.2.2	  Purification	  of	  α1-­antitrypsin	  	  
	   The	   harvested	   cell	   pellet	   was	   lysed	   using	   a	   cell	   disruptor.	   To	   prevent	  protein	  degradation,	  one	  pellet	  of	  proteinase	   inhibitor	  was	  added	  per	  50	  ml	  of	  cell	  harvest.	  The	  crude	  lysate	  was	  then	  ultracentrifuged	  at	  18	  k	  rpm,	  during	  30	  min,	   at	   4	   °C;	   and	   the	   supernatant	  was	   loaded	   onto	   a	   2	  ml	   high-­‐affinity	   nickel-­‐sepharose	   column	   that	   had	   been	   recently	   charged	   before	   washing	   to	   baseline	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U.V.	   absorbance	   of	   outflow	  with	   Buffer	   A	   (all	   buffers	   used	   for	   purification	   are	  being	  described	  in	  Table	  2.1).	  	   Nickel-­‐sepharose	  purification	  Buffer	  A	   20	  mM	  Sodium	  phosphate,	  pH	  8.0,	  20	  mM	  imidazole,	  0.05	  M	  NaCl	  Buffer	  B	   20	  mM	  Sodium	  phosphate,	  pH	  8.0,	  200	  mM	  imidazole,	  0.	  05	  M	  NaCl	  Washing	  buffer	   20	  mM	  Sodium	  phosphate,	  pH	  8.0,	  500	  mM	  imidazole,	  0.05	  M	  NaCl	  Charging	  buffer	   0.1	  M	  NiSO4	  Nickel-­‐sepharose	  purification	  Buffer	  A	   10	  mM	  Tris,	  pH	  7.4,	  5	  mM	  EDTA,	  1	  mM	  ßME	  	  Buffer	  B	   10	  mM	  Tris,	  pH	  7.4,	  0.5	  M	  NaCl,	  5	  mM	  EDTA,	  1	  mM	  ßME	  Washing	  buffer	   10	  mM	  Tris,	  pH	  7.4,	  2.5	  M	  NaCl,	  5	  mM	  EDTA,	  1	  mM	  ßME	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Storage	  Protein	  Storage	  buffer	  for	  NMR	  	   25	  mM	  Sodium	  phosphate,	  pH	  8.0,	  50	  mM	  NaCl,	  1	  mM	  EDTA	  
Table	  2.1:	  	   Buffers	  used	  in	  protein	  purification	  (all	  0.22	  µm	  filter	  sterilized)	  	  
	   The	  bound	  protein	  was	  then	  eluted	  using	  a	  20-­‐200	  mM	  (100	  %	  Buffer	  A	  to	  100	  %	  Buffer	  B)	  imidazole	  gradient.	  The	  eluted	  fractions	  were	  monitored	  for	  the	   presence	   of	   protein	   by	  U.V.	   absorbance	   spectrometry	   at	  OD280,	   and	   for	   the	  presence	  of	  protein	  with	  molecular	  weight	  consistent	  for	  α1-­‐antitrypsin	  by	  4-­‐12	  %	  Sodium	  Dodecyl	  Sulphate	  (SDS)	  Polyacrylamide	  Gel	  Electrophoresis	  (PAGE).	  α1-­‐Antitrypsin	   positive	   fractions	   were	   loaded	   onto	   a	   5	   ml	   high	   affinity	   Q-­‐sepharose	   column,	   washing	   to	   baseline	   and	   eluting	   using	   a	   0-­‐0.5	   M	   (100	   %	  Buffer	  A	   to	  100	  %	  Buffer	  B)	  NaCl	  gradient.	  The	  presence	  of	  α1-­‐antitrypsin	  was	  assessed	  by	  4-­‐12	  %	  (w/v)	  SDS-­‐PAGE.	  	   Elution	   fractions	  were	   assessed	   as	   previously	   and	   fractions	   positive	   for	  intact	   α1-­‐antitrypsin	   in	   the	   absence	   of	   co-­‐eluting	   species	  were	   concentrated	   to	  the	  required	  stock	  concentration	  using	  a	  prewashed	  5	  kDa	  molecular	  weight	  cut-­‐off	   Vivaspin	   filter	   membrane.	   The	   protein	   concentration	   was	   calculated	   using	  measurement	   of	   OD280.	   Aliquots	  were	   then	   snap	   frozen	   in	   liquid	   nitrogen	   and	  stored	   at	   -­‐80	   °C.	   	   The	   proteins	   used	   for	  HDXNMR	  were	   lyophilized	   in	   aliquots	  using	  a	  Freeze	  Dryer	  CoolSafe,	  ScanVac	  110-­‐4	  (Yorkshire,	  UK).	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2.2.3	  Biophysical	  and	  biochemical	  characterization	  	  There	  are	  various	  forms	  of	  inactive	  α1-­‐antitrypsin,	  including	  the	  latent,	  cleaved,	  and	  polymers.	  Cleaved	  α1-­‐antitrypsin	  can	  be	  easily	  identified	  by	  Sodium	  Dodecyl	  Sulphate-­‐Polyacrylamide	  Gel	  (SDS-­‐PAGE),	  since	  cleavage	  liberates	  the	  C-­‐terminal	  fragment	  of	  approximately	  4	  KDa.	  Full-­‐length	   inactive	  material	  may	  come	  from	  either	   latency	   or	   polymerisation.	   Since	   the	   α1-­‐antitrypsin	   polymers	   are	   non-­‐covalent	   they	   dissociate	   into	   monomers	   in	   presence	   of	   SDS,	   therefore	   their	  characterisation	  can	  be	  made	  using	  non	  denaturing	  Native-­‐PAGE	  gels.	  The	  latent	  forms,	   although	   inactive,	   adopt	   a	   subtly	   different	   form	   that	   can	   not	   be	  characterised	   by	   SDS-­‐PAGE	   or	   Native-­‐PAGE	   gels.	   The	   most	   accurate	   way	   to	  assess	   α1-­‐antitrypsin	   activity	   is	   to	   undertake	   an	   activity	   assay	   to	   assess	   the	  capability	  of	  α1-­‐antitrypsin	  to	  inhibit	  a	  target	  protease.	  	  
2.2.3.1	  Activity	  Assay	  
	   The	  activity	  was	  calculated	  as	  previously	  described	   148.	  5	  pmol	  of	  active	  bovine	   α-­‐chymotrypsin	   was	   incubated	   with	   increasing	   concentration	   of	   α1-­‐antitrypsin	   (initially	   estimated	   active	   site	   concentration	   of	   0.1	   µM)	   in	   a	   total	  volume	  of	  100	  µl	  reaction	  buffer	  (0.03	  M	  sodium	  phosphate,	  160	  mM	  NaCl,	  0.1	  %	  (w/v)	  PEG	  4000,	  pH	  7.4).	  	  
	  0.1	  μM	  α1-­‐antitrypsin	   1	  μM	  α-­‐chymotrypsin	  (in	  1	  mM	  HCl,	  2	  mM	  CaCl2)	   Reaction	  Buffer	  (as	  described	  above)	  0	  μl	   5	  μl	   95	  μl	  10	  μl	   5	  μl	   85	  μl	  20	  μl	   5	  μl	   75	  μl	  30	  μl	   5	  μl	   65	  μl	  40	  μl	   5	  μl	   55	  μl	  50	  μl	   5	  μl	   45	  μl	  
Table	  2.2:	  	   Buffers	  used	  in	  activity	  assay	  (all	  0.22	  µm	  filter	  sterilized)	  	  	   The	  reaction	  proceeded	  for	  >	  5x	  t1/2	  (i.e.	  >	  10	  min)	  at	  room	  temperature	  and	   the	   residual	   proteolytic	   activity	   of	   chymotrypsin	   was	   determined	   by	  addition	   of	   the	   substrate	   succinyl-­‐L-­‐alanyl-­‐L-­‐alanyl-­‐propanyl-­‐L-­‐phenylalanyl-­‐p-­‐
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nitroanilide	   to	   a	   final	   concentration	   of	   0.1	   mM	   kept	   in	   DMSO.	   The	   change	   of	  OD405	  over	  3	  minutes	  was	  observed.	  Accurate	  active	   site	   concentrations	  were	  obtained	   by	   plotting	   residual	   proteolytic	   activity	   against	   the	   volume	   of	   α1-­‐antitrypsin.	  Since	  the	  inhibitory	  serpin:protease	  complex	  has	  a	  1:1	  stoichiometry	  the	  quantity	  of	  active	  α1-­‐antitrypsin	  was	  deemed	  to	  equal	  5	  pmol	  where	  residual	  proteolytic	  activity	  reached	  zero.	  
2.2.3.2	  Far	  U.V.	  Circular	  Dichroism	  spectroscopy	  	  
	   For	   circular	   dichroism	   (CD)	   spectroscopy,	   samples	   were	   diluted	   to	   3.8	  mg/ml	   (constant	  buffer	   conditions:	  10	  mM	  Tris,	   10	  mM	  NaCl,	   1	  mM	  EDTA,	  pH	  7.4,	  0.2	  µm	  filter	  sterilized)	  and	  50	  µl	  assessed	  in	  a	  0.1	  mm	  or	  100	  µl	  assessed	  in	  a	  0.2	  mm	  pathlength	  quartz	   cuvette.	  Changes	   in	   the	   secondary	   structure	  of	  α1-­‐antitrypsin	   with	   time	   and	   temperature	   were	   measured	   by	   monitoring	   the	   CD	  signal	   at	   222	   nm	  with	   the	   protein	   at	   0.5	  mg/ml	   in	   50	  mM	   phosphate,	   pH	   7.4.	  Thermal	  unfolding	  experiments	  were	  performed	  using	  a	  heating	  rate	  of	  60 °C/h.	  	  The	   urea	   titration	   behaviour	   of	   α1-­‐antitrypsin	   was	   studied	   by	   CD	  spectroscopy	  at	  a	  protein	  concentration	  low	  enough	  to	  minimize	  polymerisation	  effects	  (0.1	  mg/ml,	  2	  µM	  in	  PBS	  pH	  7.5)	  in	  a	  0.1	  mm	  path	  length	  quartz	  cuvette	  at	  20	  °C.	  Spectra	  were	  recorded	  between	  190	  and	  260	  nm	  for	  baseline	  and	  data	  are	  the	  mean	  of	  3	  repeats	  of	  10	  spectral	  accumulation.	  Data	  were	  cropped	  from	  the	  point	  where	  the	  HT	  readings	  exceeded	  twice	  the	  starting	  value.	  	  
2.2.3.3	  Native-­PAGE	  	  
	   7.5%	  (v/v)	  non-­‐denaturing	  PAGE	  was	  used	  to	  assess	  the	  conformational	  homogeneity	  of	   the	  α1-antitrypsin	  samples.	  Separation	  gel	  buffer	  (1.5	  M	  Tris-­‐Cl,	  pH	  8.9)	  and	  stacking	  gel	  buffer	  (0.47	  M	  Tris-­‐Cl	  pH	  6.9)	  were	  used	  to	  prepare	  the	  polyacrylamide	  gel	  as	  follow:	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   Separation	  Gel	   Stacking	  Gel	  30	  %	  (v/v)	  Bis/Acrylamide	  (monomer)	   3.75	  ml	   2.7	  ml	  Separation	  Gel	  Buffer	   3.75	  ml	   -­‐	  Stacking	  Gel	  Buffer	  	   -­‐	   1.6	  ml	  ddH2O	   7.3	  ml	   10.6	  ml	  TEMED	   30	  μl	   25	  μl	  10	  %	  (w/v)	  Ammonium	  persulphate	  (AmPS	  -­‐	  added	  immediately	  before	  casting	  the	  gel)	   60	  μl	  per	  mix	   20	  μl	  per	  2	  ml	  
Table	  2.3:	  	   Buffers	  used	  for	  native-­PAGE	  	  	   Once	  the	  AmPS	  was	  added,	   the	  separation	  gel	  mix	  was	  pipetted	   into	  the	  gap	  between	  the	  gel	  casting	  plate	  at	  about	  ¾	  of	  the	  total	  volume.	  The	  rest	  of	  this	  space	  was	  filled	  with	  70	  %	  ethanol	  and	  left	  on	  the	  bench	  for	  20-­‐30	  min,	  to	  allow	  complete	   polymerisation	   of	   acrylamide.	   Once	   polymerised,	   the	   ethanol	   was	  removed,	   and	   the	   stacking	   gel	   solution	  was	   poured	   before	   inserting	   a	   10	  well	  forming	   comb.	   Once	   this	   had	   set	   samples,	   diluted	   in	   4x	   loading	   buffer,	   were	  loaded	   into	   each	  well.	   	   They	  were	   then	   discontinuously	   electrophoresed	   using	  cathode	  buffer	  (central	  chamber:	  58	  mM	  Tris,	  63	  mM	  glycine	  pH	  8.9)	  and	  anode	  buffer	  (outer	  chamber:	  100	  mM	  Tris,	  pH	  7.8)	  with	  constant	  current	  (mA)	  of	  90V	  until	   the	   loading	  dyefront	  was	  at	   the	  bottom	  of	   the	  gel.	   	  All	  proteins	  were	  then	  visualized	  using	  InstantBlue.	  
2.2.3.4	  Transverse	  Urea	  Gradient-­PAGE	  
	   A	  transverse	  Urea	  Gradient	  (TUG)	  gel	   is	  a	  native	  polyacrylamide	  poured	  gel	   with	   a	   gradient	   of	   urea	   from	   0	   to	   8	   M,	   perpendicular	   to	   the	   direction	   of	  electrophoresis101.	  	  The	  0	  M	  and	  8	  M	  urea	  gel	  mixes	  were	  poured	  between	  glass	  plates	   that	   were	   initially	   rotated	   90	   degrees	   from	   the	   orientation	   used	   for	  electrophoresis,	  using	  a	  mixer	  to	  generate	  a	  gradient	  from	  8	  M	  to	  0	  M	  urea.	  This	  requires	   minor	   modification	   of	   most	   electrophoresis	   apparatus,	   including	  spacers	   to	   fit	   the	   sides	   of	   the	   square	   glass	   plates	   (as	   oriented	   for	   casting)	   and	  bulldog	  clips	  for	  holding	  the	  plates	  in	  this	  orientation.	  1%	  agarose	  solution	  was	  used	  to	  seal	  the	  gel	  to	  avoid	  leakage	  during	  the	  gradient	  process.	  500	  µl	  of	  8	  M	  urea	  gel	  mix	  were	  used	  before	  the	  start	  of	  the	  gradient,	  and	  500	  µl	  of	  0M	  urea	  gel	  mix	  were	  used	  to	  finish.	  Once	  polymerised,	  the	  gel	  was	  rotated	  90	  degrees	  back	  to	  allow	  pouring	  of	  the	  stacking	  solution,	  and	  insertion	  of	  a	  single	  well	  comb	  (0.1	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mm	  thick,	  and	  4	  cm	  wide	  well).	  Samples	  were	  diluted	  in	  4x	  loading	  dye,	  and	  40-­‐50	   µg	   were	   loaded	   into	   the	   stacking	   gel	   and	   discontinuously	   electrophoresed	  using	  cathode	  (upper	  reservoir)	  buffer	  (58	  mM	  Tris,	  63	  mM	  glycine,	  pH	  8.9)	  and	  anode	   (lower	   reservoir)	   buffer	   (bottom	   of	   the	   gel:	   100	  mM	  Tris,	   pH	   7.8)	  with	  constant	  current	  (25	  mA	  per	  gel).	  	  	  	   0	  M	  urea	   8	  M	  urea	  Non-­‐denaturing	  PAGE	  separation	  buffer	  	   12	  ml	   12	  ml	  Acrylamide	  	   11.2	  ml	   11.2	  ml	  Urea	   -­‐	   23	  g	  Water	   To	  final	  volume	  of	  48	  ml	   To	  final	  volume	  of	  48	  ml	  TEMED	   50	  μl	   50	  μl	  10	  %	  (w/v)	  AmPS	   20	  μl	  per	  3.45	  ml	  	   20	  μl	  per	  3.45	  ml	  	  
Table	  2.4:	  	   Buffers	  used	  for	  TUG-­PAGE	  	  
	  
2.2.3.5	  1H	  NMR	  	  
	   1H	   1D	   experiments	   were	   run	   with	   excitation	   sculpting	   for	   water	  suppression,	  with	  an	  acquisition	  time	  of	  50	  ms	  and	  a	  spectral	  width	  of	  11	  ppm.	  The	  number	  of	  scans	  varied	  from	  128	  to	  512	  typically	  with	  a	  recycling	  delay	  of	  1s.	   	  
2.2.3.6	  Native	  Mass	  Spectrometry	  (MS)	  
	  	   	   The	   TWIMS-­‐MS	   experiments	   were	   carried	   out	   on	   a	   Synapt	   High	  Resolution	  Mass	  Spectrometry	  (HRMS)	  quadrupole-­‐Traveling	  Wave	  Ion	  Mobility	  Mass	  Spectrometry	  -­‐	  orthogonal	  acceleration	  –	  Time	  of	  Flight	  (TWIMS-­‐oa-­‐ToF).	  It	  was	  calibrated	  for	  mass:charge	  (m/z)	  ratios,	  using	  33	  µM	  cesium	  iodide	  in	  250	  mM	   ammonium	   acetate.	   3	   µl	   samples	   were	   loaded	   onto	   nano-­‐electrospray	  ionization	  (ESI)	  needles	  made	  in-­‐house,	  using	  a	  previously	  described	  method149.	  Conditions	   were	   optimized,	   samples	   were	   run	   under	   “mobility-­‐time	   of	   flight”	  (MOB-­‐TOF)	  mode,	  and	  spectra	  were	  acquired	  for	  at	  least	  3	  minutes	  (equivalent	  to	  90	  scans).	  Spectra	  were	  calibrated	  externally	  using	  an	  aqueous	  33	  µM	  solution	  of	  caesium	  iodide,	  in	  250	  mM	  ammonium	  acetate,	  as	  previously	  described	  by	  the	  
	   66	  
Ashcroft	   (University	   of	   Leeds,	   UK),	   and	   Robinson	   (Oxford	   University,	   UK)	  groups149.	  All	  experiments	  were	  undertaken	  under	   identical	  voltage	  conditions:	  capillary	   voltage	   0.6	   kV;	   sampling	   cone	   voltage	   35	   V;	   trap	   energy	   10	   V.	   They	  were	   repeated	   over	   a	   range	   of	   voltage	  wave	   heights,	  with	   transfer	   energies	   of	  either	   10	   or	   30	   V	   for	   non-­‐dissociative	   (native)	   MS	   experiments.	   For	   the	   Ion	  Mobility	   -­‐	   Mass	   Spectrometry	   (IM-­‐MS)	   experiments	   collision	   energy,	   transfer	  energy	  and	  trap	  energy	  were	  all	  60	  V	  each	  with	  other	  conditions	  held	  constant.	  
	  
2.2.4	  Hydrogen	  Deuterium	  exchange	  (HDXNMR)	  
2.2.4.1	  Sample	  preparation	  	  
	   α1-­‐antitrypsin	   samples	   for	   HD	   exchange	   were	   prepared	   at	   250	   µM	  concentration	   (300	   μl),	   in	   100	  mM	   ammonium	   bicarbonate	   before	   being	   snap	  frozen	   and	   lyophilized	   overnight.	   Buffer	   used	   to	   dissolve	   the	   protein	   while	  recording	  the	  NMR	  experiment	  (20	  mM	  sodium	  phosphate,	  50	  mM	  NaCl,	  1	  mM	  EDTA,	  d	  H2O	  (0.2	  μm	  filter	  sterilized)),	  was	  produced	  in	  a	  range	  of	  pH	  values:	  8.0,	  7.0,	   6.5,	   6.0,	   and	   5.75;	   and	   was	   also	   lyophilized	   using	   the	   same	   protocol.	   The	  buffer	   was	   then	   rediluted	   in	   100	  %	   D20	   (containing	   0.001	  %	   DSS	   for	   spectra	  reference)	  to	  give	  equivalent	  pD*	  (8.4,	  7.4,	  6.9,	  6.4,	  and	  6.15	  respectively).	  	  Once	  the	  NMR	  buffer	  was	  dissolved	  in	  100	  %	  D2O,	  it	  was	  used	  to	  dissolve	  the	  sample	  of	  lyophilized	  α1-­‐antitrypsin	  to	  250	  µM	  final	  concentration.	  The	  sample	  was	  then	  immediately	   used	   to	   record	   the	   HD	   exchange	   experiments.	   Dead	   times	   were	  recorded	  (5	  to	  7	  minutes	  range).	  	  
	  
2.2.4.2	  1H-­15N	  SOFAST	  HMQC	  NMR	  for	  HDXNMR	  experiments	  
	   The	   2D	   1H-­‐15N	   band-­‐Selective	   Optimized	   Flip	   Angle	   Short	   Transient	  (SOFAST)	   Heteronuclear	   Multiple	   Quantum	   (HMQC)	   NMR	   experiments138;	   150	  used	  were	   run	  with	   a	   15N	   spectral	  width	   of	   32	   ppm	   (64	   increments)	   and	   a	   1H	  spectral	   width	   of	   16	   ppm.	   The	   excitation	   pulse	   (the	   1H	   90	   degree	   pulse)	   was	  calibrated	  experimentally	  on	  each	  sample,	   to	  ensure	  optimal	  proton	  excitation.	  Acquisitions	   were	   typically	   of	   ≥	   4	   transients	   with	   a	   4	   transient	   experiment	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lasting	   4	   minutes.	   Reference	   spectra	   in	   H2O	   were	   acquired	   under	   similar	  experimental	   conditions	   (of	   concentration,	   preparation,	   pH,	   and	   temperature)	  over	  4	  hours	  SOFAST-­‐HMQC.	  For	  HDXNMR	  experiments,	  a	  250	  μM	  α1-­‐antitrypsin	  concentration	  was	  used	  in	  order	  to	  permit	  collection	  of	  satisfactory	  spectra	  in	  4	  minutes	  in	  2D	  NMR	  experiments.	  1H-­‐15N	  two-­‐dimensional	  SOFAST-­‐HMQC	  spectra	  were	   processed	   and	   analyzed	   using	   nmrPipe	   and	   CCPN.	   All	   spectra	   were	  referenced	  to	  DSS	  at	  0.0	  ppm,	  manually	  phased	  and	  baseline	  corrected.	  	  
	   	   	  
2.2.4.3.	  Spectral	  processing	  and	  NMR	  frequency	  referencing	  	  
	   The	  data	  obtained	  at	  600	  MHz	  (~	  150	  SOFAST-­‐HMQC	  experiments)	  and	  700	  MHz	  (5	  sets	  of	  ~	  250	  SOFAST	  experiments)	  were	  converted	  from	  Varian	  and	  Bruker	   files,	   respectively,	   to	  NmrPipe	  readable	   files.	  The	   first	  spectrum	  of	  each	  set	   of	   HD	   analysis	  was	   processed	   using	   NmrPipe,	   by	  multiplying	   the	   FID	   by	   a	  multiplier	   or	  window	   function	   to	   reduce	   the	   noise.	  We	   applied	   a	   filter	   solvent	  and	  a	  baseline	  correction	  before	  Fourier	   transforming	   the	   time	  domain	  data	   to	  obtain	  a	  frequency	  domain	  spectrum.	  The	  correction	  of	  the	  phase	  error	  was	  done	  by	   adjusting	   the	   phase	   of	   the	   proton,	   and	   of	   the	   nitrogen	   dimensions,	   where	  necessary.	  The	  desired	  region	  (in	  ppm)	  of	  the	  full	  spectral	  window	  was	  selected.	  Each	  HD	  exchange	  dataset	  included	  1D	  NMR	  spectra	  recorded	  30	  minutes	  post-­‐dead	   time,	  and	  one	  per	  day	  until	   the	  completion	  of	   the	  experiment.	  1D	  spectra	  were	  processed	  using	  the	  Bruker	  command:	  Set	  XCAR,	  and	  then	  calibrated	  on	  the	  δDSS	   chemical	   shift.	   The	   calibrated	  values	  δSF1	  and	  δSF3	  used	   for	   referencing	  the	  2D	  experiments	  were	  calculated	  from	  the	  following	  relations	  (for	  which	  the	  BF1,	  SF1,	  and	  SF3	  values	  are	  known	  and	  found	  in	  the	  acqus	  file):	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2.2.4.4.	  Data	  processing	  and	  analysis	  	  
	   A	   detailed	   analysis	   has	   been	   conducted	   of	   changes	   in	   protection	   from	  HDXNMR	   in	   ≤	   200	   residues	   with	   discrete,	   unambiguous	   cross-­‐peaks	   in	   well-­‐dispersed	  regions	  of	  1H-­‐15N	  spectra	  across	  a	  pH	  titration	  using	  two-­‐dimensional	  real-­‐time	   SOFAST	  Heteronuclear	  Multiple	  Quantum	  Correlation	   138;	   150	   (HMQC)	  NMR	  spectroscopy	  (pulse	  program	  and	  the	  typical	  number	  of	  scan	  patterns	  used	  for	   each	  pH	   condition	   for	   the	  HD	  exchange).	   Experiments	  were	   run	  with	   a	   15N	  spectral	  width	  of	   32	  ppm	   (64	   increments)	   and	   a	   1H	   spectral	  width	  of	   16	  ppm.	  Spectra	  were	  processed	  and	  analyzed	  using	  nmrPipe	  and	  CCPN	  suites.	  HDXNMR	  was	  measured	  using	  a	  uniformly	  15N	  labeled,	  uniformly	  protonated	  sample,	  that	  was	   lyophilized	   and	   re-­‐dissolved	   in	   100	   %	   D2O	   containing	   0.001	   %	   DSS	   for	  spectra	  reference	  with	  no	  other	  change	  to	  buffer	  conditions,	  at	  pH	  8.0,	  pH	  7.0,	  pH	  6.5,	  pH	  6.0,	  and	  pH	  5.75.	  The	  protein	  concentration	  was	  250	  µM	  and	  experiments	  were	   conducted	   at	   various	   magnetic	   field	   strengths	   (600,	   700,	   800	   MHz	  spectrometers.	  	  For	   spectral	   processing,	   the	   referencing	   and	   processing	   of	   the	   first	  spectrum	   was	   undertaken	   manually.	   A	   python	   script	   (courtesy	   of	   Dr	   Chris	  Waudby,	   UCL)	   was	   then	   generated	   to	   process,	   and	   reference	   all	   spectra	   in	   a	  similar	   manner,	   including	   the	   appropriate	   phasing	   and	   referencing.	   This	  generated	  a	  list	  of	  1H-­‐15N	  SOFAST	  HMQC	  spectra,	  and	  combined	  sequential	  scans	  to	  give	  a	  ‘3D	  experiment’	  (with	  time	  as	  3rd	  dimension)	  using	  the	  ‘series.com’	  and	  	  ‘xyz2pipe’	  nmrPipe	   commands.	  The	   resulting	   spectrum	  was	   then	  opened	  using	  the	   CCPN	   suite151.	   A	   crosspeak	   list	   was	   generated	   from	   the	   first	   scan	   of	   each	  HDXNMR	   experiment	   (the	   list	   comprised	   ~200	   crosspeaks)	   and	   resonance	  assignments	   were	   attributed	   by	   comparison	   with	   the	   assignment	   spectra	  recorded	  at	  pH	  8.0	  and	  pH	  7.0140,	  before	  being	  applied	  to	  the	  rest	  of	  the	  HDXNMR	  in	  each	  pH	  conditions.	  	  Backbone	  amide	  exchange	  is	  reported	  as	  exponential	  decline	  in	  intensity	  according	  to	  Equation	  2.1:	  
	   69	  
I(t)	  =	  I0	  .	  e	  (-­kex.t)	  +	  c	   	   	   	   Equation	  2.1	  
where	  I(t)	  is	  the	  intensity	  at	  time	  t,	  I0	  is	  the	  intensity	  at	  time	  0,	  and	  kex	  	  is	  the	  rate	  of	  
exchange.	  	  
kex	  values	  were	  therefore	  calculated	  by	  fitting	  curves	  of	  equations	  of	  the	  form	  	  y	  =	  a.e(-­‐b.x)	  +	  c	  to	  data	  for	  residues	  that	  demonstrated	  intensity	  decline,	  using	  the	  	  program	  cftool	  in	  the	  Matlab	  suite	  88.	  	  HDXNMR	  is	  related	  to	  H/D	  ion	  availability	  and	  therefore	  the	  pH	  value	  and	  the	  measured	  pD*	  values	  differ	  by	  0.4	  units152.	  	  
pH	  =	  pD*	  -­	  0.4	  	   	   	   	   Equation	  2.2	  HD	   exchange	   is	   pH	   independent	   at	   high	   values	   of	   pH	   (EX1	   regime)	   but	  entirely	  pH-­‐dependent	  (i.e.	  direct	  inverse-­‐relationship	  to	  H+/D+	  ion	  availability)	  at	   low	   pH	   values	   (EX2	   regime).	   	   Under	   EX2	   conditions	   kex	   can	   be	   readily	  converted	  to	  a	  protection	  factor	  (P)	  using	  Equation	  2.3:	  P	  =	  kint/kex	   	   	   	   	   Equation	  2.3	  Where	   kint	   is	   the	   experimentally-­‐derived,	   unprotected	   backbone	   amide	  hydrogen	  exchange	  rate	  (as	  stored	  for	  all	  residues	  within	  SPHERE	  program153).	  
	   An	   EX2	   regime	   is	   observed	   at	   pH	   values	   up	   to	   and	   including	   a	   range	  where	   variation	   by	   1.0	   pH	   unit	   (10-­‐fold	   change	   in	   deuterium	   ion	   availability)	  changes	  the	  kex	  value	  10-­‐fold	  in	  the	  same	  direction	  as	  the	  pH.	  For	  a	  pH	  change	  of	  0.5	  in	  EX2	  the	  change	  is	  √10-­‐fold	  i.e.	  3.16.	  Similarly,	  in	  the	  case	  of	  0.25	  and	  0.75	  pH	  unit	  in	  EX2,	  the	  kex	  ratios	  calculations	  the	  change	  should	  be	  equal	  to	  5.62,	  and	  1.77,	  respectively.	  Previous	  studies	  have	  indicated	  that	  α1-­‐antitrypsin	  begins	  to	  undergo	  acid	  or	   base-­‐induced	   polymerisation	   between	   pH	   6.0	   and	   5.0,	   and	   between	   pH	   8.0	  and	  9.0,	  respectively.	  	  The	  titration	  was	  therefore	  performed	  across	  the	  range	  pH	  6.0	   -­‐	   8.0	   (equivalent	   to	   pD*	   6.4	   -­‐	   pD*	   8.4).	   The	   pH	   5.75	   (pD*	   6.25)	   was	   also	  monitored,	  coupled	  with	  off-­‐pathway	  polymerisation	  characterisation.	  pH	  values	  were	  determined	  using	  a	  pH-­‐meter	  with	  NMR	  tube	  probe.	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Exponential	  fitting	  of	  the	  intensity	  decays	  over	  time	  provides	  information	  on	   the	   relative	   flexibilities	   of	   ≤	   200	   residues	   within	   the	   native	   molecule	   in	  solution.	  The	  use	  of	  Matlab	  software	  for	  fits	  of	  peaks	  intensity	  decays.	  Finally,	   P	   relates	   to	   the	   difference	   in	   free	   energy	   of	   the	   observed	   residue,	  between	  the	  “closed”	  state	  and	  the	  “open”,	  exchange-­‐competent	  state	  ∆Gop−cl	  154.	  	  
∆Gop−cl	  =	  RT	  ln(P)	  or	  ∆Gapp	  =	  -­RT	  ln(kop)	   	  Equation	  2.4	  
where	  R	  is	  1.985877534.10-3 kcal.K-1.mol-1	  and	  T	  is	  298K	  	  
2.2.5.	  NMR	  studies	  of	  α1-­antitrypsin	  in	  urea	  
2.2.5.1.	  Sample	  preparation	  	  
	  	  	   NMR	   spectroscopy	   of	   α1-­‐antitrypsin	   across	   a	   urea	   titration	   was	  performed	   at	   100	   μM	   protein	   concentration.	   This	   permitted	   collection	   of	  satisfactory	   spectra	   in	   1-­‐4	   h	   for	   2D.	   Spectra	   were	   recorded	   in	   the	   buffer	  described	  above,	  to	  which	  10	  %	  D20	  was	  added,	  as	  a	  spectrometer	  field	  lock,	  and	  0.001	  %	  DSS	  was	  added	  for	  referencing.	  	  	   Samples	  were	  prepared	   from	  250	  µM	  α1-­‐antitrypsin	  stock,	  and	  different	  volumes	  of	  a	  9.0	  M	  urea	  stock	  to	  give	  the	  appropriate	  final	  urea	  concentrations	  7.6	  M,	  6.0	  M,	  4.0	  M,	  3.0	  M,	  2.0	  M,	  1.5	  M,	  1.0	  M	  and	  0.0	  M.	  Urea	   concentrations	  were	  verified	  by	  refractometry.	  The	  homogeneity	  of	   the	  sample	  was	  confirmed	  by	  SDS-­‐,	  non-­‐denaturing-­‐	  and	  transverse	  urea	  gradient	  (TUG)-­‐PAGE	  and	  activity	  assay.	  The	  conformational	   state	  of	   the	  sample	   following	  NMR	  experiments	  was	  assessed	  by	  far	  U.V.	  circular	  dichroism	  spectroscopy.	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2.2.5.2	  1H-­15N	  -­TROSY	  HSQC	  
	   Transverse	  Relaxation	  Optimized	  Spectroscopy	  (TROSY)	  -­‐	  Heteronuclear	  Single	  Quantum	  (HSQC)	  NMR	  experiments131	  were	  used	  for	  the	  urea	  equilibrium	  studies.	   This	   experiment	   is	   useful	   for	   study	   of	   slow	   tumbling	   species	   enabling	  significant	   sensitivity	   improvements.	   The	   pulse	   sequence	   used	   allowed	   water	  suppression	   by	   suppression	   of	   radiation	   damping.	   1H-­‐15N-­‐TROSY-­‐HSQC	  experiments	   were	   recorded	   using	   enhanced	   gradient	   selection	   to	   minimise	  breakthrough	  from	  unlabelled	  urea.	  The	  spectra	  were	  referenced	  and	  processed	  as	  described	  in	  the	  section	  2.2.4.3,	  and	  2.2.4.4.	  	  
	  
2.2.6.	  NMR	  relaxation	  of	  α1-­antitrypsin	  
2.2.6.1	  Sample	  preparation	  	   Perdeuterated,	   uniformly	   15N,13C-­‐labelled	   α1-­‐antitrypsin	   sample	   was	  prepared	  as	  described	  in	  section	  2.2.1.4.	  In	  order	  to	  allow	  all	  the	  backbone	  nuclei	  to	   back	   exchange	   with	   the	   protonated	   solvent	   for	   observation	   in	   relaxation	  experiments,	   the	   sample	   was	   subjected	   to	   an	   unfolding/refolding	   cycle	   as	  follows:	   the	   protein	   sample	   was	   concentrated	   down	   to	   500	   µl	   (300uM	  concentration)	   into	  unfolding	  buffer	   (8.0	  M	  Urea,	  50	  mM	  Tris,	  pH	  8.0,	  100	  mM	  dithiothreitol	   (DTT)).	   The	   unfolded	   protein	   were	   then	   refolded	   into	   500	   ml	  refolding	  buffer	   (25	  mM	  Sodium	  phosphate	  pH	  7.0,	  50	  mM	  NaCl,	   1	  mM	  EDTA)	  drop	   by	   drop	   with	   continuous	   mixing	   on	   magnetic	   stirrer	   at	   4	   ºC,	   overnight,	  before	  being	  concentrated	  as	  described	  in	  2.2.1.3.	  	  	  The	  resulting	  sample	  was	  concentrated	  to	  250	  µM	  and	  was	  characterized	  biochemically	  via	  SDS-­‐PAGE,	  native-­‐PAGE,	  and	  activity	  assay,	   as	  well	   as	  1D	   1H-­‐	  NMR	  spectroscopy,	  before	  being	  used	  for	  NMR	  relaxation	  experiments.	  	  	  Double	  labelled	  sample	  was	  prepared	  as	  described	  in	  section	  2.2.1.4	  in	  a	  fully	  deuterated	  environment.	   In	  order	  to	  allow	  all	   the	  backbone	  nuclei	  to	  back	  exchange	   with	   the	   protonated	   solvent	   for	   relaxation	   experiments,	   the	   sample	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was	  unfolded	  and	  refolded.	  The	  protein	  sample	  was	  concentrated	  down	  to	  500	  µl	  (300	  µM	  concentration)	   into	  unfolding	  buffer	  (8.0	  M	  Urea,	  50	  mM	  Tris,	  pH	  8.0,	  100	  mM	  dithiothreitol	  (DTT)).	  The	  unfolded	  protein	  were	  then	  refolded	  into	  500	  ml	  refolding	  buffer	  (25	  mM	  Sodium	  phosphate	  pH	  7.0,	  50	  mM	  NaCl,	  1	  mM	  EDTA)	  drop	   by	   drop	   with	   continuous	   mixing	   on	   magnetic	   stirrer	   at	   4	   ºC,	   overnight,	  before	  being	  concentrated	  as	  described	  in	  2.2.1.3.	  The	  sample	  was	  concentrated	  to	   250	   µM,	   and	   characterized	   biochemically	   by	   SDS-­‐PAGE,	   native-­‐PAGE,	   and	  activity	  assay,	  as	  well	  as	  1D	  1H-­‐	  NMR	  spectroscopy,	  before	  being	  used	  for	  NMR	  relaxation	  experiments.	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3.1.	  Introduction	  	  	  
3.1.1.	  Metastability/Z-­mutant	  and	  formation	  of	  intermediate	  
ensemble.	  	  	   The	  folding,	  misfolding,	  and	  inhibitory	  mechanisms	  of	  serpins	  are	  linked	  to	   both	   thermodynamic	   metastability	   and	   conformational	   flexibility.	  Metastability	   of	   native	   α1-­‐antitrypsin	   arises	   from	   inefficient	   structural	   packing	  around	  the	  fold.	  It	  is	  most	  strikingly	  associated	  with	  a	  reactive	  loop	  motif	  that	  is	  minimally-­‐stabilized	  in	  solution	  and	  a	  parallel	  β-­‐strand	  packing	  between	  s3A	  and	  s5A	  within	  an	  otherwise	  antiparallel	   sheet.	  Such	  structural	   features	  predispose	  to	   conformational	   change	   resulting	   in	   a	   thermodynamic	   hyperstabilisation	   to	  form	   a	   stable	   serpin-­‐protease	   complex	   during	   inhibition	   or	   equivalent	   S	   to	   R	  transitions155.	  In	  general,	  the	  metastable	  native	  state	  is	  also	  believed	  to	  be	  more	  dynamic	  (kinetically	  unstable)	  in	  solution	  than	  hyperstabilised	  states92.	  	   Homozygosity	  for	  the	  Z	  allele	  of	  α1-­‐antitrypsin	  accounts	  for	  almost	  95%	  of	  all	  cases	  of	  α1-­‐antitrypsin	  deficiency88.	  The	  Z	  (Glu342Lys)	  mutation	  occurs	  at	  the	  head	   of	   strand	   5	   of	   β-­‐sheet	   A	   and	   the	   base	   of	   the	   RCL.	   It	   has	   been	   variously	  suggested	   that	   it	   stabilizes	   a	   folding	   and/or	   an	   intermediate	   S	   to	   R	   transition	  state	   of	   α1-­‐antitrypsin,	   and	   that	   it	   reduces	   the	   thermodynamic	   and/or	   kinetic	  stability	   of	   its	   native	   fold103;	   156.	   It	   is	   believed	   to	   slow	   the	   folding	   of	   the	   α1-­‐antitrypsin	  molecule157;	   148,	   and	  so	   increase	   the	  population	  of	  a	   conformer	   that	  allows	   the	   RCL	   of	   one	   molecule	   to	   insert	   into	   β-­‐sheet	   A	   in	   the	   absence	   of	  proteolytic	   cleavage,	   giving	   rise	   to	   an	   intermolecular	   linkage	   that	   can	   be	  propagated	   within	   chains	   of	   polymers95;	   158.	   The	   characterization	   of	   the	  structural	  basis	  of	  α1-­‐antitrypsin	  deficiency	  therefore	  requires	  understanding	  of	  the	   folding	   pathway,	   how	   this	   relates	   to	   formation	   of	   polymeric	   and	   latent	  conformers,	   and	   the	   mechanisms	   by	   which	   these	   species	   are	   handled	   in	   vivo.	  However,	   detailed	   characterization	   of	   stability	   and	   flexibility	   in	   serpins	   in	  solution	  using	  structural	  methods	  is	  challenging	  due	  to	  their	  relatively	  large	  size	  and	  the	  concomitant	  propensity	  for	  polymerisation/aggregation.	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   Many	   structural	   biology	   experiments	   are	   conducted	   using	   recombinant	  non-­‐glycosylated	  proteins.	  	  However	  α1-­‐antitrypsin	  is	  glycosylated	  in	  vivo,	  so	  it	  is	  useful	  to	  consider	  how	  glycosylation	  affects	  the	  protein	  folding	  and	  function,	   in	  order	  to	  determine	  whether	   findings	  are	  applicable	   to	   in	  vivo	   systems.	   	   Indeed,	  glycosylation	  usually	  increases	  the	  global	  stability	  of	  proteins,	  and	  further,	  global	  stabilization	   is	   often	   accompanied	   by	   reduced	   flexibility	   in	   the	   native	   state159.	  However,	  no	  apparent	  discrepancy	  has	  been	  observed	  between	   the	  kinetic	  and	  thermodynamic	  stability	  in	  wild	  type	  (M)	  α1-­‐antitrypsin	  in	  the	  glycosylated	  form	  observed	  in	  vivo,	  and	  its	  recombinant	  counterpart100.	  This	  indicates	  that	  further	  structural	   exploration	   of	   the	   recombinant	   non-­‐glycosylated	   molecule	   can	   be	  relevant	  to	  the	  in	  vivo	  context.	  	  
3.1.2.	  Equilibrium	  folding	  intermediate	  	  Various	   biochemical	   and	   biophysical	   techniques	   have	   been	   used	   to	  separate	  and	  characterize	  proteins	  with	  different	  oligomerization	  states	  and/or	  conformations	   formed	   by	   perturbation	   of	   the	   native	   state.	   	   Examples	   of	   such	  perturbations	   are	   those	   induced	   by	   changes	   in	   solution	   conditions,	   e.g.	  temperature	   or	   pH.	   The	  most	   physio-­‐pathologically	   relevant	   perturbations	   are	  those	   induced	   in	   the	   context	   of	   mutations	   found	   in	   patients	   presenting	   with	  plasma	   deficiency160	   under	   at	   physiological	   pH.	   	   However	   monomeric	   Z	   α1-­‐antitrypsin	   cannot	   be	   purified	   above	   trace	   yield	   from	   recombinant	   E.	   coli	  systems.	   Alternatively,	   denaturant	   studies	   (e.g.	   titrations,	   kinetic	   studies)	   are	  widely	  used	  to	  probe	  protein	  folding	  and	  unfolding	  pathways161.	   	  The	  two	  most	  commonly	  used	  denaturants	  are	  guanidine	  and	  urea.	  The	  mechanism	  by	  which	  they	  destabilize	  a	  given	  protein	  structure	  is	  controversial.	  Although	  structurally	  similar,	  urea	  and	  guanidinium	  denature	  proteins	  by	  different	  mechanisms:	  urea,	  unlike	  guanidine,	  promotes	  denaturation	  via	  formation	  of	  hydrogen	  bonds	  with	  polypeptides	  162.	  	  	  The	  polypeptide	  chains	  of	  many	  denatured	  proteins	  spontaneously	  refold	  to	   their	  native	  conformation	   in	   free	  solution	  by	  adjusting	  solvent	  conditions	   to	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near	   physiological163.	   For	   relatively	   small	   globular	   proteins,	   the	   native	   to	  denatured	  state	  transition	  involves	  no	  other	  thermodynamically	  stabilized	  states	  (two-­‐state	   transition)	   and	   is	   symmetrically	   reversible164.	   Two-­‐state	   unfolding	  transitions	  may	  be	  characterized	  by:	  	  
• Cooperative	   changes	   in	   protein	   conformation	   signals	   that	   follow	   a	  sigmoidal	  curve	  along	  a	  denaturant	  titration;	  
• Consistent	  changes	  observed	  by	  multiple	  spectroscopic	  methods;	  
• Observation	   of	   an	   isosbestic	   point	   across	   a	   denaturant	   titration	   by	  spectroscopy.	  	  If	  the	  spectra	  of	  a	  protein	  that	  is	  in	  entirely	  non-­‐denaturing	  and	  entirely	  denaturing	  conditions	  intersect	  at	  a	  specific	  wavelength	  (i.e.	  the	  two	  conformational	  states	  have	  the	  same	  molar	  absorptivity	  (ε))	  this	  is	   termed	   an	   isosbestic	   point.	   	   If	   the	   transition	   is	   two-­‐state,	   all	   spectra	  recorded	  at	  partially-­‐denaturing	  conditions	  should	  also	  pass	  through	  this	  point;	  
• The	   measurement	   of	   enthalpy	   value	   (ΔHcal),	   obtained	   using	   differential	  scanning	   calorimetry	   (DSC)	   measurements,	   calculated	   from	   the	   area	   of	  the	   transition	   peak,	   should	   match	   with	   the	   van’t	   Hoff	   enthalpy	   value	  (ΔHνH),	   calculated	   under	   the	   assumption	   of	   a	   two-­‐state	   transition.	   	   This	  can	  be	  done	  by	  comparing	  the	  calorimetric	  enthalpy	  of	  denaturation	  (the	  area	  under	  the	  peak)	  Apeak	  to	  the	  van’t	  Hoff	  enthalpy	  described	  as	  follow:	  	  	  At	   T	   =	   Td	   (temperature	   at	   which	   half	   the	   molecule	   in	   the	   system	   are	   unfolded)	  the	   can	  be	  described	  as:	  	  
	  When	   a	   two-­‐state	   unfolding	   is	   observed	   .	   The	   	   is	  the	  height	  of	  the	  heat	  capacity	  peak.	  	  	  However	  many	  proteins,	  particularly	  those	  of	  higher	  molecular	  mass,	  do	  not	   follow	   these	  patterns.	   Instead	   they	   fold/unfold	  via	   intermediate	  ensembles	  that	  are	  thermodynamically	  stabilized	  enough	  to	  be	  stably	  populated	  over	  a	  mid-­‐range	  of	  denaturant	  conditions.	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Denaturant	  studies	  have	  previously	  been	  considered	  particularly	  relevant	  in	   studying	   the	   relationship	   of	   these	   processes	   to	   disease-­‐associated	  polymerisation	   in	   systems	  where	   low	   concentrations	  of	   denaturant	   can	   induce	  the	   formation	   of	   polymeric	   states99;	   161.	   	   However	   for	   serpinopathies	   this	   has	  been	  called	  into	  question	  by	  the	  observation	  that	  denaturant-­‐induced	  polymers	  are	   poorly	   recognized	   by	   the	   2C1	   monoclonal	   antibody	   that	   very	   sensitively	  detects	  ex	  vivo	  and	  heat-­‐induced	  polymers93.	  	  
3.1.3.	  Probing	  the	  folding/unfolding	  pathway	  of	  α1-­antitrypsin	  in	  
guanidine	  
	  Over	   20	   years	   ago,	   the	   first	   study	   of	   α1-­‐antitrypsin	   unfolding	   was	  published	   by	   performing	   equilibrium	   studies	   with	   increasing	   concentration	   of	  denaturant	   (guanidinium	  hydrochloride)165.	   	   It	  was	   performed	   on	   glycosylated	  plasma	   α1-­‐antitrypsin	   using	   far-­‐ultraviolet	   circular	   dichroism,	   highlighting	   the	  presence	  of	  an	   intermediate	  ensemble	  using	  equilibrium	  unfolding	  studies.	  The	  authors	  concluded	  a	  three	  state	  transition	  was	  observed	  during	  unfolding:	  native	  (N),	   intermediate	   (I),	   unfolded	   (U).	   	   The	   data	   were	   consistent	   with	   maximal	  population	  of	  an	  intermediate	  ensemble	  around	  1.5	  M	  guanidine83.	  	  Interestingly,	  the	   polymers	   that	   form	   as	   a	   consequence	   of	   treatment	   with	   both	   urea	   and	  guanidine,	   are	   not	   recognized	   by	   the	   2C1	   monoclonal	   antibody	   (mAb),	   that	  recognizes	  the	  pathological	  polymers	  that	  form	  in	  vivo.	  	  	  	  A	   recent	   study	   by	   Krishnan	   et	   al.,	   explored	   species	   populated	   by	   α1-­‐antitrypsin	   during	   early	   guanidine-­‐induced	   unfolding	   by	   studying	   a	   series	   of	  single	   cysteine	   variants.	   	   The	   cysteine	   residues,	   engineered	   at	   various	   sites	  around	   the	   molecule,	   could	   be	   tagged	   by	   maleimide	   moieties	   if	   they	   were	  accessible	   to	   solvent.	   	   By	   quantifying	   the	   degree	   of	   maleimide	   tagging	   in	   low	  concentrations	   of	   GdnHCl	   for	   each	   variant,	   the	   authors	   proposed	   this	   showed	  intermediate	   state	   formation	   to	   be	   accompanied	   by	   local	   unfolding	   of	   the	   C-­‐terminal	  half	  of	  the	  A-­‐sheet,	  s5A-­‐hI-­‐s6A.	  They	  further	  proposed	  that,	  concertedly,	  the	   F-­‐helix	   unwinds	   and	   dissociates	   from	   its	   packing	   interactions	   with	   the	   N-­‐
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terminal	   strands	   of	   β-­‐sheet	   A,	   and	   interactions	   of	   the	   RCL	  with	   the	   B-­‐	   and	   C-­‐sheets	  are	  disrupted.	  	  In	  contrast	  strand	  3	  A,	  helix	  B	  and	  most	  of	  β-­‐sheets	  B	  and	  C	  were	   stable.	   	   These	   conclusions	   fitted	   very	   well	   with	   the	   β-­‐hairpin	   model	   of	  polymerisation	   that	   had	   been	   published	   prior	   to	   this,	   which	  was	   itself	   in	   part	  based	   upon	   selective	   cleavage	   studies	   of	   motif	   destabilization	   in	   low	  concentrations	   of	   GdnHCl99.	   Together	   these	   findings	   contribute	   to	   a	   structural	  concept	   of	   guanidine-­‐induced	   denaturation	   proceeding	   via	   a	   conformer	  resembling	   the	  putative	   intermediate	   in	   the	  β-­‐hairpin	   linkage	  model.	   	  However	  both	  the	  selective	  cleavage	  and	  maleimide	  labeling	  strategies	  are	  limited	  in	  that	  they	  will	  stabilize	  the	  states	  they	  report	  and	  so	  skew	  conformational	  equilibria	  to	  increase	  their	  population.	  	  Moreover	  they	  are	  interpreted	  on	  the	  assumption	  that	  all	   regions	   reporting	   destabilization	   within	   the	   ensemble	   in	   this	   way	   will	   be	  destabilized	  together	  within	  a	  single	  intermediate	  state.	  	  Furthermore	   these	   findings	   must	   also	   be	   taken	   in	   the	   context	   of	   other	  recent	   studies	   that	   have	   shown	   α1-­‐antitrypsin	   can	   adopt	   different	   types	   of	  polymers	   under	   different	   denaturing	   concentration93.	   These	   may	   arise	   from	  subtle	   conformational	   differences	   in	   transiently	   populated	   structures	   adopted	  early	  in	  the	  polymerisation	  pathway166.	  	  	  	  Guanidine	   cannot	   be	   used	   for	   NMR	   studies	   of	   protein	   denaturation	  because	   (i)	   it	   creates	   high	   viscosity	   giving	   rise	   to	   line	   broadening,	   (ii)	   high	  dynamic	   range	   (higher	   concentrations	   of	   guanidine,	   relative	   to	   that	   of	   the	  protein	   requires	   to	   apply	   guanidine	   suppression	   as	   well	   as	   the	   usual	   water	  suppression	   used	   for	   NMR	   experiments),	   lastly,	   (iii)	   chemical	   exchange	   (the	  hydrogens	   attached	   to	   the	   nitrogens	   of	   Gu.HCl	   exchange	   with	   the	   solvent	  hydrogens,	  and	  the	  rate	  of	  exchange	  is	  very	  high.	  This	  gives	  rise	  to	  complications	  for	   pulse	   sequences	   based	   on	   selective	   excitation	   as	   well	   as	   for	   the	   spectral	  editing	  pulse	  sequences). 	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3.1.4.	  Probing	  the	  folding/unfolding	  pathway	  of	  α1-­antitrypsin	  in	  
urea	  	   Equilibrium-­‐unfolding	   studies	   of	   α1-­‐antitrypsin	   in	   urea	   have	   been	  undertaken	   in	   a	   series	   of	   studies	   by	   the	  Bottomley	   group81;	   100;	   167.	   These	   data	  supported	   the	   presence	   of	   a	   single	   intermediate	   around	   4.0	   M	   urea81.	  	  Tryptophan	  mutagenesis	   and	   fluorescence	   studies	   indicated	   that,	   during	   urea-­‐induced	  unfolding,	  dynamic	  changes	  occurred	  around	  β-­‐sheet	  A	  consistent	  with	  its	   expansion	   in	   the	   intermediate	   state88.	   More	   limited	   structural	   change	   was	  observed	   from	   a	   tryptophan	   residue	   reporting	   on	   the	   environment	   around	   β-­‐sheet	  B	  with	  evidence	  of	  some	  residual	  secondary	  structure	  even	  at	  8.0	  M	  urea.	  	  Kinetic	   studies	   of	   wild-­‐type	   α1-­‐antitrypsin	   in	   urea	   have	   further	   supported	   the	  involvement	  of	  2	  kinetic	  intermediates	  along	  the	  polymerisation	  pathway89.	  	  Transverse	   urea	   gradient	   (TUG)	   PAGE	   distinguishes	   components	   based	  on	   their	   relative	   stability	   to	   increasing	   concentrations	   of	   urea.	   The	   native	  conformation	   of	   plasma	   α1-­‐antitrypsin	   is	   compact,	   and	   so	   migrates	   relatively	  rapidly	  at	  conditions	  <	  1.0	  M	  urea;	  however,	  at	  higher	  concentrations	  of	  urea	  it	  undergoes	   a	   transition	   to	   a	   denatured,	   poorly	   migrating	   species.	   Stabilised	  monomeric	   states	   (latent	   or	   cleaved)	   or	   enzyme	   complexed	   species	   remain	  stable	  in	  their	  compact	  conformations	  across	  the	  whole	  gradient	  88.	  Heat-­‐induced	  and	  ex	  vivo	  polymers	  are	  also	  hyperstable	  in	  urea,	  retaining	  their	  characteristic	  ladder	  appearance	  across	  the	  entire	  gradient88.	  A	  complex	  unfolding	  profile	  has	  been	  observed	  previously	  by	  TUG	  PAGE	  for	  the	  Z	  variant	  compared	  to	  the	  M	  α1-­‐antitrypsin	   that	   was	   taken	   to	   demonstrate	   a	   folding	   defect	   induced	   by	   the	  mutation168.	  However	  this	  has	  not	  been	  reproduced	  in	  other	  hands	  (Lomas	  and	  Bottomley	   groups,	   personal	   communication),	   perhaps	   reflecting	   variability	   in	  techniques	  used	  to	  form	  the	  urea	  gradient.	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3.1.5.	  Effect	  of	  stabilizing	  ‘cavity-­filling’	  mutations	  on	  the	  native	  state	  
α1-­antitrypsin	  	  	   A	  number	  of	  studies	  have	  been	  undertaken	  to	  investigate	  the	  relationship	  between	   the	   inhibitory	   mechanism	   and	   the	   thermodynamic	   stability	   of	   α1-­‐antitrypsin.	   It	  has	  been	  proposed	  that	  the	  metastability	  of	  native	  serpins	  arises	  from	  suboptimal	  structural	  packing	  that	  facilitates	  their	  transition	  to	  hyperstable	  inhibitory	   complex	   in	  which	   packing	   is	   improved155.	   	   Consequently,	  mutations	  aiming	   to	   improve	   side-­‐chain	   packing	   are	   expected	   to	   increase	   the	  thermodynamic	   stability	   of	   α1-­‐antitrypsin	   and	   reduce	   inhibitory	   function.	   One	  such	  mutation,	  Gly117Phe	  -­‐	  predicted	  to	  occupy	  the	  cavity	  between	  s2A	  and	  the	  F-­‐helix,	   exemplifies	   these	   consequences,	   and	   together	   with	   other	   variants	  validated	   	   these	   concepts169	   when	   characterised	   biochemically	   (Fig.3.1.).	   The	  subsequent	  crystal	  structure	  obtained	   for	   the	  Gly117Phe	  mutant	  demonstrated	  no	  significant	  conformational	  change	  other	  than	  a	  downward	  shift	  in	  the	  position	  of	   the	   F-­‐helix170.	   Dynamic	   effects	   of	   this	   mutation	   were	   further	   assessed	   by	  HDXMS	   studies.	   	   These	   showed	   changes	   in	   regions	   involved	   in	   inhibitory	  mechanism	  particularly	  in	  the	  C-­‐term	  part	  of	  F-­‐helix.	  Interestingly,	  however	  the	  conformational	  changes	  were	  not	  confined	  locally	  but	  instead	  were	  spread	  to	  key	  regions	  involved	  in	  the	  inhibitory	  mechanism	  such	  as	  the	  RCL	  and	  β-­‐sheet	  A,	  as	  well	  as	  β-­‐sheet	  C	  and	  helix	  D.	  Similarly,	  mutagenesis	  to	  introduce	  a	  space-­‐filling	  phenylalanine	  residue	  within	  the	  cavity	  flanking	  β-­‐sheet	  A	  was	  also	  tested	  at	  the	  residue	  Thr114.	  Indeed,	  Thr114Phe	  significantly	  raised	  the	  melting	  temperature	  of	   α1-­‐antitrypsin	   and	   was	   shown	   to	   delay	   polymer	   formation169.	   These	   data	  demonstrate	   the	   importance	   of	   this	   cavity	   as	   a	   potential	   drug	   target	   to	  ameliorate	  polymerization.	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Figure	  3.1.	  	   Crystal	   structure	   of	   monomeric	   α1-­antitrypsin	   illustrating	   the	  
environment	  of	  the	  residues	  Thr-­114	  and	  Gly-­117.	  In	  the	  left	  panel,	  the	  β-­‐sheet	   A	   (brown),	   the	   F-­‐helix	   (yellow)	   (PDB:NE4).	   The	   hydrophobic	   surface	  cavity	  of	  interest	  is	  bounded	  by	  strand	  2	  of	  β-­‐sheet	  A	  (s2A),	  helix	  B	  (hB),	  helix	  D	  (hD)	  and	  helix	  E	  (hE).	  This	  area	  is	  obliterated	  during	  conformational	  transitions	  that	  involve	  reactive	  loop	  insertion	  into	  β-­‐sheet	  A.	  The	  right	  panel	  represents	  a	  model	   of	   the	   interior	   of	   the	   hydrophobic	   cavity	   displaying	   the	   position	   of	   the	  amino	  acid	  side	  chains	  (blue),	  readapted	  from169.	  The	  residues	  Thr-­‐114	  and	  Gly-­‐117	  (red)	  on	  s2A	  were	  highlighted.	  	  I	   therefore	  undertook	  unfolding	  equilibrium	  studies	  using	  urea	   titration	  of	  the	  native	  state	  α1-­‐antitrypsin	  using	  NMR	  and	  CD	  spectroscopy	  to	  understand	  the	   equilibrium	   behaviour	   of	   α1-­‐antitrypsin	   in	   denaturant	   and	   provide	   more	  detailed	  information	  on	  the	  previously	  described	  intermediate	  state(s).	  This	  was	  complemented	  by	  additional	  stability	  studies	  using	  CD	  spectroscopy	  of	  the	  WT,	  M,	  Thr114Phe,	  Gly117Phe,	  and	  Z-­‐	  α1-­‐antitrypsin	  conformers.	  	  	  	  
3.2	  Results	  	  
3.2.1.	  NMR	  studies	  of	  α1-­antitrypsin	  unfolding	  structural	  behaviour	  	  
	   The	   1H-­‐15N	  TROSY-­‐HSQC	  NMR	  spectrum	  of	  α1-­‐antitrypsin	   in	   the	   absence	  of	  urea	  (0	  M)	  was	  as	  described	  previously140	  and	  provided	  a	  reference	  for	  spectra	  collected	   at	   low	   urea	   concentration	   where	   assignable	   cross-­‐peaks	   could	   be	  observed	  (Fig.	  3.2).	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Figure	  3.2.	  	   1H-­15N-­TROSY	   HSQC	   NMR	   spectroscopy	   urea	   titration	   for	  
recombinant	   α1-­antitrypsin.	   	   1H-­‐15N-­‐	   TROSY	   HSQC	   NMR	   spectroscopy	  spectra	  were	  recorded	  across	  the	  titration	  between	  0.0	  M	  and	  7.6	  M	  urea.	  This	  illustrate	   the	   use	   of	   assignment	   at	   0.0	  M	  urea	   to	   follow	   equilibrium	  unfolding	  behaviour,	   as	   urea	   concentration	   increases	   those	   peaks	   loose	   their	   intensity	  while	  new	  unfolding	  peaks	  appear	  at	  higher	  urea	  concentration.	  	  	   Figure	  3.3.,	  shows	  α1-­‐antitrypsin	  fingerprints	  across	  the	  titration,	  where	  the	  0	  M	   urea	   spectrum	   represents	   a	   fully-­‐folded	   monomeric	   sample	   with	   well-­‐dispersed	   resonances,	   and	   the	   8	   M	   urea	   theoretically	   contains	   fully-­‐unfolded	  proteins	  with	  resonances	  appearing	   in	   the	  8.5–7.5	  ppm	  range	   in	   the	   1H	  proton	  dimension.	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Figure	  3.3.	  	   1H-­15N-­TROSY	   HSQC	   NMR	   spectroscopy	   urea	   titration	   for	  
recombinant	   α1-­antitrypsin.	   	   1H-­‐15N-­‐	   TROSY	   HSQC	   NMR	   spectroscopy	  spectra	  were	  recorded	  across	  the	  titration	  at	  0M,	  1.0M,	  1.5M,	  2.0M,	  3.0M,	  4.0M,	  6.0M,	   and	   7.6M	   urea.	   The	   0M	   urea	   spectrum	   represents	   a	   fully-­‐folded	  monomeric	   sample	   with	   well-­‐dispersed	   resonances,	   while	   the	   7.6M	   urea	  theoretically	  contains	  fully-­‐unfolded	  proteins	  with	  resonances	  appearing	  in	  the	  8.5–7.5	  ppm	  range	  in	  the	  1H	  proton	  dimension.	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In	  order	  to	  monitor	  any	  urea-­‐induced	  off-­‐pathway	  polymerisation	  a	  series	  of	  1H	  NMR	  experiments	  have	  been	  recorded	  across	  the	  titration	  as	  illustrated	  in	  figure	   3.4.	   Only	   the	   samples	   at	   0M,	   1.0	  M,	   1.5	  M,	   2.0	  M,	   and	   2.5	  M	   urea	   could	  provide	   a	   suitable	   signal,	   as	   higher	   concentration	   of	   urea	   disturbed	   the	   NMR	  signal.	   In	   order	   to	   quantify	   urea	   induced	   polymerisation,	   intensities	   were	  measured	   at	   two	   regions	   of	   the	   spectra:	   (i)	   upfield	   (9.61-­‐9.56,	   9.44-­‐9.36,	   9.37-­‐9.29	   ppm),	   and	   (ii)	   downfield	   (0.29-­‐0.39,	   0.5-­‐0.58,	   0.66-­‐0.77	   ppm).	   At	   higher	  urea	   concentrations	   1D	   spectra	   supported	   similarly	   rapid	   equilibration	   to	   that	  seen	  at	  0	  M	  and	  1.0	  M	  urea.	  Lower	  right	  panel	  shows	  relative	  intensities	  for	  these	  conditions	  in	  terms	  of	  1D	  projections	  of	  the	  2D	  spectra	  onto	  the	  1H	  axis	  (black:	  4.0	  M;	  red:	  6.0	  M;	  blue:	  7.6	  M	  urea).	  
	  
Figure	  3.4.	  	   1D	   1H-­NMR	   spectroscopy	   urea	   titration	   for	   recombinant	   α1-­
antitrypsin.	  1H	  NMR	  spectroscopy	  spectra	  were	  recorded	  across	  the	  titration	  at	   0M,	   1.0	  M,	   1.5	  M,	   2.0	  M,	   and	  2.5	  M	  urea.	   In	   order	   to	  monitor	   urea	   induced	  polymerisation,	  intensities	  were	  measured	  at	  3	  regions	  upfield	  (9.61-­‐9.56,	  9.44-­‐9.36,	   9.37-­‐9.29	   ppm)	   and	   downfield	   (0.29-­‐0.39,	   0.5-­‐0.58,	   0.66-­‐0.77	   ppm).	   At	  higher	  urea	  concentrations	  1D	  spectra	  supported	  similarly	  rapid	  equilibriation	  to	  that	  seen	  at	  0	  M	  and	  1.0	  M	  urea.	  Lower	  right	  panel	  shows	  relative	  intensities	  for	  these	  conditions	  in	  terms	  of	  1D	  projections	  of	  the	  2D	  spectra	  onto	  the	  1H	  axis	  (black:	  4.0	  M;	  red:P	  6.0	  M;	  blue:	  7.6	  M	  urea).	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The	   upfield	   region	   is	   characterised	   by	   amide	   proton	   signals.	  While	   this	  signal	   would	   generally	   remain	   unaffected	   by	   the	   unfolding	   of	   α1-­‐antitrypsin	  induced	  by	   increasing	  concentrations	  of	  urea,	   the	  water	  suppression	  necessary	  to	   obtain	   1D	   NMR	   removes	   the	   magnetization	   of	   the	   water	   molecules	   of	   the	  solvent.	  Therefore,	  as	  the	  protein	  unfolds	  the	  NMR	  invisible	  protons	  of	  the	  water	  molecules	   exchange	   with	   α1-­‐antitrypsin	   and	   the	   amide	   signal	   decays	   as	   the	  molecule	   unfolds.	   The	   downfield	   region	   is	   characterised	   by	   the	   methyl	   signal	  between	   0.3	   and	   0.75	   ppm,	   which	   is	   unaffected	   by	   the	   folding	   state	   of	   the	  protein,	   and	   generally	   is	   a	   great	   indicator	   of	   the	   sample	   concentration	   and	  integrity.	   	   The	   region	   located	   below	   zero	   (-­‐0.3	   -­‐	   -­‐0.8	   ppm,	   figure	   3.5),	   is	   an	  indicator	  of	  the	  folding	  state	  of	  the	  protein,	  where	  a	  well-­‐folded	  protein	  lead	  to	  the	  appearance	  of	  small	  peaks	  in	  this	  particular	  region.	  	  	  
	  
	  
Figure	  3.5.	  	   1D	   1H-­NMR	   spectroscopy	   urea	   titration	   for	   recombinant	   α1-­
antitrypsin	  integrals	  measurements.	  1H	  NMR	  spectroscopy	  spectra	  were	  recorded	  across	  the	  titration	  from	  0M,	  to	  8.0	  M	  urea.	   In	  order	  to	  monitor	  urea	  induced	  loss	  of	  folding,	  integrals	  were	  measured	  at	  3	  regions	  below	  0	  ppm	  (-­‐0.3	  -­‐	  -­‐0.4	  ppm;	  -­‐0.4	  -­‐	  -­‐0.6	  ppm;	  -­‐0.64	  -­‐	  -­‐0.78	  ppm).	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Compared	  with	  this,	  the	  spectrum	  collected	  at	  1.0	  M	  urea	  reported	  changes	  in	  the	  solution	  behaviour	  of	  α1-­‐antitrypsin	  (Fig.3.4.),	  despite	  the	  lack	  of	  unfolding	  in	  this	   range	   noted	   in	   previous	   studies.	   These	   therefore	   likely	   report	   changes	   in	  dynamic	  behaviour	  rather	  than	  a	  clear	  structural	  transition.	  	  	  Residues	   in	   the	   periphery	   of	   β-­‐sheet	   A	   reported	   increased	   conformational	  lability	   compared	   to	   their	   behaviour	   at	   0	  M	   urea.	   Intriguingly	   however,	   a	   few	  residues	  in	  β-­‐sheet	  C	  reported	  enhanced	  “native-­‐like”	  signal	  in	  these	  conditions,	  raising	   the	   possibility	   that	   these	   α1-­‐antitrypsin	   residues	   are	   more	  conformationally	  labile	  at	  0	  M	  than	  at	  1.0	  M	  urea.	  	   At	   conditions	   >	   1.5	   M	   urea,	   equilibriation/pseudo-­‐equilibriation	   was	  associated	  with	  signals	  of	  polymerisation	  and	  a	  highly	  unfolded	  state	  (Fig.3.6.).	  	  Polymerisation	  was	  reported	  by	  decline	  in	  1D	  NMR	  spectral	  intensity	  over	  time	  within	  a	   sample	  and/or	   relative	   to	   the	   signal	   intensities	  observed	  at	  0	  M	  urea,	  across	  the	  entire	  range	  where	  different	  polypeptide-­‐related	  signals	  are	  observed.	  	  It	   appeared	   maximal	   at	   3.0-­‐4.0	   M	   and	   minimal	   by	   7.6	   M.	   	   Unfoldedness	   was	  defined	  as	  a	  2D	  spectral	  pattern	  of	  cross-­‐peak	  chemical	  shifts	  closely	  related	  to	  those	  observed	  at	  7.6	  M	  urea.	  	  	  At	  2.0	  M	  urea,	  assignable	  cross-­‐peaks	  reporting	  on	  the	  native	  state	  were	  gradually	  lost	  over	  7	  hours	  and	  this	  could	  be	  detected	  over	  sequential	  scans.	  	  The	  rates	  of	  signal	  loss	  over	  this	  period	  varied	  between	  different	  residues	  (Fig.	  3.7.).	  This	  appeared	  not	  to	  be	  simply	  a	  function	  of	  differential	  signal:noise	  ratios	  since	  cross-­‐peaks	   with	   similar	   initial	   intensities	   demonstrated	   different	   decay	  patterns.	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Figure	  3.6.	  	   Intensity	   and	   chemical	   shift	   changes	   occurring	   at	   1.0	   and	   1.5	   M	  
urea,	  residue-­specific	  data	  for	  intensity	  changes.	  	  These	  are	  calculated	  as	  the	  ratios	  of	  intensities	  recorded	  at	  1.0	  M	  urea	  to	  those	  recorded	  at	  0	  M	  urea.	  	  Heatmap	   colouring	   here	   is	   such	   that	   increasing	   intensity	   is	   indicated	   by	  increasing	  redness	  and	  decreasing	  intensity	  by	  increasing	  blueness.	   	  The	  range	  for	  I1/I0	  values	  is	  0.00	  -­‐	  1.29.	  	  No	  change	  (i.e.	  ratio	  of	  1.00)	  is	  shown	  in	  white	  and	  the	   minimal	   observed	   value	   (0.00)	   in	   blue.	   	   Maximal	   redness	   therefore	  corresponds	  to	  a	  theoretical	  maximum	  ratio	  of	  2.00.	  Magnitude	  of	  chemical	  shift	  changes	  (Δδ):	  	  The	  data	  are	  represented	  by	  heatmap	  colouring.	  	  Increasing	  Δδ	  is	  indicated	  by	  increasing	  redness.	   	  This	  is	  scaled	  relative	  to	  all	  changes	  reported	  between	  0	  and	  2.0	  M	  urea	  by	  the	  subset	  of	  assigned	  and	  well-­‐dispersed	  residues	  unambiguously	   observable	   in	   1H-­‐15N	   TROSY-­‐HSQC	   spectra	   (spheres).	   	   The	  colour	   range	  was	   therefore	   between	   no	   change	   (0.0	  Hz	   -­‐	  white)	   and	  maximal	  change	  (80.7	  Hz,	  observed	  for	  Thr144	  at	  1.5	  M	  urea	  -­‐	  red).	  	  Residues	  that	  could	  not	  be	  followed	  in	  this	  way	  via	  1H-­‐15N	  TROSY	  HSQC	  spectra	  are	  coloured	  grey.	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Figure	  3.7.	  	   Real-­time	  2D	  NMR	  and	  intensities	  changes	  occurring	  at	  2.0M	  urea.	  A)	   1H-­‐15N-­‐	   TROSY	   HSQC	   NMR	   spectroscopy	   spectra	  were	   recorded	   across	   the	  titration	   at	   2.0	  M	  urea	   successively	   for	   2	   hours	   acquisition	   times.	   The	   spectra	  were	   grouped	   three	   at	   the	   time,	   0-­‐6	   hours,	   6-­‐12	   hours,	   12-­‐18	   hours	  experiments.	  B)	  Where	  residues	  lost	  native-­‐like	  signal	  over	  a	  longer	  period	  (i.e.	  ≥	   4	   timepoints)	   in	   a	   progressive	   manner,	   these	   declines	   were	   fitted	   to	   an	  exponential	   decay	   function	   and	   the	   rate	   constant	   calculated	   were	   plotted	  against	  the	  amino-­‐acids	  sequence;	  (C)	  These	  rates	  are	  indicated	  by	  colour-­‐coded	  spheres	  representation.	  Residues	  for	  which	  signal	  intensity	  was	  lost	  at	  the	  first	  (0	  h),	  second	  (2	  h)	  and	  third	  (4	  h)	  timepoints	  are	  indicated	  by	  black,	  brown	  and	  purple	  colouring	  respectively.	  The	  spheres	  with	  rate	  constants	  are	  illustrated	  on	  a	   red-­‐white	   heatmap	   scale	  where	  white	  would	   represent	   no	   change	   over	   this	  time	  period	  from	  native	  signal	  intensity	  and	  maximal	  redness	  corresponds	  to	  a	  decay	   rate	   of	   7.10-­‐5	   s-­‐1.	   Overall	   therefore,	   apparent	   rates	   of	   unfolding	   for	   the	  various	  residues	  follow	  the	  order:	  black>brown>purple>red>white.	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The	   observable	   2D	   spectra	   at	   3.0,	   4.0	   and	   6.0	   M	   urea	   were	   of	   lower	  intensity	  corresponding	  to	  the	  degree	  of	  polymerisation	  to	  that	  seen	  at	  7.6	  M,	  but	  otherwise	  closely	  related	  to	  it.	   	  Successive	  urea	  increments	  from	  4.0	  M	  resulted	  in	   increased	   spectral	   intensities	   and	   gradual,	   small-­‐scale	   migration	   of	   cross-­‐peaks	  between	  successive	  conditions	  (Fig.	  3.8).	  	  
	  
Figure	  3.8.	  	   1H-­15N-­TROSY	   HSQC	   NMR	   spectroscopy	   urea	   titration	   for	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The	  observable	  2D	  spectra	  at	  4.0	  and	  7.6	  M	  urea	  were	  of	  lower	  intensity	  corresponding	  to	  the	  degree	  of	  polymerisation	  to	  that	  seen	  at	  7.6	  M,	  relative	  to	  the	   overall	   intensity	   obtained	   at	   0.0	   M	   urea,.	   This	   explains	   the	   expected	  disappearance	   of	   the	   well-­‐folded	   peaks	   and	   the	   partial	   appearance	   of	   the	  unfolded	  signals	  at	  4.0	  M	  urea	  compared	  to	  7.6	  M	  urea	  (Fig.3.9).	  
	  
Figure	  3.9.	  	   1H-­15N-­TROSY	   HSQC	   NMR	   spectroscopy	   urea	   titration	   for	  
recombinant	  α1-­antitrypsin.	  Overlays	  of	  0.0	  M	  (blue),	  4.0	  M	  (red),	  and	  7.6	  M	   (black)	  urea,	   and	  below	   individual	   spectra	   zoomed	   in	  between	  7.5-­‐9.0	  ppm	  (1H	  dimension)	  and	  100-­‐130	  ppm	  (15N	  dimension).	  	  	  
	   92	  
3.2.2.	  Circular	  Dichroism	  studies	  of	  the	  plasma	  derived	  and	  
recombinant	  α1-­antitrypsin	  	  
[work	  carried	  out	  in	  collaboration	  with	  Dr	  James	  Irving	  and	  Dr	  Imran	  Haq	  (Lomas	  group,	  
CIMR,	  University	  of	  Cambridge]	  The	   absence	   of	   any	   NMR	   spectral	   signal	   clearly	   attributable	   to	   a	  thermodynamically-­‐stabilised	   intermediate	   state	   in	   the	   equilibria	   and	   pseudo-­‐equilibria	   studied	   raised	   the	   question	   of	  whether	   any	   such	   states	  were	   in	   fact	  present	   in	   the	  equilibrium	  state.	   	  A	  possible	   explanation	   for	   their	   absence	  was	  that,	   at	   the	   high	   α1-­‐antitrypsin	   concentrations	   required	   for	   2D	   NMR	  spectroscopy,	  intermediates	  were	  all	  rapidly	  taken	  up	  into	  polymers.	  	  To	  assess	  this	   further	   I	   undertook	   CD	   spectroscopy	   studies	   at	   very	   low	   α1-­‐antitrypsin	  	  concentration	   (0.1	   mg/ml,	   2.2	   μM)	   to	   minimize	   the	   effects	   of	   urea-­‐induced	  polymerisation	   while	   preserving	   changes	   within	   the	   fold.	   	   The	   low	   protein	  concentration	  led	  to	  relatively	  noisy	  but	  interpretable	  traces	  (Fig.3.10.).	  	  In	  order	  to	   assess	   in	   detail	   the	   secondary	   structure	   characteristics	   of	   intermediate	  formation	   I	   collected	   all	   interpretable	   far	   u.v.	   spectra	   for	   all	   conditions	   in	  contrast	   to	   the	   single	   (222.0	   nm)	   wavelength	   studies	   reported	   previously.	  	  Surprisingly	   however,	   across	   urea	   titrations,	   all	   traces	   for	   both	   recombinant,	  non-­‐glycosylated	  and	  plasma-­‐derived,	  glycosylated	  (M)	  wild-­‐type	  α1-­‐antitrypsin	  appeared	   to	   pass	   through	   a	   common	   iso-­‐elliptic	   (isosbestic)	   point	   (~208	   nm).	  	  Since	   this	   had	   to	   be	   judged	   for	   an	   inherently	   low	   signal:noise,	   the	   residual	  differences	  between	  the	  apparent	   iso-­‐elliptic	  point	  and	   individual	   traces	  across	  the	   urea	   range	   were	   calculated.	   No	   systematic	   pattern	   of	   variation	   was	  discernible	   by	   this	   approach	   and	   so	   the	   variation	  was	   felt	  most	   likely	   to	   be	   a	  function	  of	  the	  noise	  of	  the	  system.	  	  	  	  This	  type	  of	  pattern	  is	  most	  consistent	  with	  a	  two-­‐state	  (native-­‐unfolded)	  transition	   for	   α1-­‐antitrypsin	   in	   urea.	   	   In	   a	   two-­‐state	   system,	   in	   equilibrium	  conditions	   a	   polypeptide	   chain	   populates	   only	   native	   or	   unfolded	   states.	   The	  proportions	  of	  each	  are	  determined	  by	  the	  concentration	  of	  denaturant,	  but	  for	  all	  ratios	   the	  net	  CD	  spectral	   trace	  must	  pass	  through	  the	   iso-­‐elliptic	  point	   that	  the	  traces	  associated	  with	  the	  folded	  and	  random	  coil	  states	  will	  share.	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Figure	  3.10.	  	   Circular	  Dichroism	  urea	  titration	  of	  recombinant	  α1-­antitrypsin.	  Recombinant	  non-­‐glycosylated	  WT	  α1-­‐antitrypsin	  demonstrated	  unfolding	  behaviour	  converging	  at	  a	  single	  iso-­‐elliptic	  point	  characteristic	  of	  a	  two-­‐states	  unfolding	  pathway.	  	  	   The	   apparent	   fraction	   unfolded	   (Fapp)	   can	   therefore	   be	   assessed	   by	   the	  equation	  Fapp	  =	   (θ-­‐θ0M)/(θ8M-­‐θ0M)	  where	  θ	   is	   the	  ellipticity	  observed	  at	  a	  given	  wavelength	  and	  θ0M	  and	  θ8M	  are	  the	  ellipticities	  recorded	  at	  the	  same	  wavelength	  at	  0M	  and	  8.0M	  urea	  respectively	  (Fig.	  3.11).	  All	  Fapp	  values	   in	  the	  210-­‐230	  nm	  wavelength	  ranges	  where	  folded	  and	  unfolded	  spectra	  were	  well	  diverged,	  were	  calculated.	   Mean	   (±/-­‐SD)	   values	   are	   plotted	   for	   all	   variants	   across	   the	   urea	  titration.	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Figure	  3.11.	  	   The	   apparent	   fraction	   folded	   (Fapp)	   Circular	   Dichroism	   urea	  
titration.	   For	   the	   plasma	   glycosylated	   M-­‐	   and	   Z-­‐;	   and	   recombinant	   WT,	  Thr114Phe,	  and	  Gly117Phe	  mutants	  α1-­‐antitrypsin	  measured	  at	  210-­‐230	  nm.	  	  	   Fapp	  were	  measured	  by	   the	  equation	  Fapp	  =	   (θ-­‐θ0M)/(θ8M-­‐θ0M)	  where	  θ	   is	  the	  ellipticity	  observed	  at	  a	  given	  wavelength	  and	  θ0M	  and	  θ8M	  are	  the	  ellipticities	  recorded	  at	  the	  same	  wavelength	  at	  0	  M	  and	  8.0	  M	  urea	  respectively.	  Overall	   recombinant	   non-­‐glycosylated	   wild-­‐type	   and	   plasma	   derived	  glycosylated	   M	   α1-­‐antitrypsin	   showed	   very	   similar	   secondary	   structure	  behaviour	  across	  the	  equilibrium	  state	  urea	  titration.	  The	  subtle	  differences	  that	  are	   noted	   may	   be	   due	   to	   glycosylation	   status	   or	   presence	   of	   a	   non-­‐cleavable	  hexahistidine	  N-­‐terminal	  tag	  on	  the	  recombinant	  constructs.	  	  Having	   defined	   this	   system	   for	   wild-­‐type	   α1-­‐antitrypsin	   in	   the	   absence	  and	   presence	   of	   glycosylation	   I	   then	   used	   it	   to	   investigate	   the	   effects	   of	  polymerogenic	   (Z)	   and	   stabilizing	   (Thr114Phe,	   Gly117Phe)	   variants	   on	   the	  equilibrium	   behaviour	   of	   the	   protein	   fold	   in	   urea.	   	   Plasma-­‐derived	   Z	   α1-­‐antitrypsin	  was	  provided	  by	  kind	  gift	  of	  Dr	  Imran	  Haq	  (Lomas	  group,	  University	  of	  Cambridge)	  whilst	  the	  two	  phenylalanine	  variants	  had	  previously	  been	  made	  recombinantly	   and	   characterized	   within	   the	   Gooptu	   group	   (ISMB/Birkbeck,	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University	   of	   London)	   as	   described	   previously88.	   	   CD	   spectral	   data	  were	   again	  consistent	  with	   two-­‐state	  behaviour	   for	  both	  variants	  and	  analysed	   in	   terms	  of	  the	  unfolded	  fraction	  (Fig.3.10.).	  Whilst	  the	  Thr114Phe	  and	  Gly117Phe	  mutation	  resulted	  in	  a	  moderate	  and	  large	  increases	  in	  the	  thermodynamic	  stability	  of	  α1-­‐antitrypsin	  respectively,	   the	  Z	  mutation	  was	  associated	  with	  no	  clear	  reduction	  in	   thermodynamic	   stability	   as	   reflected	   by	   the	   transition	  midpoint	   (U0.5,	   Table	  3.1).	   	   If	   anything	   it	   appears	   to	   be	   associated	   with	   a	   somewhat	   increased	  transition	   midpoint.	   However	   the	   CD	   spectra	   for	   the	   Z	   variant	   (and	   to	   some	  degree	   plasma-­‐derived	   M	   α1-­‐antitrypsin	   that	   is	   its	   appropriate	   control)	   were	  more	   affected	   by	   noise	   than	   the	   other	   traces.	   	   More	   studies	  may	   therefore	   be	  required	  to	  confirm	  this	  surprising	  finding	  and	  at	  present	  the	  most	  conservative	  interpretation	  is	  favoured.	  	  	   WT	   Thr114Phe	   Gly117Phe	   M	   Z	  U0.5	  (SD)	   3.3	  (0.2)	  M	   3.4	  (0.2)	  M	   5.0	  (0.4)	  M	   2.7	  (0.2)	  M	   3.2	  (0.4)	  M	  
Table	  3.1.	  	   Thermodynamic	  stability	  as	  reflected	  by	  the	  transition	  midpoint	  
U0.5	  	  
3.2.3.	  Transiently	  populated	  α1-­antitrypsin	  intermediates	  form	  off-­
pathway	  polymers	  with	  defined	  secondary	  structure	  in	  urea	  	   The	   off-­‐pathway,	   urea-­‐induced	   polymers	   arose	   within	   a	   two-­‐state	  unfolding	  system.	  Since	  polymers	  do	  not	  arise	  when	  the	  native	  state	  is	  maximally	  populated,	   this	   finding	   can	   only	   be	   explained	   in	   two	   ways.	   Urea-­‐induced	  polymers	   could	   be	   formed	   from	   mechanistic	   but	   not	   thermodynamically	  stabilized	   intermediate	   species	   that	   are	   transiently	   populated	   in	   the	   native-­‐unfolded	   transition.	   Alternatively,	   urea-­‐induced	   polymers	   might	   form	   from	  unfolded	   α1-­‐antitrypsin	   but	   only	   be	   stable	   at	   ~2.0-­‐4.0	   M	   urea.	   Indeed,	   unlike	  heat-­‐induced	  or	  pathological	  polymers,	  urea-­‐induced	  polymers	  do	  not	  appear	  to	  be	   stable	   at	   high	   urea	   concentration.	   However	   urea-­‐induced	   oligomers	   appear	  sufficiently	  ordered	  to	  form	  electrophoretically	  distinct	  assemblies	  on	  TUG-­‐PAGE	  (Fig.3.12).	   Aggregation	   of	   fully	   unfolded	   polypeptide	   species	   is	   best	  characterized	   in	   terms	   of	   the	   formation	   of	   disordered	   assemblies	   or	   amyloid	  species	  made	   up	   of	   many	   subunits.	   	   It	   therefore	   seems	  most	   likely	   that	   urea-­‐
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induced	  polymers	  form	  from	  partially	  folded,	  transiently-­‐populated	  states	  on	  the	  urea-­‐induced	  unfolding	  pathway.	  	  	  
	  
Figure	  3.12.	  	   Transiently	   populated	   α1-­antitrypsin	   intermediates	   form	   off-­
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3.3.	  Discussion	  	  	  	   It	   is	   important	   to	   characterize	   the	   folding/unfolding	   behaviour	   of	   α1-­‐antitrypsin	  since	  various	   lines	  of	  study	  have	   indicated	  that	   intermediates	  along	  these	   pathways	   are	   responsible	   for	   its	   polymerisation	   in	   disease.	   The	   biggest	  burden	   of	   α1-­‐antitrypsin	   polymer	   load	   appears	   to	   be	   within	   its	   folding	  compartment:	   the	   hepatocyte	   ER102.	   The	   Z	   mutation	   has	   been	   proposed	   to	  perturb	   normal	   folding	   of	   α1-­‐antitrypsin171	   and	   thermodynamically	   destabilize	  its	  native	  conformer103.	  Various	  biophysical	  data	  have	  supported	  the	  presence	  of	  thermodynamically	   stabilized	   intermediates	   across	   denaturant	   titrations81;	   83	  and	  upon	  heating101;	  113.	  It	  is	  also	  a	  goal	  of	  the	  host	  groups	  for	  this	  project	  to	  use	  NMR	   spectroscopy	   and	   complementary	   methods	   to	   understand	   folding	   of	   the	  polypeptide	   nascent	   chain	   on	   the	   ribosome	   and	   within	   the	   ER,	   and	   also	   how	  pathogenic	   mutations	   affect	   this.	   	   Urea	   equilibrium	   titration	   studies	   are	   the	  classical	  way	  to	  explore	  the	  folding	  behaviour	  of	  a	  full-­‐length	  polypeptide	  chain	  by	   NMR	   spectroscopy172.	   	   Such	   studies	   were	   therefore	   undertaken	   for	   α1-­‐antitrypsin.	  	   The	   NMR	   spectroscopic	   data	   in	   this	   chapter	   identify	   residue-­‐specific	  changes	   in	   native	   wild-­‐type	   α1-­‐antitrypsin	   at	   low	   urea	   concentrations	   (1.0	   M	  urea).	   	   These	   likely	   reflect	   alterations	   in	   conformational	   dynamics	   (kinetic	  instability)	  rather	  than	  a	  transition	  to	  a	  different	  state.	  A	  few	  residues,	  e.g.	  in	  β-­‐sheet	  C	  show	  this	  as	  a	  reduction	  rather	  than	  an	  increase	  in	  native-­‐like	  signal,	  and	  may	  indicate	  features	  that	  become	  more	  stable	  and	  so	  prevent	  global	  unfolding	  in	   low	   denaturant	   conditions.	   	   At	   1.5	   M	   urea	   the	   changes	   become	   more	  generalized	  and	  are	  compounded	  by	  a	   low	  constant	   level	  of	  sample	   loss	  due	  to	  polymerisation.	  	  	   In	  the	  urea	  range	  2.0-­‐6.0	  M,	  with	  an	  α1-­‐antitrypsin	  concentration	  of	  100	  μM,	  urea-­‐induced	  polymerisation	  becomes	  the	  dominant	  phenomenon.	  	  Residual	  monomeric	  polypeptide	  signal	  at	  equilibrium	  is	  highly	  similar	  to	  that	  of	  the	  fully	  unfolded	   state	  maximally	   populated	   at	   7.6	  M	   urea.	   	   Despite	   the	   occurrence	   of	  polymerisation,	  no	  signal	  attributable	  to	  a	  distinct	  thermodynamically-­‐stabilised	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intermediate	   state	   is	   observed.	   	   It	   seemed	   likely	   that,	   at	   relatively	   high	   α1-­‐antitrypsin	   concentrations,	   any	   such	  monomeric	   intermediate	   could	  be	   rapidly	  taken	  up	  within	  polymers.	  	  To	  explore	  this	  possibility,	  CD	  spectroscopy	  was	  used	  for	   complementary	   urea	   equilibrium	   studies	   at	   50-­‐fold	   lower	   protein	  concentration	  where	   polymerisation	   effects	  would	   be	  much	   less	   evident.	   	   This	  system	   also	   allowed	   relatively	   straightforward	   assessment	   of,	   and	   comparison	  between:	   wild-­‐type,	   stabilized	   and	   disease-­‐variant	   recombinant	   (non-­‐glycosylated)	  and	  plasma-­‐derived	  (glycosylated)	  α1-­‐antitrypsin.	  	   Remarkably	   these	   data	   also	   strongly	   supported	   the	   2	   state	   solution	  behaviour	  of	  α1-­‐antitrypsin	  in	  urea.	  These	  data	  are	  in	  apparent	  contradiction	  to	  earlier	   urea	   equilibrium	   studies	   using	   more	   limited	   CD	   spectral	   findings	   that	  defined	   an	   intermediate	   state	   based	   upon	   a	   plateau	   phase	   around	   4.0	  M	   urea	  within	  the	  loss	  of	  signal	  associated	  with	  unfolding83;166;81;	  100;	  167.	  The	  discrepancy	  may	  best	  be	  explained	  by	  confounding	  effects	  of	  urea-­‐induced	  polymerisation	  at	  the	   higher	   α1-­‐antitrypsin	   used	   in	   the	   earlier	   work.	   The	   absence	   of	   an	  intermediate	   species	   characterised	   by	   urea	   equilibrium	   studies	   does	   not	  necessarily	   suggest	   that	   intermediate	   states	   cannot	   be	   accessed	   in	   other	  unfolding	   (e.g	   guanidine)	   systems.	   	   Moreover	   the	   absence	   of	   a	  thermodynamically	   stabilised	   intermediate	   in	   equilibrium	   conditions	   does	   not	  preclude	  the	  existence	  of	  a	  kinetic	  intermediate.	   	   	  Similarly	  it	  does	  not	  preclude	  the	  potential	   for	   intermediates	  along	  other	  polymerogenic	  pathways	  within	  the	  energy	  landscape	  (as	  illustrated	  in	  fig.1.16.).	  	  Such	  a	  pathway	  will	  be	  explored	  in	  Chapter	  5	  in	  the	  context	  of	  a	  deficiency	  mutation.	  	   In	   addition	   the	   relatively	   mild	   thermodynamic	   destabilization	   of	   the	  native	  fold	  by	  the	  Z	  mutation	  in	  plasma-­‐derived	  α1-­‐antitrypsin	  contrasts	  with	  its	  highly	  polymerogenic	  effects	  in	  disease	  and	  when	  native	  protein	  is	  incubated	  at	  physiological	   temperatures148.	   	   This	   is	   demonstrated	  by	   the	  opposite	   effects	   of	  the	   ‘stabilizing’	   Thr114Phe	   and	   Gly117Phe	   mutations.	   They	   increase	   the	  thermodynamic	   stability	   of	   α1-­‐antitrypsin	  more	  markedly	   than	   the	   Z	  mutation	  reduces	  it.	  However	  they	  have	  no	  rescue	  and	  minor	  rescue	  effects,	  respectively,	  on	  ER	  polymer	  load	  and	  native	  α1-­‐antitrypsin	  secretion	  when	  introduced	  on	  a	  Z	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4.1.	  Introduction	  
4.1.1.	  General	  principle	  of	  HDXNMR	  	  Members	  of	  the	  serpin	  superfamily	  of	  proteins	  regulate	  key	  physiological	  processes	   through	   their	  ability	   to	  undergo	  major	  conformational	   transitions174.	  As	   was	   described	   in	   Chapter	   I,	   function	   is	   intimately	   related	   to	   the	   unusual	  metastability	   of	   the	   native	   state	   to	   which	   serpins	   fold.	   Pathogenic	   mutations	  trigger	   abnormal	   conformational	   transitions	   to	   populate	   intermediate	   state(s)	  that	   result	   in	   serpin	   polymerisation	   through	   a	   mechanism	   that	   remains	  controversial96;	   97;	   99.	   Using	   NMR	   spectroscopy,	   we	   are	   investigating	   the	  interrelated	   processes	   of	   serpin	   folding,	   misfolding	   and	   polymerisation	   in	  solution	   using	   the	   45	   kDa	   prototypic	   serpin	   α1-­‐antitrypsin.	   The	   recent	  assignment	  of	  the	  backbone	  resonances	  of	  α1-­‐antitrypsin	  by	  our	  group	  has	  been	  a	  major	  breakthrough	   in	   this	   regard173.	   	   It	   allows	  us	   to	  ask	  more	  sophisticated	  questions	   by	   a	   range	   of	   NMR	   techniques,	   for	   instance	   to	   understand	   how	   the	  dynamic	   proprieties	   of	   individual	   residues	   within	   native	   α1-­‐antitrypsin	   may	  facilitate	  conformational	  change.	  	  	  To	  probe	  the	  conformational	  dynamics	  of	  the	  native	  state	  in	  solution	  over	  slow	   (>ms)	   timescales,	   backbone	   amide	   hydrogen/deuterium	   (HD)	   using	  NMR	  (HDXNMR)	   exchange	  was	  used.	   	   Figure	  4.1	   shows	   the	  HDXNMR	  method	  based	  upon	  a	  chemical	  reaction	  in	  which	  a	  covalently	  bonded	  hydrogen	  amide	  atom	  is	  exchanged	  by	  a	  deuterium	  atom.	  The	  rate	  of	  exchange	  is	  related	  to	  the	  degree	  of	  solvent	  exposure	  and	  protection	  due	  to	  secondary	  structure	  interactions	  within	  a	  molecule.	  HD	  exchange	  can	  be	  monitored	  by	  Mass	  Spectrometry	  (HDXMS)90;	  175;	  176;	  177;	  178	  at	  the	  level	  of	  peptide	  fragments,	  or	  at	  the	  residue-­‐specific	  level	  using	  NMR	   spectroscopy129.	   	   The	   rate	   of	   exchange	   for	   protein	   backbone	   amide	  hydrogen	   atoms	  varies	   across	   timescales	   from	   seconds	   to	   years.	   The	   exchange	  rate	   is	   slow	  when	   the	   amide	   is	   buried	   in	   the	   core	  of	   the	  protein,	   or	  when	   it	   is	  involved	   in	   a	   hydrogen	   bond	   (closed)179.	   Conversely	   exchange	   will	   be	   faster	  when	  it	  is	  exposed	  to	  the	  solvent	  (open)	  (Fig.4.1.A).	  HDXNMR	  can	  be	  monitored	  by	  recording	  the	  stability	  or	  disappearance	  of	  signal	  over	  time	  after	  rapid	  solvent	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exchange	   into	   D2O	   using	   15N-­‐1H-­‐correlation	   NMR	   experiments,	   typically	   ‘rapid	  acquisition’	  SOFAST-­‐HMQC	  experiments138	  are	  used.	  	  Solvent	  exchange	   is	  undertaken	  using	   lyophilization,	  a	  desalting	  column,	  or	   dilution	   into	   D2O.	   The	   opposite	   process	   (i.e.	   gain	   of	   signal)	   occurs	   if	   a	  deuterated	  sample	  is	  solvent	  exchanged	  into	  H2O.	  Here,	  the	  former	  approach	  has	  been	  used.	  As	   for	   the	   concepts	  underpinning	   the	  experiment,	   the	  Linderstrøm-­‐Lang	  model	  of	  H-­‐D	  exchange	  proposes	  that	  the	  rate	  of	  H-­‐D	  exchange:	  kex,	  can	  be	  related	   to	   the	   open/closing	   of	   structural	   segments	   of	   the	   protein180.	   In	   the	  ‘closed’	   state,	   the	   amides	   are	   protected	   and	   less	   likely	   to	   exchange	   with	   the	  deuterium	  of	   the	   solvent.	   In	   the	   ‘open’	   state,	   the	  proton	  will	   exchange	  with	   an	  intrinsic	   rate,	   kint,	   that	   depends	   upon	   pH,	   temperature	   and	   the	   protection	  provided	   by	   the	   peptide	   bond	   and	   the	   side-­‐chains	   of	   the	   two	   adjacent	   amino-­‐acids.	  The	  relationships	  of	  kint	  with	  these	  variables	  are	  known.	  	  Therefore,	   by	   comparing	   the	   observed	   exchange	   rate	   kex	   of	   a	   particular	  backbone	   amide	   proton	  within	   the	   sequence	   at	   a	   specific	   temperature	   and	   pH	  with	  kint,	   the	  degree	  of	  protection	  afforded	  by	  local	  structure	  and	  dynamics	  can	  be	   quantified.	   kex	   can	   be	   derived	   by	   fitting	   intensity	   decay	   data	   of	   the	   amide	  backbone	  resonance	  to	  the	  exponential	  function:	  I(t)	  =	  I0	   .	  e	   (-­‐kex.t)	  +	  c	  (Fig.4.1.B),	  where	  I(t)	  is	  the	  intensity	  at	  time	  t	  following	  solvent	  exchange	  and	  I0	  is	  the	  initial	  intensity	   before	   solvent	   exchange.	   Once	   the	   constant	   of	   exchange	   is	  characterised	  at	  a	  residue-­‐specific	  level,	  two	  regimes	  can	  be	  analyzed	  depending	  on	  the	  relative	  values	  of	  kint	  	  and	  kcl.	  	  Since	   proton	   exchange	  will	   be	   rapid	   at	   high	  pH	   and	   slow	   at	   low	  pH,	  kex	  values	   relate	   to	  pH	   (Fig.4.1.C)	  with	   the	   relationship	  determined	  by	   the	  kint	  and	  the	   protection	   factor,	   P	   for	   the	   individual	   residue.	   In	   all	   cases	   the	   curve	   is	  characterised	  by	  complete	  pH	  independence	  at	  high	  pH	  (where	  the	  rate-­‐limiting	  step	   is	   achieving	   open	   state,	   kop	   =	   kex,	   kint	   >>	   kcl:	   EX1	   exchange	   regime)	   and	  complete	   pH	   dependence	   at	   low	  pH	   values	   (limiting	   step	   is	  HD	   exchange,	   EX2	  regime).	   In	   the	   EX2	   regime,	   kex	   is	   directly	   related	   to	   the	   protection	   factor,	   P	  (Fig.4.1.C).	  The	  determination	  of	   the	  protection	   factor	   for	  each	  amino	  acid	  of	   a	  protein	   can	  be	   used	   to	   probe	   its	   stability,	   folding	   or	   analogous	   conformational	  
	   104	  
change.	  Therefore,	  under	  appropriate	  conditions,	  the	  labile	  hydrogen	  atoms	  in	  a	  region	   of	   a	   folded	   protein	   that	   unfold	   cooperatively	   will	   be	   exchanged	  simultaneously	   and	   irreversibly	   at	   all	   solvent	   exposed	   sites.	   P	   relates	   to	   the	  difference	  in	  free	  energy	  of	  the	  observed	  residue,	  ∆Gop−cl	  =	  RT	  ln(P)	  between	  the	  “closed”	  state	  and	  the	  “open”,	  exchange-­‐competent	  state,	  which	  also	  corresponds	  to	  ∆Gapp	  =	  -­‐RT	  ln(kop)	  where	  kop	  =	  1/P.	  By	  measuring	  the	  protection	  factors	  of	  a	  different	   folding	   equilibrium	   than	   the	   native	   equilibrium	   (using	   chemical	  denaturation	  for	  example),	  the	  folding	  free	  energy	  landscape	  can	  be	  mapped	  at	  a	  residue	  specific	  level	  181;	  182;	  183	  and	  the	  protection	  factors	  of	  the	  native	  state	  can	  be	  used	  to	  map	  the	  stability	  of	  the	  structure	  179;	  184;	  185;	  186.	  Furthermore,	  the	  use	  of	  HDXNMR	   also	   provides	   insights	   into	   intermediates	   populated	   in	   solution120;	  186;	  187	  at	  equilibrium.	  
	  
	  
Figure	  4.1.	  	   Hydrogen	  Deuterium	  exchange.	   A-­‐	   Linderstrøm-­‐Lang	  model	   of	   hydrogen	  exchange	   reaction.	   Refer	   to	   main	   text	   for	   definitions	   of	   rates	   as	   well	   as	   for	  details	   of	   the	   analysis	   of	   the	   different	   HD	   exchange	   regimes188.	   B-­‐	   Schematic	  illustration	  of	  HDXNMR	  to	  allow	  the	  determination	  of	  kex	  by	  fitting	  	  (Panel	  C)	  the	  decay	   in	   intensity	   at	   a	   residue–specific	   level	   to	   an	   exponential	   decay	   function	  using	   the	   formula	   indicated	   in	   red;	   the	   variation	   of	   kex	   across	   the	   pH	   range	  (Panel	  D),	  allows	  the	  determination	  of	  regime	  (EX1	  or	  EX2),	  and	  the	  calculation	  of	   the	   protection	   factor,	   P,	   for	   residues	   in	   the	   EX2	   phase,	   using	   the	   ratio	  P=kint/kex	  and	  the	  free	  energies	  as	  described	  in	  the	  main	  text.	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4.1.2.	  HDXMS	  studies	  of	  α1-­antitrypsin	  	   HD	   of	   α1-­‐antitrypsin	   in	   the	   native	   and	   polymeric	   states	   and	   during	  complexation	   with	   ß-­‐trypsin	   has	   previously	   been	   assessed	   using	   mass	  spectrometry	   (HDXMS)	   90;	   91;	   92.	   	  When	  HDXMS	  data	  are	  obtained,	   resolution	   is	  limited	   by	   the	   lengths	   of	   the	   peptide	   products	   of	   enzymatic	   treatment.	  Nevertheless,	   these	   studies	   have	   provided	   a	   number	   of	   useful	   insights.	   Firstly,	  HDXMS	  of	  native	  α1-­‐antitrypsin	  showed	  a	  highly	  dynamic	  F-­‐helix,	  particularly	  at	  its	   C-­‐terminal	   end92.	   In	   contrast,	   strands	  3	   and	  5	   of	   the	  β-­‐sheet	  A,	  which	  must	  separate	  to	  allow	  insertion	  of	  the	  RCL,	  during	  both	  polymerisation	  and	  enzyme	  inhibition,	  are	  highly	  stable.	  Strand	  1C	  (s1C),	  which	  anchors	  the	  distal	  end	  of	  the	  RCL	  is	  also	  stable,	  while	  strand	  6	  of	  the	  β-­‐sheet	  A	  was	  found	  to	  be	  surprisingly	  flexible.	   A	   subsequent	   study	   investigated	   the	   conformational	   changes	   in	   α1-­‐antitrypsin	  during	  complex	  formation	  with	  β-­‐trypsin176.	  The	  data	  indicated	  that	  a	  substantial	   proportion	   of	   α1-­‐antitrypsin	   was	   unfolding	   transiently	   before	  refolding,	   not	  only	   in	   the	   expected	   regions,	   such	  as	  RCL,	  helix	  F,	   and	   following	  loops;	  but	  also	  helix	  A,	  strand	  6	  of	  the	  β-­‐sheet	  B	  (s6B)	  and	  the	  N-­‐terminus.	  	   More	   recently,	   the	   conformational	   changes	   during	   heat-­‐induced	  polymerisation	   were	   characterised	   using	   HDXMS	   by	   Wintrode	   et	   al90.	   Heat-­‐induced	  polymerisation	  was	  found	  to	  be	  preceded	  by	  a	  significant	  destabilization	  of	  β-­‐sheet	  C.	  As	  expected	  the	  flexible	  RCL	  became	  far	  more	  strongly	  protected	  (5-­‐10	  %	  and	  above	  20	  %)	  once	  polymerisation	  had	  occurred,	  and	  the	  centre	  of	  β-­‐sheet	  A	  and	  helix	  F	  became	  substantially	  more	  protected	  (10-­‐20	  %	  and	  above	  20	  %).	  These	  data	  are	  consistent	  with	  a	  single-­‐strand	  model	  of	  polymerisation37.	  	  	   A	   second	   model	   of	   polymerisation	   has	   been	   derived	   from	   the	   crystal	  structure	  of	  a	  closed	  dimer	  of	  antithrombin97	   that	   involved	  a	  β-­‐hairpin	  domain	  swap	   of	   the	   RCL	   and	   strand	   5	   of	   β-­‐sheet	   A	   (s5A)	   comprising	   50	   residues,	  between	  molecules.	  The	  dimer	  and	  intermediate	  states	  studied	  biochemically	  in	  the	   same	   work	   were	   induced	   by	   low	   pH	   and/or	   mild	   denaturant	   (GuHCl)	  conditions.	   	  It	  was	  proposed	  that,	  if	  considerably	  more	  structure	  were	  unfolded	  relative	   to	   the	   native	   fold	   (helix	   I	   and	   its	   linker	   to	   s5A),	   such	   a	   β-­‐hairpin	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intermolecular	  linkage	  could	  also	  underlie	  the	  formation	  of	  extended	  polymers.	  	  This	  would	  also	  lead	  to	  the	  observed	  increase	  in	  protection	  of	  the	  RCL	  and	  s5A	  regions	   data.	   	   However	   upon	   polymerisation,	   helix	   I,	   and	   adjacent	   residues	  demonstrate	  a	  small	   increase	   in	  protection	  from	  exchange	  by	  HDXMS	  (5-­‐10	  %)	  rather	  than	  the	  reduction	  that	  the	  β-­‐hairpin	  model	  would	  predict.	  A	  subsequent	  study	   showed	   that	   a	   monoclonal	   antibody	   (2C1)	   specific	   for	   α1-­‐antitrypsin	  polymers	   found	   in	   hepato-­‐cellular	   inclusions189,	   reacted	   strongly	   with	   heat-­‐induced	   polymers	   but	   not	  with	   those	   induced	   by	   guanidine93,	   urea	   or	   low	   pH.	  The	  findings	  indicated	  that	  polymers	  produced	  in	  vivo	  are	  structurally	  distinct	  to	  those	  induced	  by	  partial	  denaturation.	  	  	   The	  most	  recently	  proposed	  model	  arises	  from	  a	  low	  resolution	  structure	  of	  a	  self-­‐terminating	  trimer	  of	  α1-­‐antitrypsin	  (PDB	  structure:	  3NDD)88.	  This	  was	  formed	  by	  prolonged	  heating	  of	  an	  engineered	  mutant	  of	  α1-­‐antitrypsin	  in	  which	  conformational	   lability	  was	  constrained	  by	  an	  artificial	  disulfide	  bond	  between	  strands	   5	   and	   6	   of	   β-­‐sheet	   A.	   This	   species	   does	   contain	   the	   2C1	   monoclonal	  antibody	  recognition	  epitope	  that	  differentiates	  polymers	  found	  in	  liver	  disease	  or	   formed	   by	   heating	   from	   those	   formed	   in	   urea	   or	   guanidine88.	   The	   linkage	  demonstrates	   intermolecular	   insertion	   of	   the	   RCL	   into	   β-­‐sheet	   A.	   The	  intermolecular	  linkage	  is	  a	  domain	  swap	  of	  the	  three	  β-­‐strands	  between	  the	  RCL	  and	  the	  C-­‐terminus	   involving	  the	  s1C	  and	  the	  core	  stands	  4	  and	  5	  of	  β-­‐sheet	  B.	  None	   of	   those	   motifs	   were	   observed	   to	   demonstrate	   a	   significant	   increase	   in	  protection	   upon	   polymerisation	   in	   the	   HDXMS	   study	   (0-­‐10	  %).	   	   However,	   the	  likely	   slight	   increase	   in	  protection	  of	   the	   three	  β-­‐strands	  between	   the	  RCL	  and	  the	  C-­‐terminus	  involving	  the	  s1C	  and	  the	  core	  stands	  4	  and	  5	  of	  β-­‐sheet	  B	  upon	  polymerisation	  might	   be	   difficult	   to	   differentiate	   from	   that	   of	   the	   native	   state	  from	   changes	   in	   peptide	   deuteration	   rates.	   	   Therefore	   validation	   of	   the	   third	  model	  of	  polymerisation	  over	  another	  using	  HDXMS	  data	  is	  difficult.	  	  Together,	   these	   data	   from	   HDXMS	   studies	   surveyed	   the	   lability	   of	   α1-­‐antitrypsin	   in	   the	   native	   state	   and	   evaluated	   of	   changes	   in	   protection	   upon	  polymerisation	   and	   during	   enzyme	   inhibition,	   typically	   with	   ~70	  %	   sequence	  coverage.	  Nevertheless,	  the	  resolution	  of	  this	  technique	  is	  limited	  by	  the	  lengths	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of	  the	  tryptic-­‐digested	  peptides,	  assessed	  by	  MS.	  These	  may	  report	  the	  combined	  effects	   from	   contiguous	   residues	   that	   behave	   differently	   e.g.	   contributing	   to	  different	  structural	  motifs.	  	  HDXNMR	  studies	  were	  therefore	  undertaken	  in	  order	  to	   characterize	   backbone	   amide	   protection	   and	   dynamics	   at	   the	   level	   of	  individual	  residues.	  
4.2.	  Results	  
4.2.1.	  Sample	  integrity	  	  	   Using	   biochemical	   techniques	   aiming	   to	   measure	   the	   kinetics	   of	  polymerisation	   of	   α1-­‐antitrypsin190,	   Mahadeva	   et	   al.,	   measured	   the	   rate	   of	  polymer	   formation	   over	   a	   range	   of	   pH	   by	   measuring	   the	   intrinsic	   tryptophan	  fluorescence	  of	  plasma	  α1-­‐antitrypsin	  (excited	  at	  295	  nm	  and	  measured	  at	  340	  nm).	   Their	   results	   showed	   that	   α1-­‐antitrypsin	   begins	   to	   undergo	   acid	   or	   base-­‐induced	   polymerisation	   between	   pH	  6.0	   and	   5.0,	   and	   between	   pH	  8.0	   and	   9.0,	  respectively.	  	  The	  titration	  used	  in	  this	  analysis	  was	  therefore	  performed	  across	  the	   range	   pH	  6.0	   -­‐	   8.0	   (equivalent	   to	   pD*	   6.4	   -­‐	   pD*	   8.4).	  However,	   in	   order	   to	  increase	  the	  number	  of	  residues	  reaching	  the	  EX2	  phase,	  the	  pH	  5.75	  (pD*	  6.25)	  was	   also	   monitored,	   and	   together,	   these	   experiments	   were	   coupled	   with	   a	  complete	   set	   of	   biophysical	   and	   biochemical	   characterisation	   experiments	   to	  assess	  this	  into	  detail.	  Since	   pH	   conditions	   can	   induce	   polymerisation,	   the	   integrity	   of	   the	  protein	   samples	  used	   for	  HDXNMR	  analysis	  under	  different	  pH	  conditions	  was	  tested	  during	  each	  HDXNMR	  experiment	  using	  1H	  NMR.	   In	  particular	  cases,	  MS	  experiments	  and	  functional	  activity	  assays	  were	  also	  used.	  Figure	  4.2	  illustrates	  the	  characterisation	  of	  the	  HDXNMR	  samples	  using	  1H	  NMR	  and	  MS,	  which	  was	  undertaken	  for	  every	  pH	  condition.	  Since	  α1-­‐antitrypsin	  begins	  to	  undergo	  acid-­‐induced	   polymerisation	   between	   pH	   6.0	   and	   5.0,	   the	   characterisation	   of	   the	  sample	   integrity	   at	   pH	   6.0	   is	   shown,	   as	   a	   typical	   example	   of	   the	   type	   of	  characterisation	  undertaken	  in	  these	  analyses.	  	  	  Consideration	   of	   the	   1H	   1D	   NMR	   spectrum	   during	   the	   HDXNMR	  acquisition	  period	  from	  t=	  0	  to	  t=	  4	  days	  (Fig.4.2.A)	  and	  in	  particular	  focusing	  on	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the	   methyl	   region	   (Fig.4.2.B)	   can	   inform	   on	   sample	   integrity	   as	   this	   region	   is	  unaffected	  by	  exchange	  with	  deuterons	  .	  The	  excellent	  overlay	  observed	  indeed,	  shows	  that	  the	  entire	  sample	  has	  retained	  its	  native	  structure.	  In	  addition,	  post-­‐HDXNMR	   all	   samples	   were	   characterised	   using	   MS	   (Fig.4.2.C.).	   The	   spectra	  obtained	  show	  that	  the	  proportion	  of	  monomeric	  species	  present	  in	  the	  sample	  post-­‐NMR	   at	   pH	   6.0,	   was	   identical	   to	   that	   observed	   for	   the	   control	   (pH	   8.0,	  identical	  concentration:	  250	  μM,	  and	  100%	  active).	  	  
	  
Figure	  4.2.	  	   HDXNMR	  protein	  integrity	  characterisation	  using	  1H	  NMR	  and	  MS:	  
example	  of	  pH	  6.0	  set	  of	  data	   from	  t=0	  to	   t=4	  days.	  A-­‐	  Represents	  an	  overlay	  of	  HDXNMR	  1H	  NMR	  experiments	  monitored	  from	  t=0	  to	  t=4	  days	  at	  pH	  6.0	  across	   the	  ppm	  range.	  B-­‐	  Represents	  a	  zoom-­‐in	  of	   the	  same	  overlay	  of	   the	  methyl	  region	  unaffected	  by	  the	  exchange.	  The	  former	  illustrates	  perfect	  overlay	  between	  t=0	  and	  t=4	  days,	  demonstrating	  that	  the	  structure	  of	  α1-­‐antitrypsin	  at	  pH	   6.0	   during	   the	   HDXNMR	   experiment	   remained	   unchanged.	   C-­‐	   The	  characterisation	  of	  the	  sample	  integrity	  was	  completed	  with	  MS	  experiment	  pre-­‐	  (blue)	  and	  post	  –	  (red)	  HDXNMR	  experiments.	  This	  data	  shows	  that	  the	  quantity	  of	  monomeric	  species	  present	  in	  the	  sample	  post-­‐HDXNMR	  at	  pH	  6.0	  remained	  unchanged	  compared	  to	  the	  control	  (pH	  8.0).	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In	  order	  to	  increase	  the	  number	  of	  residues	  reaching	  the	  EX2	  phase	  in	  this	  analysis,	  HDXNMR	  was	  undertaken	  at	  pH	  5.75	  where	  the	  exchange	  is	  expected	  to	  occur	   even	   slower	   than	   at	   pH	   6.0.	   However,	   as	   described	   before,	   this	   pH	  condition	  corresponds	  to	  the	  range	  where	  α1-­‐antitrypsin	  begins	  to	  undergo	  acid-­‐induced	  polymerisation	  between	  pH	  6.0	  and	  5.0.	  Therefore	   in	  order	  to	  monitor	  the	  integrity	  of	  the	  sample	  present	  in	  solution,	  1H	  1D	  NMR	  was	  used	  (Fig.4.3.A.).	  	  
	  
Figure	  4.3.	  	   HDXNMR	   protein	   integrity	   characterisation	   using	   1H	   NMR	   for	   pH	  
5.75	   from	   t=0	   (red)	   to	   t=4	   days	   (blue).	   A-­‐	   Represents	   an	   overlay	   of	  HDXNMR	   1H	  NMR	  experiments	  monitored	   from	   t=0	   to	   t=4	  days	   at	   pH	  5.75	  B-­‐	  Represents	  the	  zoom-­‐in	  the	  methyl	  region	  0.0	  –	  2.0	  ppm.	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The	   methyl	   region	   (0-­‐2	   ppm,	   Fig.4.3.B)	   which	   is	   characteristic	   of	   the	  sample	  integrity,	  and	  homogeneity,	  unaffected	  by	  the	  exchange	  occurring	  in	  the	  sample,	  was	  overlaid	  at	  t=	  0	  (red)	  and	  t	  =	  4	  days	  (blue).	  A	  15	  %	  loss	  in	  intensity	  in	   the	  methyl	   region,	   occurring	   steadily	   over	   the	  4	   days	   of	  HDXNMR,	   reported	  loss	   of	   detectable	   monomeric	   sample	   due	   to	   polymerisation	   occurring	   at	   a	  constant	  rate.	  Before	  analysis	  of	  HD	  exchange	  rates,	  the	  intensity	  data	  recorded	  at	   pH	   5.75	   were	   therefore	   scaled	   in	   a	   time-­‐dependent	   manner	   to	   correct	   for	  sample	  loss	  using	  the	  following	  formula:	  	  	  
Corr	  (t=Ttot)	  =	  1	  –	  [Δcorr	  x	  t/Ttot]	   	   	   Equation	  3.5	  (where	  Δcorr	  =	  0.15)	  
	  
4.2.2.	  Reproducibility	  of	  HD	  exchange	  at	  pH	  7.0.	  	  	   Typically	   HDXNMR	   experiments	   record	   single	   datasets	   for	   each	   pH	  condition,	   and	   internal	   consistency	   between	   data	   at	   different	   pH-­‐points	   is	  assumed	   to	   reflect	   accuracy.	  However	   in	   order	   to	   assess	   the	   reproducibility	   of	  the	  derived	  kex	  values,	   I	  undertook	  a	  repeat	  of	  HD	  exchange	  experiments	  at	  pH	  7.0	  and	  compared	  the	  observed	  kex	  values	  (Fig.4.4).	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Figure	  4.4.	   HDXNMR	  of	  α1-­antitrypsin	  at	  pH	  7.0.	  Comparison	  of	  the	  rates	  of	  backbone	  amide	  HD	   exchange	   (kex)	   assessed	   via	   independent	   experiments	   at	   pH	   7.0	   for	  residues	  where	  the	  curve	  fits	  allowed	  R2	  values	  >	  0.8.	  The	  green	  represents	  the	  first	  set	  of	  data	  monitored	  at	  pH	  7.0,	  and	  the	  yellow	  corresponds	  to	  the	  repeat	  of	  this	  experiment.	  	  
	   The	  details	  of	  the	  HDXNMR	  results	  at	  pH	  7.0	  including	  the	  spectra	  and	  the	  fits	  are	  described	  in	  Section	  4.2.2.	  (vide	   infra).	   I	   focus	  here	  initially	  however	  on	  the	  reproducibility	  of	  these	  fits	  in	  order	  to	  show	  that	  this	  method	  is	  viable.	  This	  approach	  showed	  that	  ~2/3	  of	  kex	  values	  from	  the	  2	  experiments	  were	  broadly	  consistent	   (defined	   as	   overlap	   of	   error	   bars	   in	   Fig.4.4).	   Since	   data	   for	   a	  substantial	   minority	   of	   residues	   gave	   apparently	   poor	   agreement	   between	  experiments,	  I	  interrogated	  the	  residue-­‐specific	  data	  further	  by	  visual	  analysis	  of	  data	   from	   residues	   that	   showed	   poor	   correlation	   between	   kex	   values.	   This	  demonstrated	   two	   reasons	   for	   such	   discrepancies.	   Data	   from	   some	   residues	  showed	   curve-­‐fits	   that	  were	   visually	   poor	   despite	   high	  R2	   values	   in	   one	   of	   the	  two	   datasets.	   These	   were	   removed	   from	   the	   analysis.	   In	   other	   cases	   the	   data	  appeared	  broadly	  consistent	  but	  the	  curve-­‐fits	  were	  best	  optimized	  for	  different	  elements	  of	  the	  curve.	  Typically	  these	  fitted	  the	  transition	  between	  initial	  rapid	  decline	   and	   curve	   plateau	   in	   different	   ways,	   since	   this	   was	   the	   least	   linear	  section.	   In	   these	   cases	   the	   situation	   did	   not	   resolve	   when	   data	   in	   the	   plateau	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phase	  were	  truncated,	  or	  when	  data	  from	  sequential	  time	  points	  were	  averaged	  together	   in	   sets	   of	   four	   to	   smooth	   the	   curve.	   Faced	   with	   a	   choice	   between	  discarding	  data	  from	  one	  of	  a	  pair	  of	  similarly	  valid	  fits,	  or	  improve	  accuracy	  at	  the	  expense	  of	  consistent	  handling	  of	  different	  datasets,	  I	  opted	  in	  such	  cases	  to	  retain	  the	  mean	  of	  the	  alternative	  kex	  values.	  	  The	  grey	  dots	  (Fig.4.5.)	  show	  the	  paired	  kex	  values	  retained	  following	  this	  analysis.	  The	  trend	  line	  obtained	  for	  the	  correlation	  was	  shifted	  towards	  a	  better	  agreement	  by	  ~5	  %	  (from	  y=	  0.5333x	  -­‐0.0016,	  to	  y=	  0.5861x	  -­‐0.0023)	  following	  this	  quality	  control	  step.	  Furthermore,	  the	  R2	  value	  for	  the	  correlation	  was	  also	  improved	  (~12	  %)	  using	  this	  strategy.	  	  Overall	  the	  findings	  were	  reassuring	  that,	  when	  curve-­‐fits	  were	  assessed	  by	   both	   R2	   values	   (≥	   0.8)	   and	   by	   visual	   inspection,	   the	   data	   selected	   were	  sufficiently	   robust	   to	   rely	  on	  single	  datasets	  across	   the	  rest	  of	   the	  pH	   titration.	  	  The	  remaining	  errors	  are	  likely	  inherent	  due	  to	  the	  large	  size	  of	  the	  system	  being	  studied	  by	  NMR	  spectroscopy.	  In	  contrast,	  visual	  evaluation	  of	  curves	  for	  which	  the	  R2	  values	  were	  0.6	  –	  0.8	  confirmed	  that	  the	  fits	  were	  insufficiently	  successful	  to	  have	  confidence	  in	  the	  derived	  kex	  values	  compared	  with	  those	  retained	  with	  R2	  >	  0.8.	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Figure	  4.5.	  	   Correlation	   plot	   comparing	   the	   rates	   of	   exchange	   comparison	  
between	  HDXNMR	   sets	   of	   data	  monitored	  pH	  7.0.	   Red	   dots	   show	   the	  relationship	  between	  the	  rates	  of	  exchange	  if	  all	  curve	  fits	  with	  R2	  values	  of	  ≥	  0.8	  were	   accepted.	   Grey	   dots	   indicate	   those	   kex	   values	   retained	   from	   this	   set	  following	   visual	   evaluation	   of	   fit	   quality.	   For	   residues	   in	   this	   selected	   subset	  mean	   kex	   values	  were	   carried	   forward	   for	   comparison	  with	   those	   obtained	   at	  other	  pH	  points.	  	  
4.2.3.	  Patterns	  of	  HDXNMR	  observed	  for	  α1-­antitrypsin	  	   HDXNMR	  was	  undertaken	  at	  six	  pH	  points	  between	  pH	  5.75	  and	  pH	  8.0,	  as	  described	  in	  the	  Chapter	  II.	  Typically	  over	  150	  spectra	  were	  recorded	  at	  each	  pH	  value.	  Spectra	  were	  typically	  acquired	  for	  4	  min	  each	  (ns=8),	  with	  experiments	  with	  increased	  numbers	  of	  transients	  (NS	  =	  16,32,64,128,256,	  512	  for	  increased	  signal).	  The	  early,	  HDXNMR	  experimental	  timepoints	  collected	  over	  short	  (e.g.	  4	  min)	  timescales	  resulted,	  as	  expected,	  in	  relatively	  noisy	  SOFAST-­‐HMQC	  spectra.	  	  Nonetheless	   they	   allowed	   the	   close	  monitoring	   of	   rapidly	   exchanging	   residues	  that	   occurred	  within	   the	   first	   few	  hours.	   Typical	   SOFAST-­‐HMQC	   spectra	   at	   t=0	  and	  t=	  4	  days	  (Fig.4.6.)	  illustrates	  the	  challenge	  that	  lies	  behind	  HDXNMR	  studies	  of	  high	  molecular	  weight	  proteins	   such	  as	  α1-­‐antitrypsin.	   Indeed,	   the	   relatively	  short	   number	   of	   scans	   early	   in	   the	   exchange	   resulted	   in	   line-­‐broadening,	   and	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consequently	  low	  sensitivity.	  The	  large	  number	  of	  cross-­‐peaks	  resonances	  (~400	  amino	  acids)	  led	  to	  peaks	  overlapping.	  
	  
Figure	  4.6.	  	   1H-­15N	   SOFAST-­HMQC	   spectra	   of	   HDXNMR	   across	   the	   pH	   titration	  
from	  pH	  6.0	  to	  pH	  8.0	  at	  post	  deadtime.	  This	  figure	  illustrates	  the	  typical	  SOFAST-­‐HMQC	  spectra	  obtained	   for	   the	  HDXNMR	  experiments	   from	  pH	  6.0	   to	  pH	  8.0,	  post-­‐deadtime	   from	  which	  pH-­‐specific	  crosspeaks	   lists	  were	  generated	  to	  monitor	  atomic-­‐resolution	  intensity	  decays	  used	  for	  HDXNMR	  analysis	  of	  the	  45kDa	  α1-­‐antitrypsin,	   resulting	   in	  major	  peak	  overlapping	   in	  between	  8.0	   and	  9.0	  ppm	  in	  the	  proton	  dimension.	  	  	  
	   As	  would	  be	  expected,	  HD	  exchange	  was	  faster	  at	  higher	  values	  of	  pH	  and	  crosspeaks	  obtained	  (at	  298K	  for	  all	  datasets)	  were	  followed	  by	  transposition	  of	  the	  wild-­‐type	   α1-­‐antitrypsin	   assignment	   available	   at	   pH	   7.0	   and	   pH	   8.0,	   to	   the	  first	   exchange	   spectrum.	   Once	   crosspeaks	   were	   transferred,	   the	   resulting	  crosspeak	   set	   for	   each	  pH	  dataset	  were	   individually	   selected	  based	   on	  manual	  inspection	   for	   overlap	   and	   identity	   and	   then	   centered,	   The	   resulting	   peak	   lists	  generated	  were	   then	   applied	   to	   each	   spectrum	  within	   an	  HDXNMR	  datasets.	  A	  total	   of	   approximately	   200	   crosspeaks	   (out	   of	   394	   amino-­‐acids)	   formed	   the	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initial	   peaklist.	   The	   4	   min	   SOFAST-­‐HMQC	   experiments	   required	   for	   a	   fast	  monitoring	   of	   the	   exchange	   in	   intensity,	   unsurprisingly	   demonstrated	   a	   low	  sensitivity,	   as	   a	   consequence	   of	   both	   the	   large	   size	   of	   the	   protein,	   and	  experimental	  timescale.	  Even	  though	  remarkable	  given	  the	  size	  of	  α1-­‐antitrypsin,	  the	   spectra	   low	   sensitivity	   rendered	   the	   transfer	   of	   the	   assignment	   across,	   a	  challenging	  process	  that	  was	  undertaken	  cautiously.	  	  
	  
Figure	  4.7.	  	   Characterisation	  of	  the	  EX2	  regime.	  The	  kex	  ratios	  of	  pH	  6.5/pH	  6.0	  (pink),	  pH	  7.0/pH	  6.5	  (red),	  pH	  8.0/pH	  7.0	  (light	  blue),	  pH	  7.0/pH	  6.0	  (dark	  blue),	  pH	  6.5/pH	  5.75	  (dark	  green),	  and	  pH	  6.0/pH	  5.75	  were	  measured	  to	  assess	  whether	  residues	   reached	   EX2	   to	   allow	   further	   protection	   factor	   calculation.	   Since	  [H+]=10-­‐pH,	   therefore	  ratios	  between	  one	   full	  pH	  unit,	  will	  be	  equal	   to	  10,	  0.75	  pH	  units	  ratio	  corresponds	  to	  a	  value	  of	  5.62,	  0.5	  pH	  units	  ratio	  corresponds	  to	  a	  value	  of	  3.16,	  and	  0.25	  pH	  units	  ratio	  corresponds	  to	  a	  value	  of	  1.77.	  Residues	  that	   reached	   the	   EX2	   phase,	   by	   reaching	   the	   corresponding	   theoretical	   ratio,	  were	  further	  investigated	  for	  protection	  factors	  and	  free	  energy	  calculations.	  	  	  Analysis	   of	   exchange	   curves	   using	   exponential	   fitting	   was	   possible	   for	  approximately	  50	  residues.	  When	  exchange	  is	  directly	  proportional	  to	  pH	  (‘EX2	  regime’),	  accurate	  protection	  factors	  can	  be	  calculated	  (Fig.4.7).	  The	  EX2	  regime	  was	   assessed	   by	   quantifying	   the	   kex	   ratios	   between	   the	   various	   pH	   conditions	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used	   in	   this	   analysis,	   and	   the	   subsequent	   theoretical	   values	   corresponding	   to	  linear	  dependency	  between	  the	  exchange	  rate	  and	  the	  pH.	  Since	  the	  exchange	  is	  directly	  proportionate	   to	  pH	   in	  EX2	   regime,	   and	   since	   the	  difference	   in	  proton	  concentration	  between	  different	  pH	  conditions	  is	  equal	  to	  10-­‐ΔpH;	  the	  theoretical	  ratios	  for	  a	  residue	  to	  be	  in	  the	  EX2	  regime	  can	  be	  characterised	  as	  described	  in	  Fig.4.7.	   	   The	   exchange	   behaviour	   of	   residues	   identified	   as	   being	   in	   EX2	   is	  described	  further	  below.	  This	   study	   identified	   three	   categories	   of	   HD	   exchange	   occurring	  within	  native	   α1-­‐antitrypsin:	   (i)	   Slow	   exchange	   (observed	   by	   constant	   crosspeak	  intensity	  across	  the	  timespan	  measured	  of	  4	  days,	  suggesting	  a	  highly	  structured	  environment	  and	  consequent	  protection	   from	  deuterated	  solvent,	  Fig.4.8.	   set1)	  (ii)	  crosspeak	  exchange	  observed	  as	  exponential	  intensity	  decay	  (I(t)	  =	  I0	  .	  e	  (-­‐kex.t);	  Fig.4.8.	   set2);	   and	   (iii)	   fast	   exchange	   (complete	   resonance	   exchange	   occurring	  during	   the	   assay	   deadtime,	   Fig.4.8.	   set3).	   For	   the	   residues	   entering	   an	   EX2	  regime	   (see	   below	   for	   these),	   subsequent	   calculation	   of	   protection	   factors	   and	  ∆G	  values	  at	  a	  residue-­‐specific	  level	  was	  undertaken.	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Figure	  4.8.	   Defining	   residue	  protection	   in	  native	  α1-­antitrypsin.	   	   Centre:	   Typical	  SOFAST-­‐HMQC	  spectral	  overlay	  from	  HDXNMR	  experiment	  at	  pH	  7.0	  over	  time	  (t	  =	  0,	   in	   grey;	   t=	  1	  hour,	   in	  magenta;	   and	   t=	  4	  days,	   in	   cyan,	   SOFAST-­‐HMQC).	  Contour	   levels	   standardised	   for	   the	  number	  of	   scans	   in	  each	  experiment.	  Top:	  Highly	  protected	   residues	   showed	  no	   intensity	  decay	   throughout	   the	  duration	  (4	  days)	  of	  the	  experiment	  at	  the	  highest	  pH	  studied	  (pH	  8.0,	  set1).	  Lower	  right:	  Residues	  showing	  higher	  lability	  show	  the	  loss	  of	  their	  own	  crosspeak	  intensity	  during	  the	  experimental	  deadtime	  (5-­‐7	  minutes)	  even	  at	  the	  lowest	  pH	  studied	  (pH	  6.0,	  set	  3).	  Lower	   left:	  The	  residues	   in	  set	  2	  are	  those	  for	  which	  the	  decay	  over	  time	  was	  fitted	  with	  an	  exponential	  function	  allowing	  determination	  of	  kex	  values.	  An	  example	  of	  a	   typical	  SOFAST-­‐HMQC	  spectrum	  undergoing	  HDXNMR	  exchange	  at	  pH	  7.0	  was	  illustrated	  in	  the	  centre	  part,	  demonstrating	  examples	  of	  these	   three	   different	   behaviours	   from	   a	   spin	   dynamic	   prospect.	   Residues	  belonging	  to	  each	  set	  are	  illustrated	  by	  representative	  ‘decay’	  curves.	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   Approximately	  50	  crosspeaks	  showed	  kex	  changes	  consistent	  with	  an	  EX2	  regime	  over	  the	  titration	  (Fig.4.9.).	  Under	  these	  conditions,	  the	  exchange	  rate	  kex	  probes	   for	   the	   thermodynamic	   equilibrium	   for	   the	   opening-­‐closing	   of	   the	  structure	  (quantified	  by	  the	  protection	  factor	  P):	  P	  =	  kcl/kop	  =	  kint/kex.	  P	  relates	  to	  the	  difference	  in	  free	  energy	  of	  the	  observed	  residue,	  ∆Gapp	  =	  -­‐	  RTln(kop)	  where	  
kop	  =1/P.	  	  
	  
Figure	  4.9.	   	  HDXNMR	   of	   α1-­antitrypsin:	   ∆Gapp	   as	   a	   function	   of	   the	   residues	  
number	  HDXNMR	  experiments	  on	  α1-­‐antitrypsin	  allowed	  200	  well	  dispersed,	  non-­‐overlapped	   backbone	   amide	   signals	   to	   be	   followed	   across	   the	   pH	   range	  between	   pH	   8.0	   and	   pH	   5.75.	   The	   data	   inform	   upon	   the	   stability	   of	   the	  corresponding	  residues	  in	  the	  solution	  native	  state.	  Out	  of	  these,	  approximately	  50	   residue	   demonstrated	   an	   exchange	   rate	   that	   followed	   a	   linear	   dependency	  with	  pH,	  consequently	  allowing	  calculation	  of	   free	  energies	  derived	   from	  their	  protection	  factor	  values	  using	  the	  relation	  ∆Gapp	  =	  -­‐	  RTln(kop),	  as	  plotted	  against	  the	  sequence	  of	  residues.	  The	  error	  in	  the	  rate	  of	  exchange	  were	  obtained	  by	  the	  ratio	  of	  errors	  calculated	   for	   the	  rate	  of	  exchange:	   (a/x+b/y)x(a/b)	  (for	  errors	  x±a/y±b).	  The	  free	  energy	  errors	  were	  derived	  from	  the	  rate	  of	  exchange	  errors	  where	   θkop	   =	   θkex/	   kex2	   and	   θ∆Gapp	   =	   θkop/	   kop.	   (as	  was	   described	   in	   Chapter	   II,	  Section	  2.2.4.4.).	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4.3.	  Discussion	  	   The	   HD	   exchange	   data	   derived	   in	   this	   study	   allowed	   us	   to	   assess	  dynamics	  of	  the	  native	  state	  of	  native	  wild-­‐type	  α1-­‐antitrypsin	  in	  solution	  in	  the	  millisecond	   to	   second	   timescale	   range.	   Globally,	   the	   lability	   (Fig.4.10.)	   ranged	  between	   0.4	   kcal.mol-­‐1	   ≥	   ΔGapp	   ≤	   9	   kcal.mol-­‐1.	   	   This	   is	   broadly	   consistent	  with	  global	   ΔG	   values	   derived	   for	   native	   wild-­‐type	   α1-­‐antitrypsin	   by	   other	  experimental	  methods92.	  This	  range	  should	  be	  approximately	  comparable	  to	  the	  0-­‐100%	  protection	   scale	  used	   to	   interpret	   the	  earlier	  HDXMS	  studies	  of	  native	  α1-­‐antitrypsin	  in	  solution	  (Fig.4.10.A)	  92.	  	  	  Overall,	  our	  data	  indicate	  that	  residues	  demonstrate	  high	  rigidity	  or	  high	  lability	  on	  this	  scale,	  with	  relatively	  few	  residues	  reporting	  intermediate	  levels	  of	  protection,	   the	   differential	   findings	   are	   consistent	   with	   those	   obtained	   by	  HDXMS	   (Fig.4.10.B).	   	   Although	   the	   HDXNMR	   data	   covers	   fewer	   residues,	   the	  increased	  resolution	   indicates	   that	  exchange	  behaviour	  may	  be	  more	  polarised	  at	  the	  residue-­‐specific	  level	  around	  the	  native	  conformer.	  	  Alternatively,	  a	  similar	  pattern	  could	  arise	  from	  thresholding	  effects.	  
	  
Figure	  4.10.	  	   Stability	  indices	  derived	  by	  HD	  exchange	  observations	  from	  MS	  and	  
NMR	  spectra	  A-­‐	  HDXMS	  data	  plotted	  on	  the	  structure	  of	  native	  α1-­‐antitrypsin	  (PDB	  ID	  3NE4)	  with	  reported	  peptide	  regions	  coloured	  according	  to	  calculated	  degree	  of	  protection92;	  B-­‐	  HDXNMR	  data	  plotted	  on	  the	  same	  structure.	  Spheres	  identify	   the	   residues	   that	   were	   unambiguously	   assignable	   and	   for	   which	   ∆G	  values	   could	   be	   attributed	   relative	   to	   the	   quantifiable	   range	   in	   this	   HDXNMR	  analysis.	  	  ∆G	  ≥	  9	  kcal.mol-­‐1	  are	  represented	  in	  blue	  (stable),	  and	  where	  ∆G	  ≤	  0.4	  kcal.mol-­‐1	  are	  represented	  in	  red	  (labile).	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More	  specifically,	  the	  data	  define	  a	  region	  of	  high	  HD	  exchange	  protection	  extending	  from	  β-­‐sheet	  C	  through	  the	  core	  (β-­‐sheet	  B	  and	  B-­‐helix)	  through	  to	  the	  middle	   of	   β-­‐sheet	   A.	   	   Breaking	   this	   down	   further	   (Fig.4.11.)	   the	   interactions	  suggest	   2	   hydrophobic	   clusters.	   Cluster	   1	   locks	   closed	   the	   centre	   of	   β-­‐sheet	   A	  (strands	  3	  and	  5,	  residues	  Phe119,	  Ala183,	  Val185,	  Tyr297,	  Lys335,	  Leu338)	  by	  interaction	  with	  the	  B-­‐helix	  (Ala60,	  Phe61,	  Met63,	  Leu64)	  and	  the	  lower,	  buried	  strand	   residues	   in	   β-­‐sheet	   B	   (Lys368,	   Leu373,	   Met374,	   Phe384).	   This	  corresponds	   to	   the	  shutter	   region,	  and	  boundaries	  of	   s4A/loop	   insertion	  site77;	  140.	   Cluster	   2	   affects	   hydrophobic	   residues	   interacting	   in	   a	   β-­‐barrel	   region	  between	  β-­‐sheets	  B	  and	  C.	  Destabilisation	  of	  this	  region	  by	  ‘latch	  mutations’	  was	  recently	  described	  as	  a	  pathogenic	  mechanism	  in	  mild	  deficiency	  variants	  of	  α1-­‐antitrypsin191.	   	   Latch	   interactions	   constrain	   the	   RCL	   by	   stabilising	   the	   closed	  conformation	   of	   the	   ‘gate’	   (s4C-­‐s3C),	   their	   loss	   may	   facilitate	   release	   of	   s1C,	  enabling	   further	   conformational	   change	   and	   intermediate	   formation191.	   This	  region	  is	  also	  proposed	  as	  a	  nucleation	  site	  for	  protein	  folding90.	  
	  
Figure	  4.11:	  	   Stability	   Hydrophobic	   clusters	   highlighted	   by	   HD	   exchange	  
observations	   for	   residues	   within	   the	   structure	   of	   native	   α1-­
antitrypsin	   (PDB	   ID	   3NE4)	   with	   alpha	   helices	   and	   beta	   strands	   colored	  according	   to	   the	   ratio	   of	   the	   number	   of	   slow-­‐exchanging	   hydrogens	  (experiment)/the	  number	  of	  protected	  hydrogens	  highlighting	  two	  hydrophobic	  clusters	  involving	  the	  β-­‐sheet	  A	  and	  the	  β-­‐sheet	  C.	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Chapter	  5	  –	  CHARACTERISATION	  OF	  THE	  SOLUTION	  BEHAVIOUR	  OF	  
THE	  NOVEL	  MILD	  DEFICIENCY	  MUTANT	  Lys154Asn	  α1-­ANTITRYPSIN	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5.1	  Introduction	  	  	   α1-­‐antitrypsin	  is	  synthesized	  by	  hepatocytes	  and	  released	  in	  the	  plasma	  to	  protect	   the	   lung	   from	   neutrophil	   elastase.	   The	   most	   clinically	   significant	  mutation	   leading	   to	   α1-­‐antitrypsin	   deficiency	   is	   the	   homozygote	   of	   Z-­‐mutation	  (Glu342Lys),	  and	  is	  carried	  by	  1	  in	  27	  of	  North	  European	  population.	  Formation	  of	   polymers	   in	   Z-­‐	   α1-­‐antitrypsin	   deficiency	   is	   believed	   to	   occur	   via	   an	  intermediate	   conformation	   before	   polymers	   form	   and	   accumulate	   within	   the	  Endoplasmic	  Reticulum	  (ER)	  of	  hepatocytes,	  resulting	  in	  both	  a	  gain-­‐	  and	  loss-­‐of-­‐function.	  As	  an	  inhibitory	  serpin,	  the	  function	  and	  dysfunction	  of	  α1-­‐antitrypsin	  depends	   on	   the	   structures	   and	   dynamics	   of	   the	   conformers	   available	   to	   the	  polypeptide	  chain	  and	  the	  energy	  landscape	  that	   incorporates	  them.	   	  These	  are	  complex	  interrelationships.	   	  They	  have	  been	  tractable	  to	  systematic	  analysis	  by	  biochemical,	  biophysical	  and	  structural	  methods	  in	  large	  part	  because	  of	  insights	  derived	   from	  characterization	  of	  naturally	  occurring	  mutations	  associated	  with	  disease197;	   198.	   Such	   mutations	   typically	   disrupt	   regulation	   of	   the	   stressed	   (S,	  metastable)	   to	   relaxed	   (R,	   hyperstable)	   transition	   required	   for	   function.	   	   Thus	  the	   Z	   (Glu342Lys)	   mutation	   in	   α1-­‐antitrypsin	   points	   up	   the	   importance	   of	  proximal	   hinge	   and	   upper	   s4A	   (“breach”	   region)	   behaviour88.	   The	   cluster	   of	  polymerogenic	   mutations	   affecting	   interactions	   that	   stabilize	   closure	   of	   the	  middle	  of	  β-­‐sheet	  A	  defines	   the	  regulatory	   importance	  of	   the	  so	  called	  “shutter	  region”196.	  	  Other	  mutations	  point	  to	  a	  minor	  role	  for	  stabilization	  of	  the	  residues	  around	   and	   beyond	   the	   C-­‐terminal	   of	   the	   RCL191.	   The	   discovery	   of	   a	   novel	  mutation	   affecting	   the	   F-­‐helix	   of	   α1-­‐antitrypsin	   and	   associated	   with	   mild	  deficiency	   but	   not	   overt	   disease	   (i.e.	   a	   forme	   fruste	   mutation)	   provided	   an	  opportunity	   to	   extend	   this	   principle	   to	   NMR	   studies	   of	   the	   conformational	  behaviour	  of	  α1-­‐antitrypsin.	  	  	  	  	  
5.1.1.	  Case	  report	  	   A	   34	   year-­‐old	   man	   participated	   in	   family	   screening	   for	   α1-­‐antitrypsin	  deficiency	   following	  the	  diagnosis	  of	  his	  daughter	  as	  a	  PiZZ	  homozygote.	   Initial	  iso-­‐electric	  focusing	  (IEF)	  phenotyping	  of	  his	  circulating	  α1-­‐antitrypsin	  indicated	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he	  was	  also	  a	  PiZZ	  homozygote.	  However	  his	  circulating	  levels	  of	  α1-­‐antitrypsin	  were	   only	  moderately	   reduced	   (median	   0.6	  mg/ml,	   normal	   range	   1.5-­‐3.5),	   i.e.	  higher	  than	  expected	  for	  a	  PiZZ	  homozygote	  (typical	  levels	  ~	  0.2	  mg/ml).	  He	  was	  therefore	   genotyped	   at	   Queen’s	   Medical	   Centre,	   Nottingham,	   UK	   (Prof	   N.	  Kalsheker	  and	  Dr	  M.	  Hill).	   	  This	  revealed	  him	  to	  be	  compound	  heterozygous	  for	  the	  Z	  (Glu342Lys)	  allele	  and	  a	  novel	  variant	  (Lys154Asn)	  of	  α1-­‐antitrypsin.	  This	  was	   named,	   the	   Queen’s	   variant	   of	   α1-­‐antitrypsin,	   after	   the	   centre	   where	   the	  mutation	  was	  identified.	  
	  
Figure	  5.1.	  	   Lys154Asn	  α1-­antitrypsin	  mutation	  associated	  with	  mild	  deficiency	  The	   Lys154Asn	   (green)	   mutation	   is	   located	   on	   the	   F-­‐helix	   (magenta)	   and	  highlighted	   here	   on	   the	   crystal	   structure	   of	   wild-­‐type	   native	   α1-­‐antitrypsin	  (PDB:3NE4)	  88.	  	  
	  	  
5.1.2	  Involvement	  of	  the	  F-­helix	  in	  conformational	  transitions	  	  	   The	  Lys154Asn	  mutation	  arises	  within	   the	  F-­‐helix	  (hF)	  of	  α1-­‐antitrypsin	  (Fig.	  5.1).	  	  	  The	  F-­‐helix	  lies	  across	  β-­‐sheet	  A	  and	  with	  which	  it	  shares	  a	  number	  of	  interactions88.	  Its	  N-­‐terminus	  arises	  from	  the	  base	  of	  strand	  1	  of	  β-­‐sheet	  A	  (s1A)	  and	   it	   is	   comprised	  of	   four	   turns.	  The	  C-­‐terminal	  precedes	  a	   linker	   region	   that	  runs	   antiparallel	   to	   hF	   before	   linking	   to	   the	   base	   of	   s3A.	   The	   helix	   and	   linker	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share	   a	   number	   of	   polar	   interactions	   and	   together	   enclose	   a	   hydrophobic	  interface	   with	   the	   underlying	   part	   of	   β-­‐sheet	   A	   that	   is	   further	   stabilized	   by	   a	  number	   of	   polar	   interactions88.	   Several	   lines	   of	   evidence	   indicate	   this	   motif	  remodels	  during	  serpin	  conformational	  transitions	  and	  that	  it	  may	  play	  a	  role	  in	  regulating	  the	  opening	  of	  β-­‐sheet	  A.	  	  	  
5.1.2.1	  Rouen-­VI	  antithrombin	  	   Firstly,	   almost	   2	   decades	   ago,	   Perry	   and	   colleagues	   characterized	   the	  Asn187Asp	   mutant	   of	   antithrombin	   (Rouen-­‐VI	   variant)199;	   200.	   The	   mutation	  disrupts	  an	  hF-­‐linker	  interaction	  that	  is	  conserved	  within	  the	  serpin	  superfamily	  and	  allows	  the	  spontaneous	  conversion	  of	  native	  antithrombin	  to	  inactive	  latent	  and	  polymerised	  conformations.	  These	  data	  support	  a	  role	  for	  the	  interaction	  in	  holding	  β-­‐sheet	  A	  in	  its	  closed,	  native	  conformation.	  	  	  
5.1.2.2.	  Leu55Pro	  α1-­antichymotrypsin	  	   The	  Leu55Pro	  mutation	  in	  the	  serpin	  α1-­‐antichymotrypsin	  that	  is	  closely	  related	   to	   α1-­‐antitrypsin	   is	   associated	   with	   circulating	   deficiency	   and	  emphysema.	  Biochemically,	   the	  mutant	   behaves	   characteristically	   for	   a	   shutter	  region	   variant,	   favouring	   polymerisation	   and	   adoption	   of	   the	   latent	  conformation.	  However	  it	  also	  facilitates	  formation	  of	  the	  alternative	  monomeric	  δ	  conformation.	  X-­‐ray	  crystallography	  demonstrates	  how	  this	  conformation	  has	  an	  expanded	  β-­‐sheet	  A	  with	  the	  s4A	  site	  filled	  by	  remodeling	  of	  residues	  from	  2	  distinct	  motifs	  (Fig.	  5.2.;	  PDB:	  1QMN)77.	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Figure	  5.2.	  	   α1-­antichymotrypsin	  serpin	  in	  the	  delta	  conformation	  (partial	  loop	  
insertion).	  Inactive	  conformation	  of	  the	  serpin	  α1-­‐antichymotrypsin	  indicates	  two-­‐stage	  insertion	  of	  the	  reactive	  loop:	  implications	  for	  inhibitory	  function	  and	  conformational	  disease.	  (PDB:	  1QMN).	  The	  dashed	  line	  represents	  the	  parts	  that	  aren’t	  seen	  in	  the	  crystal	  structure.	  	  The	   upper	   s4A	   (breach)	   site	   is	   occupied	   by	   partial	   insertion	   of	   the	  reactive	   centre	   loop.	   Fascinatingly,	   however,	   the	   lower	   s4A	   site	   is	   filled	   by	  unwinding	  of	  the	  last	  turn	  of	  F-­‐helix	  to	  allow	  the	  linker	  residues	  Asn-­‐163	  to	  Thr-­‐170	   to	   adopt	   the	   requisite	   β-­‐sheet	   structure77.	   Leu55Pro	  α1-­‐antichymotrypsin	  adopts	   the	   δ	   conformation	   in	   parallel	   with	   latent	   and	   polymeric	   states.	   The	   δ	  conformation	   has	   been	   interpreted	   as	   a	   trapped	   form	   of	   the	   common	  intermediate	  (M*)	  along	  a	  branched	  pathway	  from	  which	  all	  three	  conformations	  raising	   the	   possibility	   that	   hF	   remodeling	   was	   involved	   in	   intermediate	  formation.	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5.1.2.3.	  Solution	  studies	  of	  F-­helix	  remodeling	  
	   The	   prospect	   of	   hF	   remodeling	   in	   conformational	   transitions	   is	   also	  implied	   by	   the	   structure	   of	   the	   serpin-­‐enzyme	   inhibitory	   complex65.	   	   In	   the	  absence	  of	  such	  remodeling	  the	  F-­‐helix	  represents	  a	  physical	  impediment	  to	  the	  rapid	   insertion	   of	   the	   RCL	   and	   translocation	   of	   the	   covalently	   bound	   target	  protease	   that	   is	   required	   for	   inhibitory	   function201.	   This	   hypothesis	   was	  therefore	   explored	   by	   Cabrita	   et	   al.	   who	   used	   alanine	   and	   tryptophan	  mutagenesis	  studies	  to	  probe	  F-­‐helix	  stability	  and	  conformational	  change	  of	  this	  helix	   during	   proteinase	   inhibition,	   serpin	   folding,	   and	   polymerisation192	   193.	  Taken	  together,	  the	  data	  from	  these	  studies	  demonstrated	  that	  F-­‐helix	  undergoes	  different	   degrees	   of	   remodeling	   during	   these	   different	   conformational	  transitions.	  A	  reversible	  conformational	  change	  was	  observed	  in	  both	  N-­‐	  and	  C-­‐termini	   of	   hF	   during	   inhibition	   pathways,	   but	   only	   the	   C-­‐terminus	   reported	  changes	   during	   polymerisation.	   Conversely,	   unfolding	   was	   associated	   with	  changes	   throughout	   the	   length	   of	   the	   helix.	   These	   studies	   were	   further	  complemented	  by	  HD	  exchange	  mass	   spectrometry	  data	  highlighting	   lability	  of	  the	  upper	  hF	  region	  in	  the	  native	  state	  of	  α1-­‐antitrypsin92.	  	   The	   characterization	   and	   X-­‐ray	   crystal	   structure	   of	   Gly117Phe	   α1-­‐antitrypsin	   also	   promoted	   the	   importance	   of	   F-­‐helix	   as	   a	   motif	   that	   could	  propagate	   conformational	   change	   between	   upper	   and	   lower	   s4A	   opening170.	  Conversion	   from	   the	   native	   conformation	   to	   the	   M*	   model	   derived	   from	   the	  structure	  of	  δ	  Leu55Pro	  α1-­‐antichymotrypsin	  entails	  potential	  steric	  clashes	  with	  the	  upper	  hF-­‐linker	  motif	  as	  configured	  in	  the	  native	  state.	  These	  clashes	  can	  be	  resolved	  by	  transient	  remodeling	  of	  the	  hF-­‐linker	  region	  prior	  to	  opening	  of	  the	  lower	  s4A	  site.	  Consistent	  with	  this	  hypothesis,	  native	  Gly117Phe	  α1-­‐antitrypsin	  is	  dramatically	  stabilized	  against	  polymerisation	   in	  association	  with	  a	  half-­‐turn	  downward	   shift	   in	   hF.	   The	   shift	  will	   predictably	   prevent	   the	   induction	   of	   such	  remodeling	  and	  therefore	  reduce	  the	  tendency	  of	  the	  lower	  s4A	  site	  to	  open.	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5.1.2.4.	   Potential	   structural	   effects	   of	   the	   Lys154Asn	   mutation	   in	   α1-­
antitrypsin	  	   Taken	  together,	  these	  data	  strongly	  support	  a	  role	  for	  the	  hF+linker	  motif	  mediating	   functional	   and	   pathological	   conformational	   transitions	   in	   α1-­‐antitrypsin	   and	   other	   serpins.	   Lys154Asn	   α1-­‐antitrypsin	   was	   associated	   with	  mild	  contribution	   to	  circulating	  deficiency	   in	  a	   compound	  heterozygote	  and	  no	  clinical	   disease.	   These	   considerations	   led	   to	   the	   hypothesis	   that	   the	   mutation	  would	   destabilize	   the	   hF+linker	   motif	   in	   α1-­‐antitrypsin	   to	   give	   a	   mildly	  polymerogenic	   biochemical	   phenotype.	   	   Analysis	   of	   the	   high-­‐resolution	   crystal	  structures	  of	  the	  native	  state	  of	  α1-­‐antitrypsin	  indicated	  that	  such	  an	  effect	  could	  arise	  by	  destabilizing	  one	  or	  more	  of	  3	  polar	  interactions	  (Fig.5.3.).	  These	  were	  probed	  in	  a	  mammalian	  cell	  model	  and	  the	  biochemical	  phenotype	  of	  the	  Queen’s	  variant	  characterized	  following	  recombinant	  expression	  in	  E.	  coli.	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Figure	  5.3.	  	   Potential	   structural	   effects	   of	   the	   Lys154Asn	   mutation	   in	   α1-­
antitrypsin.	  The	  Lys154	  side	  chain	  participates	   in	  2	  polar	   interactions,	  a	  salt	  bridge	  to	  Glu151	  nearby	  on	  hF	  and	  a	  hydrogen	  bond	  to	  the	  main	  chain	  carbonyl	  of	  Lys174.	  	  	  
5.2.	  Results	  
5.2.1.	  Production	  of	  recombinant	  Lys154Asn	  α1-­antitrypsin	  	   Lys154Asn	  α1-­‐antitrypsin	  was	   expressed	   recombinantly	   and	   purified	   as	  described	  in	  Chapter	  II	  (Figure	  5.3).	  Monomeric	  Lys154Asn	  α1-­‐antitrypsin	  eluted	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intact	  and	  without	  contaminant	  from	  the	  second,	  Q-­‐sepharose	  column	  in	  a	  single	  peak.	  	  
	  
Figure	  5.3.	  	   Lys154Asn	   α1-­antitrypsin	   Ni-­sepharose	   -­	   Q-­sepharose	  
purification.	  Gel	   labels:	  L:	   ladder	  of	  molecular	  weight	  markers;	  C:	  Control	  wild-­‐type	  α1-­‐antitrypsin;	  numbers	  refer	   to	   fraction	  order;	  FT:	  Flow-­‐through	  of	  material	  not	  binding	   to	   the	   column	  during	   loading,	  10μl	  of	   fractions	  and	  flow-­‐through	   loaded	   per	   lane).	   (a)	   Elution	   profile	   from	   initial	   high	   affinity	  nickel-­‐sepharose	   column,	   the	   peak	   representing	   the	   elution	   profile	   of	  Lys154Asn	  α1-­‐antitrypsin	   is	  shown	  by	  the	  arrow;	  (b)	  composition	  of	   the	  20	  fractions	   obtained	   after	   nickel-­‐sepharose	   purification	   shown	   by	   SDS-­‐PAGE	  electrophoresis	   Typically	   monomeric	   Lys154Asn-­‐	   α1-­‐antitrypsin	   eluted	   at	  50-­‐150mM	   imidazole.	   (c)	   High-­‐affinity	   Q-­‐sepharose	   elution	   profile;	   (d)	  composition	  of	  fractions	  obtained	  after	  Q-­‐sepharose	  purification	  assessed	  by	  SDS-­‐PAGE	  electrophoresis	  otherwise	   loaded	  and	   labelled	  as	   in	   (b).	   (e)	  SDS-­‐PAGE	  of	  final	  Lys154Asn	  α1-­‐antitrypsin	  product.	  	  
	  	  	  
5.2.2.	  Biochemical	  characterization	  	  	   Conformational	   homogeneity	   of	   the	   Lys154Asn	   α1-­‐antitrypsin	   product	  was	   assessed	   by	   7.5%	   (v/v)	   non-­‐denaturing	   PAGE	   (Fig.5.4.).	   Lys154Asn	   α1-­‐antitrypsin	   demonstrated	   the	   doublet	   appearance	   characteristic	   of	   native	   α1-­‐antitrypsin	  purified	  from	  this	  system.	  	  A	  trace	  of	  a	  slower	  migrating	  species	  was	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also	  apparent	  (shown	  by	  *),	  consistent	  with	  a	  dimer	  or	  monomeric	  intermediate	  conformation.	  This	  band	  varied	  in	  intensity	  (both	  waning	  and	  waxing)	  between	  successive	  gels	  from	  the	  same	  aliquot,	  and	  was	  occasionally	  apparent	  in	  the	  wild-­‐type	  material	  also.	  Native	  MS	  experiments	  (detailed	  below)	  also	  indicated	  there	  was	   no	   significant	   population	   of	   dimeric	   material	   in	   either	   wild	   type	   or	  Lys154Asn	   α1-­‐antitrypsin	   products.	   Taken	   together	   these	   data	   suggested	   the	  extra	  band	  represented	  a	  monomeric	  intermediate	  state	  observable	  upon	  native	  electrophoresis,	  whose	  stability	  relative	  to	  the	  native	  state	  was	  very	  sensitive	  to	  electrophoresis	  conditions.	  
	  
Figure	  5.4.	  	   7.5%	  (v/v)	  non	  denaturing	  PAGE	  of	  Lys154Asn	  α1-­antitrypsin.	  Both	  wild-­‐type	  (WT)	  and	  Lys154Asn	  (K154N)	  α1-­‐antitrypsin	  products	  predominantly	  migrate	   consistent	   with	   recombinant	   protein	   in	   the	   native	   conformation.	   	   A	  trace	  band	  of	  material	  with	  a	  slower	  migration	  pattern	  was	  also	  observed	  (*)	  for	  the	   Lys154Asn	   mutant	   (and	   occasionally	   for	   the	   wild-­‐type)	   that	   varied	   in	  intensity	  between	  experiments	  without	  a	  temporal	  trend.	  	  	  	   TUG-­‐PAGE	   unfolding	   of	   native	   Lys154Asn	   α1-­‐antitrypsin	   confirmed	   its	  metastability	   (Fig.5.5.)	   and	   indicated	   it	   was	   more	   conformationally	  heterogeneous	   than	   the	   wild-­‐type	   protein	   under	   low	   urea	   concentration	  electrophoresis	  conditions.	  Once	  again	  an	  intermediate	  state	  was	  evident	  under	  these	   conditions	   (indicated	   by	   *).	   However	   the	   profile	   for	   Lys154Asn	   α1-­‐antitrypsin	   showed	   less	   cooperative	   unfolding	   than	   the	   wildtype	   protein,	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consistent	  with	   prolonged	   population	   of	   an	   intermediate	   species.	   Furthermore	  nondenaturing	  and	  TUG-­‐PAGE	  revealed	  that	  Lys154Asn	  α1-­‐antitrypsin	  populated	  a	   state	   that	   migrated	   more	   slowly	   than	   the	   native	   conformer.	   It	   persisted	   in	  reducing	   conditions	   but	   not	   following	   SDS	   denaturation,	   and	   it	   was	   only	  minimally	  populated	  by	  the	  wildtype	  protein.	  	  
	  
Figure	  5.5.	  	   Transverse	   Urea	   Gradient	   (TUG)	   electrophoresis	   of	   wild-­type	   and	  
Lys154Asn	  α1-­antitrypsin.	   TUG	   gels	   loaded	  with	   50	   μg	   protein	   shows	   the	  typical	   metastable	   behaviour	   for	   the	   wild-­‐type	   (WT)	   sample,	   while	   the	  Lys154Asn	   variant	   indicates	   population	   of	   an	   intermediate	   ensemble	   at	   low	  concentration	   of	   urea	   as	   well	   as	   some	   formation	   of	   latent	   and	   oligomeric	  material.	  
	  
5.2.3	  Activity	  assay	  and	  inhibitory	  kinetics	  
	   The	   Lys154Asn	  mutant	   had	   67	  %	   of	   the	   functional	   activity	   (Fig.5.6.)	   of	  wildtype	  α1-­‐antitrypsin	  (i.e.	  1.6-­‐fold	  greater	  stoichiometry	  of	  inhibition	  (SI)).	  Its	  apparent	   association	   rate	   constant	   (kapp’)	   with	   bovine	   α-­‐chymotrypsin	   was	  3.3x105	  M-­‐1s-­‐1,	  47	  %	  of	   the	  value	   for	   the	  wild-­‐type	  protein.	  When	  corrected	   for	  the	   increase	   in	   SI,	   the	   association	   rate	   constant	   (kapp)	   for	   Lys154Asn	   α1-­‐antitrypsin	  was	  7.3x105	  M-­‐1s-­‐1	  (n=3),	  63	  %	  of	  the	  value	  of	  the	  wild-­‐type	  control	  (1.16x106	  M-­‐1s-­‐1)193.	  	  
	   134	  
	  
Figure	  5.6.	  	   Kinetics	  of	  α1-­antitrypsin.	  The	  curves	  (left)	  are	  the	  colourimetric	  readouts	  of	   substrate	   breakdown	   by	   chymotrypsin	   over	   time,	   in	   the	   presence	   of	  increasing	  α1-­‐antitrypsin	  indicated	  by	  line	  colour	  key.	  	  The	  curve	  fit	  data	  can	  be	  processed	   to	  give	  observed	  association	  rate	  constants	   (kobs,	   in	  seconds)	  values	  for	   α1-­‐antitrypsin	   with	   chymotrypsin	   specific	   for	   each	   α1-­‐antitrypsin	  concentration	   (relationship	   plotted	   on	   the	   right,	   n=3).	   	   The	   slope	   of	   the	   line	  gives	   the	   general	   apparent	   association	   rate	   constant	   (kapp’)	   that	   holds	   true	  across	  all	  α1-­‐antitrypsin	  concentrations	  (in	  M-­‐1.s-­‐1).	  	   SDS-­‐PAGE	   and	   enzyme	   inhibitory	   activity	   assay,	   confirmed	   increased	  substrate-­‐like	   behaviour	   in	   Lys154Asn	  α1-­‐antitrypsin	   relative	   to	   the	  wild-­‐type,	  characterised	  by	  concomitant	  loss	  of	  activity	  (figure	  5.7).	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Figure	  5.7.	  	   Enzyme	   inhibitory	   activity	   of	   the	   wild-­type	   compared	   to	   the	  
Lys154Asn	  disease	  mutant.	  	  (A)	   10%	  SDS-­‐PAGE	   of	  wild-­‐type	   (WT,	   left)	   and	   Lys154Asn	   (Lys154Asn,	   right)	  α1-­‐antitrypsin	   interactions	   with	   bovine	   α-­‐chymotrypsin.	   Molecular	   weights	  (kDa)	  are	  indicated	  by	  marker	  bars.	  Molar	  ratios	  of	  α1-­‐antitrypsin:chymotrypsin	  are	  shown	  beneath	  each	  lane.	  (B)	  Inhibitory	  activity	  of	  the	  wild-­‐type	  compared	  to	  the	  disease	  mutant	  Lys154Asn	  by	  assessing	  the	  chymotrypsin	  activity	  in	  (%)	  against	  the	  Ratio	  (Inhibitor/Enzyme),	  demonstrating	  an	  activity	  of	  67%	  for	  the	  Lys154Asn	  relative	  to	  the	  wild-­‐type.	  	  
	  
5.2.4.	  Thermal	  stability	  and	  polymerisation	  	  
[work	  carried	  out	  in	  collaboration	  with	  Lakshmi	  Segu	  (Gooptu	  group,	  ISMB,	  UCL/Birkbeck,	  
University	   of	   London)	   and	   Dr	   Benoit	   Roussel	   (Lomas	   group,	   CIMR,	   University	   of	  
Cambridge]	  
5.2.4.1.	  Circular	  Dichroism	  To	   investigate	   changes	   in	   the	   thermal	   denaturation	   transition	   of	   α1-­‐antitrypsin	   induced	   by	   the	   Lys154Asn	   mutation	   I	   undertook	   CD	   spectroscopy	  studies	  of	  the	  wild-­‐type	  and	  variant	  protein	  (Fig.5.8.).	  These	  indicated	  that	  in	  the	  mutant	   the	   fold	   underwent	   a	   biphasic	   transition,	  with	   an	   initial	   subtle	   change	  between	  35	  °C	  and	  45	  °C	  before	  a	  more	  dramatic	  transition	  between	  50	  °C	  and	  60	  °C.	  Increasing	  concentration	  did	  not	  affect	  the	  first	  transition	  but	  caused	  the	  second	  transition	  to	  commence	  at	  a	  lower	  temperature.	  Wild-­‐type	  α1-­‐antitrypsin	  remained	  stable	   to	  60	  °C	  and	  underwent	  a	  sharp	  unfolding	  transition	  at	  higher	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temperatures,	   consistent	   with	   previous	   studies202.	   Increasing	   concentration	  cold-­‐shifted	   the	  second	  half	  of	   the	   transition	  but	  did	  not	  affect	   its	   initial	  phase.	  	  Increasing	  protein	   concentration	  2.5-­‐fold	   (from	  0.4	   to	   1.0	  mg/ml)	   reduced	   the	  midpoint	  of	  the	  overall	  transition	  for	  wild-­‐type	  α1-­‐antitrypsin	  by	  1.5	  °C	  and	  that	  of	   Lys154Asn	   α1-­‐antitrypsin	   by	   1.0	   °C.	   The	   profiles	   of	   the	   first	   part	   of	   the	  transition	  observed	  for	  wild-­‐type	  α1-­‐antitrypsin	  and	  the	  first	  transition	  observed	  for	   Lys154Asn	   α1-­‐antitrypsin	   are	   both	   concentration-­‐independent.	   Therefore,	  this	   likely	  reports	  upon	  structural	  change	  within	   the	  molecule.	  The	  subsequent	  transition	   is	   concentration-­‐dependent.	   It	   therefore	   likely	   reports,	   to	   some	  degree,	  upon	  polymerisation	  of	  a	  species	  populated	  during	  the	  first	  phase	  since	  polymer	  formation	  occurs	  via	  population	  of	  a	  monomeric	  intermediate	  state	  that	  is	  polymerogenic103.	  
	  
Figure	  5.8.	  	   Biphasic	   thermal	   transition	   of	   Lys154Asn	   α1-­antitrypsin	  
observed	  by	  CD	   spectroscopy.	   Thermal	   denaturation	   CD	   spectroscopy	  (mean	  ellipticity	  at	  222	  nm,	  n	  =	  10)	  for	  wild-­‐type	  (blue)	  and	  Lys154Asn	  (red)	  α1-­‐antitrypsin.	  Wild-­‐type	  α1-­‐antitrypsin	  starts	  unfolding	  at	  ~60	  °C,	  while	  the	  Lys154Asn	  α1-­‐antitrypsin	  mutant	  unfolds	  in	  a	  biphasic	  manner	  beginning	  at	  ~30	   °C.	   The	   dashed-­‐bracket	   highlights	   the	   initial	   phase	   (~35-­‐50	   °C,	  concentration	   independent)	   consistent	   with	   population	   of	   an	   intermediate	  ensemble	   in	   conditions	   including	   the	   physiological-­‐pyrexial	   temperature	  range	  (36.5–37.5	  °C).	  	  	   Native	   PAGE	   analysis	   of	   wild-­‐type	   and	   Lys154Asn	   α1-­‐antitrypsin	  incubated	  for	  30	  minutes	  over	  a	  similar	  temperature	  range	  to	  that	  observed	  by	  CD	   spectroscopy	   indicated	   that	   the	  variant	  was	  more	   thermally	   labile	   than	   the	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wild-­‐type	  (Fig.5.9.).	   	  Polymerisation	  was	  observed	  at	  ≥45	  °C	  for	  Lys154Asn	  α1-­‐antitrypsin	  compared	  with	  ≥	  60	  °C	  for	  the	  wildtype	  protein	  (both	  at	  0.5	  mg/ml)	  in	  these	  conditions.	  	  	  
	  
	  
Figure	  5.9.	  	   Thermal	  stability	  and	  polymerisation	  of	  α1-­antitrypsin	  assessed	  by	  
Native-­PAGE.	  Thermal	   stability	  was	  assessed	  at	  0,	  25,	  37,	  40,	  45,	  50,	  60,	  70,	  80°C	  by	  incubating	  WT	  and	  Lys154Asn	  α1-­‐antitrypsin	  samples	  for	  2	  hours	  prior	  to	   assessing	   the	   thermal	   stability	   and	   polymerisation	   using	   non-­‐denaturing	  Native-­‐PAGE.	  	  	  	   Polymer	   formation	   by	   Lys154Asn	   α1-­‐antitrypsin	   between	   room	  temperature	  and	  50	  °C	  was	  next	  monitored	  by	  2C1	  monoclonal	  antibody	  ELISA	  (Fig.5.10.)	   and	   compared	   with	   results	   for	   wild-­‐type	   α1-­‐antitrypsin	   control.	  	  Differences	   between	   wild-­‐type	   and	   mutant	   were	   significant	   (p	   <	   0.05	   to	   p	   <	  0.005)	   for	  all	   temperatures.	   	  The	   increase	   in	  signal	  relative	  to	  starting	  material	  reached	   significance	   for	   Lys154Asn	   α1-­‐antitrypsin	   for	   incubations	   at	   47.5	   (p	   <	  0.05)	  and	  50	  (p	  <	  0.005)	  °C.	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Figure	  5.10.	  	   Formation	   of	   polymers	   recognised	   by	   2C1	  mAb	   by	   Lys154Asn	   α1-­
antitrypsin.	  Polymers	  formed	  by	  30	  min	  incubation	  between	  40	  °C	  and	  50	  °C	  of	   wild-­‐type	   (blue)	   and	   Lys154Asn	   (red)	   α1-­‐antitrypsin	   quantified	   by	   2C1	  monoclonal	   antibody	   ELISA	   (calibrated	   using	   a	   standard	   curve	   of	   Z	   α1-­‐antitrypsin	  polymer)189.	  	  	  
5.2.4.2.	  Native-­PAGE	  of	  polymerisation	  at	  37	  °C	  and	  42	  °C	  	   I	  next	  wished	  to	  assess	  polymerisation	  of	  Lys154Asn	  α1-­‐antitrypsin	  over	  time	  in	  the	  physiological-­‐pyrexial	  (36.5–37.5	  °C)	  temperature	  range	  (pH	  and	  α1-­‐antitrypsin	   concentration	   also	  mimicking	   those	   found	   in	   vivo).	   	  Wild-­‐type	   and	  Lys154Asn	   α1-­‐antitrypsin	   was	   therefore	   incubated	   at	   0.5	   mg/ml	   pH	   7.4	   and	  either	   37	   or	   42	   °C	   for	   up	   to	   12	   days	   (Fig.5.11).	   Wildtype	   α1-­‐antitrypsin	   was	  highly	   stable	   in	  monomeric	   form	   at	   incubation	   for	   12	   days	   at	   37	   or	   42	   °C.	   In	  contrast	  most	  Lys154Asn	  α1-­‐antitrypsin	  polymerised	  after	  6	  days	  at	  37	   °C	  and	  within	  1	  day	  at	  42	  °C,	  confirming	  population	  of	  a	  polymerogenic	  intermediate	  in	  solution	  across	  this	  temperature	  range.	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Figure	  5.11.	  	   Lys154Asn	   α1-­antitrypsin	   biochemical	   characterization	   of	  
polymerization.	   7.5	   %	   non-­‐denaturing	   PAGE	   analysis	   of	   time-­‐dependent	  polymerisation	  at	  37	  °C	  and	  42	  °C	  for	  wild-­‐type	  (WT)	  and	  Lys154Asn	  (K154N)	  α1-­‐antitrypsin.	  N:	  native,	  I:	  putative	  intermediate,	  P:	  polymers.	  
	  
5.2.4.3.	  Polymerisation	  in	  mammalian	  cells	  
	   pcDNA3.1	   plasmids	   containing	   cDNA	   encoding	   wild-­‐type	   or	   Lys154Asn	  α1-­‐antitrypsin	   were	   transiently	   transfected	   into	   COS-­‐7	   cells.	   The	   resulting	  protein	   expression	   was	   characterized	   by	   western	   blot	   analyses	   of	   SDS-­‐	   and	  nondenaturing	   PAGE.	   The	   polymer	   load	   was	   quantified	   by	   ELISA	   using	   the	  polymer-­‐specific	   2C1	   monoclonal	   antibody	   specific	   to	   polymers	   observed	   in	  disease189	  as	  the	  primary	  antibody.	  The	  expression	  of	  M	  α1-­‐antitrypsin	  resulted	  in	  very	   low	  levels	  of	  polymers	   intracellularly,	  while	  expression	  of	   the	  Z	  variant	  generated	  very	  high	   levels.	   Expression	  of	   Lys154Asn	  α1-­‐antitrypsin	   resulted	   in	  far	  less	  polymerisation	  than	  seen	  with	  the	  Z	  mutant.	  (Fig.5.12)	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Figure	  5.12.	  	   Biochemical	   characterization	   of	   polymerisation	   in	   the	   M,	   Z,	  
Lys154Asn,	   Lys154Asp	   mutant	   α1-­antitrypsin	   as	   reported	   by	   2C1	  
monoclonal	   antibody	   recognition.	   Intracellular	   polymerisation	   of	   α1-­‐antitrypsin	   following	   transient	   transfection	   of	   COS-­‐7	   cells.	   The	   polymer	   load	  was	  detected	  after	  48	  h	  of	  expression	  by	  ELISA	  using	  the	  2C1	  mAb.	  The	  data	  are	  the	  mean	   and	   SD	  of	   3	   repeats.	   Asterisks	   indicate	   differences	  with	   significance	  p<0.05	  (t	  test);	  n.s.	  indicates	  p>0.05.	  
	  
5.2.4.4.	   Polymerogenic	   intermediate	   formation	   assessed	   by	   ANS	  
fluorescence	  	  	   Polymerogenic	   intermediate	   formation	   in	   α1-­‐antitrypsin	   has	   been	  previously	  studied	  by	  ANS	  fluorescence.	  ANS	  fluoresces	  strongly	  upon	  binding	  to	  regions	  in	  which	  both	  polar	  and	  hydrophobic	  motifs	  are	  exposed	  to	  solvent	  and	  so	   binds	   to	   intermediate	   states,	   rather	   than	   fully	   folded	   or	   unfolded	  polypeptides.	  The	  ability	  of	  the	  Queen’s	  variant	  of	  α1-­‐antitrypsin	  to	  bind	  ANS	  was	  therefore	   assessed	   (Fig.5.13.).	   Lys154Asn	   α1-­‐antitrypsin	   showed	  hyperfluorescence	   compared	   with	   the	   wild-­‐type	   protein	   at	   25	   °C.	   This	   was	  unexpected,	   since	   assays	   directly	   reporting	   structural	   information	   (CD	  spectroscopy,	   intrinsic	   fluorescence,	  and	  NMR	  spectroscopy)	  strongly	   indicated	  that	   both	   proteins	   were	   similarly	   well-­‐folded	   and	   stable	   at	   this	   temperature.	  These	   observations	   of	   Lys154Asn	   α1-­‐antitrypsin	   behavior	   are	   similar	   to	   those	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described	   for	   Z	   α1-­‐antitrypsin.	   Moreover,	   incubating	   Lys154Asn	   α1-­‐antitrypsin	  with	   ANS	   for	   longer	   resulted	   in	   even	   greater	   hyperfluorescence,	   whereas	  increasing	  the	  temperature	  to	  37	  °C	  did	  not	  enhance	  this	  further.	  Wild-­‐type	  α1-­‐antitrypsin	  showed	  no	  change	  in	  ANS	  fluorescence	  at	  either	  temperature	  or	  upon	  prolonged	   incubation.	   These	   data	   indicate	   that	   for	   α1-­‐antitrypsin	   variants	   in	  which	   conversion	   to	   the	   polymerogenic	   intermediate	   in	   solution	   is	   facile,	   ANS	  binding	  stabilizes	  the	  intermediate	  state	  sufficiently	  to	  skew	  the	  position	  of	  the	  native-­‐intermediate	  equilibrium	  to	  the	  right.	  For	  Lys154Asn	  α1-­‐antitrypsin,	  this	  effect	   is	   so	   significant	   that	   it	   outweighs	   any	   effect	   of	   temperature	   change	  between	   25	   °C	   and	   37	   °C.	   This	   supports	   the	   general	   view	   that	   the	   degree	   to	  which	   assays	   perturb	   solution	   equilibria	   must	   be	   considered	   when	   studying	  intermediate	  formation.	  
	  
Figure	  5.13.	  	   Lys154Asn	   α1-­antitrypsin	   biophysical	   characterization,	   using	   ANS	  
binding	  assay.	  Effects	  of	  mutation,	  temperature	  and	  incubation	  time	  of	  wild-­‐type	   (WT)	   and	   Lys154Asn	   (Lys154Asn)	   α1-­‐antitrypsin	   with	   ANS	   upon	  fluorescence	   at	   480	   nm	   wavelength	   (n=3	   for	   each	   condition,	   error	   bars	  represent	  standard	  deviation	  values).	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5.2.4.5.	  Ion	  Mobility-­Mass	  Spectrometry	  	  	  It	  was	  hypothesized	  that	  ion-­‐mobility	  mass	  spectrometry	  (IM-­‐MS)	  might	  	  have	   sufficient	   sensitivity	   to	   identify	   population	   of	   the	   intermediate	   while	  minimally	  perturbing	  the	  solution	  equilibrium.	  The	  measurement	  of	  the	  collision	  cross-­‐section	   (CCS)	   monitored	   by	   ion-­‐mobility	   mass	   spectrometry	   can	   be	  obtained	  by	  comparison	  of	  arrival	  time	  distributions,	  which	  indicates	  a	  change	  in	  conformation.	  It	  therefore	  provides	  an	  accurate	  measurement	  of	  conformational	  compactness.	   There	   has	   been	   a	   significant	   increase	   in	   the	   use	   of	   ion	   mobility	  mass	  spectrometry	  (IM-­‐MS)	  to	  investigate	  conformations	  of	  proteins	  and	  protein	  complexes	   following	   electrospray	   ionization.	   Investigations	   which	   employ	  traveling	   wave	   ion	   mobility	   mass	   spectrometry	   (TW	   IM-­‐MS)	   instrumentation	  rely	  on	  the	  use	  of	  calibrants	  to	  convert	  the	  arrival	  times	  of	  ions	  to	  collision	  cross	  sections	  (CCS)	  providing	  "hard	  numbers"	  of	  use	  to	  structural	  biology.	  Using	  this	  approach	  we	  measured	   the	  CCS	  at	  20,	  34	  and	  39	   °C	   .	  At	  both	  20	   °C	  and	  34	   °C,	  monomeric	  Lys154Asn	  α1-­‐antitrypsin	  was	   indistinguishable	   from	  the	  wild-­‐type	  protein	  by	   IM-­‐MS.	  However,	  at	  39	   °C,	   there	  was	  a	  7.8	  %	   increase	   in	   the	  CCS	  of	  monomeric	   Lys154Asn	   α1-­‐antitrypsin	   relative	   to	   the	   wild-­‐type	   protein	   in	  keeping	   with	   population	   of	   an	   intermediate	   state	   (Fig.5.14.).	   The	   CCS	   of	   the	  intermediate	  state	  has	  been	  calculated	  as	  ~18%	  greater	   than	  the	  native	  state93	  so	  a	  7.8	  %	  increase	  in	  CCS	  is	  consistent	  with	  substantial	  population	  (~	  40	  %)	  of	  the	  intermediate	  state	  in	  equilibrium	  at	  physiological	  temperatures.	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Figure	  5.14.	  	   Lys154Asn	   α1-­antitrypsin	   biophysical	   characterization,	   using	  
Collision	   Cross	   Section	   studies	   (CCS)	   Arrival	   times	   and	   collision	   cross-­‐section	   (CCS)	   values	   calculated	   by	   IM-­‐MS	   for	  wild-­‐type	   (blue)	   and	   Lys154Asn	  α1-­‐antitrypsin	  indicated	  a	  7.8	  %	  increase	  in	  CCS	  in	  Lys154Asn	  relative	  to	  wild-­‐type	  α1-­‐antitrypsin	  at	  39	  °C	  (no	  difference	  was	  seen	  at	  20	  °C	  and	  34	  °C).	  Data	  are	  mean	  ±	  standard	  deviation	  (error	  bars)	  of	  three	  experiments.	  	  	  
5.2.5.	  Assignment	  of	  the	  Lys154Asn	  α1-­antitrypsin	  using	  NMR	  
spectroscopy	  	  	   The	  1H-­‐15N	  TROSY-­‐HSQC	  backbone	  resonance	  spectrum	  of	  Lys154Asn	  α1-­‐antitrypsin	   at	   25	   °C	  was	   of	   high	   quality	   and	   generally	   corresponded	   very	  well	  with	  that	  recently	  assigned	  for	  the	  wild-­‐type	  protein140	  (Fig.5.15.).	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Figure	  5.15.	  	   1H-­15N	   TROSY-­HSQC	   Spectrum	   of	   Wild-­Type	   and	   Lys154Asn	   α1-­
antitrypsin.	  Zoom	  (right)	  illustrates	  examples	  of	  reporter	  residues	  (wild-­‐type,	  black	  with	  cyan	  assignment;	  Lys154Asn,	  red).	  The	  excellent	  overlay	  between	  the	  wild-­‐type	  and	  the	  Lys154Asn	  allows	  the	  transfer	  of	   the	  assignment	   for	   further	  NMR	  studies.	  
	   The	   assignments	   could	   therefore	   be	   unambiguously	   transferred	   for	   123	  resonances	   that	   were	   well-­‐dispersed	   in	   the	   2D	   spectra	   allowing	   further	  comparisons	  to	  be	  made	  at	  37	  °C	  as	  below.	  The	  total	  number	  of	  cross-­‐peaks	   in	  the	  dispersed	  regions	  were	  similar	  in	  the	  wildtype	  and	  mutant	  proteins	  at	  25	  °C	  (152	  and	  148	  respectively),	  as	  was	  the	  combined	  intensity	  of	  crosspeaks	  in	  the	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central	   region.	   The	   inability	   to	   transfer	   29	   assignments	   of	   well-­‐dispersed	  crosspeaks	   from	   the	   1H-­‐15N	   TROSY	   HSQC	   backbone	   spectrum	   of	   wild-­‐type	   α1-­‐antitrypsin	   to	   that	   of	   Lys154Asn	   α1-­‐antitrypsin	   was	   likely	   related	   to	   the	  magnitude	  of	  the	  change	  in	  chemical	  shift	  for	  these	  cross-­‐peaks	  in	  the	  Lys154Asn	  mutant	  rather	  than	  a	  major	  change	  in	  local	  dynamics.	  The	  123	  comparable	  cross-­‐peaks	  were	  analysed	   in	   terms	  of	  signal	   intensity	  and	  chemical	  shift	   similarities	  between	   wild-­‐type	   and	   Lys154Asn	   α1-­‐antitrypsin.	   The	   degree	   of	   variation	  reported	  by	   the	   relative	   intensity	   and	   chemical	   shift	   changes	   is	   represented	   in	  figure	  5.16.	  The	  magnitude	  of	  changes	  is	  shown	  by	  heatmap	  colouring	  of	  spheres	  mapped	   to	   the	   1.8	   Å	   crystal	   structure	   of	   native	   α1-­‐antitrypsin.	   	   These	   data	  indicate	   that,	   in	   the	   native	   state	   ensemble,	   the	  mutation	  most	   affects	   residues	  around	  the	  F-­‐helix,	  strands	  1-­‐3	  of	  β-­‐sheet	  A	  and	  the	  reactive	  loop.	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Figure	  5.16.	  	   Solution	   behaviour	   and	   residue-­specific	   changes	   induced	   by	   the	  
Lys154Asn	  mutation	  in	  α1-­antitrypsin.	  A-­‐	  Changes	  in	  cross-­‐peak	  intensity	  and	   B-­‐	   magnitude	   of	   cross-­‐peak	   chemical	   shift	   (Δδ,	   below)	   for	   Lys154Asn	  relative	   to	   wild-­‐type	   α1-­‐antitrypsin	   at	   25	   °C	   for	   the	   subset	   of	   unambiguous	  resonances	   in	   2D	   spectra.	   Error	   bars	   are	   defined	   according	   to	   the	   standard	  deviation	  observed	  for	  peak	  intensities	  across	  the	  wild-­‐type	  (WT)	  or	  Lys154Asn	  (K154N)	  datasets	  at	  25	  °C	  using	  the	  formula:	  [(IK154N/IWT)]	  x	  √[(dK154N/IK154N)2	  +	  (dWT/IWT)2]	  where	   I	   is	   cross-­‐peak	   intensity	   and	  d	   is	   the	   standard	  deviation.	   C-­‐	  Residues	  corresponding	  to	  cross-­‐peaks	  that	  could	  not	  be	  followed	  are	  shown	  in	  black.	   Other	   residues	   are	   coloured	   grey.	   Relative	   intensity	   (left)	   data	   shown	  plotted	   on	   a	   Red-­‐white-­‐blue	   heatmap	   colouring	   (increases	   -­‐	   red,	   no	   change	   –	  white,	   decreases	   –	   blue).	   The	   greatest	   change	   was	   an	   increase	   in	   relative	  intensity	   to	   1.58	   (residue	   199):	   represented	   by	   maximal	   redness	   on	   an	   RGB	  colour	   scale.	   Chemical	   shift	   (right)	   data	   all	   changes	   were	   calculated	   as	  magnitudes	  and	  were	  therefore	  positive	   for	  chemical	  shift	  data.	  The	  maximum	  change	   that	   could	   be	   assigned	   to	   a	   specific	   residue	   (0.169	   ppm),	   occurred	   at	  residue	  149	  and	  so	  this	  is	  represented	  by	  maximal	  RGB	  scale	  redness.	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5.2.6.	  NMR	  of	  polymerogenic	  intermediate	  ensemble	  at	  37	  °C	  	   1H-­‐15N	  TROSY-­‐HSQC	  spectra	  reported	  on	  the	  formation	  of	  the	  pathological	  intermediate	  at	  37	  °C	  by	  non-­‐uniform	  broadening	  of	  previously	  assigned	  cross-­‐peaks	   in	   Lys154Asn	   α1-­‐antitrypsin	   relative	   to	   wild-­‐type	   α1-­‐antitrypsin.	   This	   is	  shown	   in	   Fig.	   5.17.	   by	   residue-­‐specific	   intensity	   change	   across	   the	   primary	  sequence.	   This	   was	   associated	   with	   the	   appearance	   of	   a	   further	   12	   discrete	  cross-­‐peaks	   in	   the	   well-­‐dispersed	   region	   of	   the	   spectrum	   in	   Lys154Asn	   α1-­‐antitrypsin,	  as	  illustrated	  by	  some	  examples	  in	  figure	  5.17.	  
	   	  
Figure	  5.17.	  	   1H-­15N	   TROSY-­HSQC	   Spectrum	   of	   Wild-­Type	   and	   Lys154Asn	   α1-­
antitrypsin.	   1H-­‐15N	  TROSY-­‐HSQC	  of	   Lys154Asn	  α1-­‐antitrypsin	   at	   25	   °C	   (grey	  contours,	  blue	  labels)	  and	  37	  °C	  (green	  contours,	  red	  labels).	  Example	  of	  ‘extra’	  cross-­‐peak	  appearing	  at	  37	  °C	  in	  Lys154Asn	  α1-­‐antitrypsin	  but	  not	  seen	  at	  25	  °C	  or	   in	   wild-­‐type	   α1-­‐antitrypsin	   at	   either	   temperature	   is	   highlighted	   (dashed	  intersection).	  	   There	  was	   no	   loss	   in	   the	   summed	   cross-­‐peak	   intensity	   observed	   in	   the	  central	   region	  of	   the	   spectrum	  relative	   to	   the	  wildtype	  protein	   at	  37	   °C.	  These	  data	   are	   consistent	   with	   a	   process	   of	   native	   →	   intermediate	   conformational	  exchange	  that	  is	  slow	  (milliseconds	  to	  seconds)	  relative	  to	  NMR	  timescales.	  The	  mean	   intensity	   of	   the	   extra	   peaks	   was	   roughly	   half	   (0.47)	   that	   of	   the	   mean	  intensity	   of	   all	   other	   discrete	   cross-­‐peaks	   in	   the	   spectrum,	   suggesting	   an	  approximate	   2:1	   ratio	   of	   native:intermediate	   conformers	   of	   Lys154Asn	   α1-­‐antitrypsin	  at	  37	  °C	  (Fig.5.18.A).	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Figure	  5.18.	  	   Population	  of	  the	  Intermediate	  by	  Lys154Asn	  α1-­antitrypsin	  under	  
Physiological	   Conditions.	   A-­‐	   Differential	   change	   in	   intensity	   for	   reporter	  cross-­‐peaks	   in	   the	   1H-­‐15N	   TROSY-­‐HSQC	   of	   Lys154Asn	   α1-­‐antitrypsin	   at	   37	   °C.	  Intensities	  are	  scaled	  relative	  to	  the	  wildtype	  protein	  at	  the	  same	  temperature	  and	  the	   intensities	  observed	  for	  Lys154Asn	  α1-­‐antitrypsin	  relative	  to	  the	  wild-­‐type	   at	   25	   °C	   {(IK154N,37/IWT,37)/(IK154N,25/IWT,25)}.	   B-­‐	   Relative	   intensities	  quantified	  mapped	  onto	  the	  subset	  of	  reporter	  residues	  (spheres)	  in	  red-­‐white-­‐blue	   heatmap	   colouring	   (increases,	   red;	   unchanged,	   white;	   reductions,	   blue).	  Greatest	  change	  (maximally	  blue	  by	  RGB,	  residue	  39)	  corresponds	  to	  a	  relative	  intensity	  of	  0.11.	  Increasing	  redness	  indicates	  increasing	  intensity	  on	  the	  same	  scale.	  Ellipse:	  hA	  region	  reporting	  major	  change	  from	  native-­‐like	  intensity.	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Values	   are	   scaled	   for	   monomer	   concentration;	   they	   take	   into	   account	  changes	  observed	  between	  wild-­‐type	  and	  mutant	  protein	  at	  25	  °C	  in	  the	  absence	  of	  polymerisation	  and	  changes	  observed	  in	  wild-­‐type	  α1-­‐antitrypsin	  between	  25	  and	   37	   °C.	   They	   therefore	   report	   differential	   changes	   in	   Lys154Asn	   α1-­‐antitrypsin	   associated	  with	   population	   of	   the	   polymerogenic	   state.	  Most	   cross-­‐peaks	   that	   remained	   unambiguously	   assigned	   in	   Lys154Asn	   α1-­‐antitrypsin	  reported	  minimal	   change	   at	   37	   °C	   relative	   to	  wild-­‐type	   protein	   and	   compared	  with	   observations	   at	   25	   °C	   (Fig.5.18.B).	   Most	   reporter	   cross-­‐peaks	   signalled	  minimal	   change	   in	   Lys154Asn	   α1-­‐antitrypsin	   at	   37°C.	   NMR	   intensity	   data	   are	  highly	   sensitive	   reporters	   of	   changes	   in	   structure	   and	   dynamics,	   so	   relatively	  large	   changes	  may	  be	   induced	  by	  quite	   small	   changes	   in	   solution	  behaviour.	  A	  value	   of	   100%	   relative	   intensity	   would	   therefore	   indicate	   entirely	   native-­‐like	  structural	   and	   dynamical	   behaviour	   in	   a	   particular	   residue.	   Nevertheless	  residues	   reporting	   the	   most	   dramatic	   intensity	   change	   in	   the	   polymerogenic	  ensemble	  notably	  occur	  in	  regions	  previously	  linked	  with	  conformational	  change	  (upper	  s3A,	  upper	  hF,	  underlying	  the	  upper	  s4A	  site,	  hA).	  However	  Phe189	  in	  the	  upper	  part	  of	  strand	  3	  and	  the	  nearby	  Thr165	  at	  the	  top	  of	  F-­‐helix	  showed	  a	  clear	  decrease	  in	  intensity.	  Changes	  of	  similar	  magnitude	  were	  also	  seen	  in	  β-­‐sheet	  B	  where	   it	   underlies	   the	   breach	   (upper	   s4A)	   region	   and,	   interestingly,	   at	   longer	  range	  around	  the	  site	  of	  another	  polymerogenic	  mutation	  (I39C)	  in	  the	  A-­‐helix.	  Mutations	   in	   contiguous	   residues	   in	   α1-­‐antitrypsin	   and	   antithrombin	   are	   also	  associated	  with	  deficiency	  and	  disease.	  Our	  data	  suggest	  that	  structural	  changes	  here	   are	   integral	   to	   formation	   of	   the	   pathological	   intermediate.	   These	   effects	  may	   be	   transmitted	  most	   directly	   to	   the	   A-­‐helix	   from	   s3A	   via	   the	   intervening	  shutter	  and	  s6B	  motif.	  Residues	  in	  strand	  5	  in	  β-­‐sheet	  A,	  helix	  I	  and	  the	  intervening	  linker,	  which	  were	  described	  to	  expand	  during	  intermediate	  formation	  in	  the	  β-­‐hairpin	  model,	  showed	   strongly	   preserved	   intensity,	   therefore	   the	   data	   presented	   here	   using	  Lys154Asn	   α1-­‐antitrypsin	   mild-­‐disease	   mutant	   do	   not	   support	   this	   model	   of	  polymerisation.	   	   Similarly	   residues	   in	   strands	   4	   and	   5	   of	  β-­‐sheet	   B,	   that	  must	  unfold	  in	  the	  triple-­‐strand	  polymerisation	  model,	  are	  also	  among	  the	  more	  stable	  residues	  assessed	  in	  this	  way.	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5.3	  Discussion	  	  	   Studying	  key	  native	  to	  intermediate	  transitions	  can	  elucidate	  mechanisms	  of	  the	  conformational	  diseases	  and	  aid	  targeting	  of	  novel	  therapeutic	  strategies.	  However	   the	   intrinsic	   tendency	   of	   intermediates	   to	   adopt	   more	   stable,	  polydisperse,	   multimeric	   conformations	   renders	   this	   inherently	   challenging.	  Moreover,	   structurally	   distinct	   serpin	   polymers	   are	   induced	   by	   chemical	  denaturants	  compared	  to	  pathological	  mutations	  or	  heating93.	  	  	   The	   Lys154Asn	   mutant	   of	   α1-­‐antitrypsin	   (α1-­‐antitrypsin	   Queen’s)	   was	  identified	   in	   an	   individual	  with	  deficiency	  of	   the	  plasma	  protein.	  The	  mutation	  results	  in	  the	  formation	  of	  polymers	  in	  vitro	  and	  when	  expressed	  in	  a	  eukaryotic	  cell	  model	  of	  disease.	  Lys154Asn	  α1-­‐antitrypsin	  polymers	  induced	  by	  heating	  or	  expression	  within	  the	  cell	  model	  are	  recognised	  by	  the	  2C1	  monoclonal	  antibody	  (mAb).	  2C1	  recognizes	  disease	  polymers	  of	  Z	  α1-­‐antitrypsin	  that	  form	  in	  vivo	  and	  when	   induced	   in	   vitro	   by	   heating.	   It	   is	   highly	   conformer-­‐specific	   and	   can	   even	  discriminate	  these	  polymers	  from	  those	  formed	  in	  the	  presence	  of	  denaturant93;	  189.	   Accordingly,	   data	   obtained	   for	   Lys154Asn	   α1-­‐antitrypsin	   are	   likely	   to	   be	  applicable	  to	  other	  pathological,	  polymerogenic	  mutants	  of	  α1-­‐antitrypsin.	  	  	   	  Furthermore	  the	  Queen’s	  variant	  adopts	  the	  native	  conformation	  at	  25	  °C	  but	   readily	   populates	   a	   polymerogenic	   intermediate	   ensemble	   in	   physiological	  conditions.	   However	   it	   forms	   polymers	   far	  more	   slowly	   than	   Z	   α1-­‐antitrypsin.	  This	  combination	  explains	  the	  low	  level	  of	  polymerisation	  within	  the	  cell	  model	  and	   the	   relatively	   mild	   deficiency	   of	   circulating	   protein	   and	   lack	   of	   clinical	  disease	   in	   the	   index	   case	   (Queen’s/Z	   compound	   heterozygote).	   Critically	   the	  same	   combination	   of	   characteristics	   rendered	   the	   polymerogenic	   intermediate	  ensemble	  unusually	   amenable	   to	  biophysical	   and	  biochemical	   characterization,	  including	   the	   use	   of	   NMR	   spectroscopy.	   These	   studies	   report	   at	   the	   level	   of	  multiple	  specific	  residues	  located	  all	  around	  the	  protein,	  representing	  >	  30	  %	  of	  the	   entire	   sequence.	   Thus	   they	   allow	   the	   first	   detailed	   characterization	   of	   the	  structural	  and/or	  dynamic	  solution	  behaviour	  of	  α1-­‐antitrypsin	  during	  formation	  of	  a	  disease-­‐relevant	  polymerogenic	  intermediate	  ensemble.	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   Wild-­‐type	   and	   Lys154Asn	   α1-­‐antitrypsin	   demonstrated	   similar	   peak	  counts	  in	  1H-­‐15N	  TROSY-­‐HSQC	  NMR	  spectra	  at	  25	  °C,	  consistent	  with	  IM-­‐MS	  data	  suggesting	  a	  similarly	  high	  population	  of	  the	  native	  state	  in	  the	  two	  proteins	  in	  these	   conditions.	   However	   at	   37	   °C	   the	   data	   were	   consistent	   with	   increased	  population	  of	  the	  intermediate	  in	  Lys154Asn	  α1-­‐	  antitrypsin	  compared	  with	  the	  wildtype	   protein.	   The	   findings	   were	   in	   good	   agreement	   with	   the	   data	   from	  biochemical,	  biophysical	  and	  cellular	  studies	  across	  physiological	  temperatures.	  Intermediate	   formation	   was	   therefore	   assessed	   by	   comparing	   spectra	   of	  wildtype	  and	  Lys154Asn	  α1-­‐antitrypsin	  at	  both	  25	  °C	  and	  37	  °C.	  Residue-­‐specific	  changes	   in	   intensity	   were	   quantified	   by	   ratios	   that	   accounted	   for	   changes	   in	  native	  signal	  reporting	  due	  to	  the	  mutation	  and	  the	  increase	  in	  temperature,	  and	  a	   low	   constant	   loss	   of	   global	   signal	   due	   to	   background	   polymerisation.	   The	  changes	   that	   are	   observed	   by	   this	   approach	   therefore	   solely	   report	   structural	  and/or	  dynamic	   changes	   affecting	   individual	   residues	  due	   to	   the	  population	  of	  the	  polymerogenic	  intermediate	  ensemble.	  	  	  	   The	   average	   relative	   intensity	   across	   the	   entire	   subset	   of	   residues	   that	  could	   be	   analysed	   in	   this	   way	   was	   82%.	   It	   is	   therefore	   unlikely	   that	   the	  intermediate	  state	  is	  substantially	  unfolded	  as	  required	  for	  extensively	  proposed	  domain-­‐swapped	  models	   of	   polymerisation.	   Moreover,	   analysis	   of	   cross-­‐peaks	  indicates	  widespread	  preservation	  of	  highly	  native-­‐like	  solution	  behaviour	  over	  most	  of	  the	  molecule.	   In	  particular	  the	  data	  support	  high	  stability	   in	  the	  hI-­‐s5A	  and	   s4B,	   s5B	   regions	   proposed	   to	   unfold	   in	   the	   β-­‐hairpin	   and	   triple-­‐strand	  models	   of	   polymerisation	   respectively	   97;	   99.	   Instead	   intermediate	   ensemble	  formation	   was	   characterized	   by	   highly-­‐localized	   changes	   in	   structural	   and/or	  dynamic	  behaviour.	  These	  changes	  affected	  residues	   in	  regions	  associated	  with	  remodeling	  during	  intermediate	  ensemble	  formation	  in	  the	  single	  strand	  model	  of	  polymerisation	  (Thr165	  at	  the	  top	  of	  F-­‐helix,	  relative	   intensity	  0.46,	  Phe189,	  upper	  s3a,	  0.31).	  Moreover,	  a	  major	  loss	  of	  relative	  intensities	  was	  noted	  at	  the	  C-­‐terminal	   end	   of	   the	   A-­‐helix	   (relative	   intensity:	   Arg39,	   0.11	   and	  His43,	   0.33).	  The	  F-­‐helix	  and	  linker	  region	  may	  therefore	  constitute	  a	  ‘‘clasp’’	  motif,	  sealing	  a	  network	   of	   interactions	   that	   regulate	   conformational	   change.	   Similar	   clasp	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Figure	  6.1.	  	   Energy	  free-­energy	  landscape	  α1-­antitrypsin.	  Protein	  energy	  landscapes	  are	   typically	   many-­‐dimensional,	   defining	   more	   or	   less	   favoured	   pathways	  between	   distinct	   conformational	   states.	   This	   figure	   schematically	   illustrates	  such	  a	  landscape	  for	  α1-­‐antitrypsin.	  The	  putative	  unfolded	  to	  folded	  transition	  is	  shown	   in	   blue,	   with	   the	   metastable	   native	   state	   shown	   as	   a	   local	   energy	  minimum.	  Binding	   to	   its	   target	  proteinase	   results	   in	   a	  highly	   stable	   inhibitory	  complex	   (cyan).	   Furthermore,	   genetic	   mutations	   observed	   in	   disease	   lead	   to	  misfolding	   and	   aggregation	   to	   highly	   stable	   polymers	   (red)	   (also	   shown	   in	  section	  1.2.2,	  Chapter	  I).	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This	   thesis	   puts	   forward	   a	   strategy	   for	   the	   use	   of	   Nuclear	   Magnetic	  Resonance	  spectroscopy	   together	  with	  complementary	  biophysical	  methods,	   to	  unveil	   processes	   of	   folding,	  misfolding	   and	   polymerisation	   of	   α1-­‐antitrypsin	   in	  unprecedented	  detail.	  These	  processes	  underlie	  function	  and	  dysfunction	  in	  the	  serpin	  superfamily	  of	  proteins.	  	  Human	   diseases	   characterized	   by	   protein	   conformational	   modifications	  have	  been	  recognized	  for	  almost	  two	  centuries47;	  53;	  204;	  205;	  206.	  It	  has	  now	  become	  clear	   that	   many	   different	   proteins	   can	   misfold	   and	   form	   extracellular,	   or	  intracellular	   aggregates	   that	   initiate	   profound	   cellular	   dysfunction207.	  Particularly	   challenging	   examples	   of	   such	   disorders	   include	   Alzheimer's	   and	  Parkinson's	   diseases.	   Another	   predominant	   pathology	   characterized	   by	   the	  ordered	   aggregation	   and	   tissue	   deposition	   of	   aberrant	   protein	   conformation,	  described	  in	  this	  work,	  are	  the	  serpinopathies208.	  	  As	  well	  as	  for	  most	  conformational	  diseases,	  the	  structure	  and	  the	  formation	  of	  pathogenic	  polymers	  remains	  subject	  of	  debate.	  For	  the	  serpinopathies	  this	  is	  of	  particular	   importance.	   They	   differ	   from	   other	   conformational	   diseases	   where	  fibrillar	  deposited	   states	  may	  be	   less	   toxic	   than	   smaller	   soluble	   species	   in	   that	  deposition	   of	   polymeric	   species	   appears	   to	   tightly	   correlate	   with	   disease	  severity209.	   This	   implies	   that	   the	   pathogenic	   state(s)	   are	   likely	   to	   occur	   on	   the	  pathway	   to	   polymerisation	   and	   that	   the	   polymers	   themselves	   are	   toxic.	   The	  presence	   of	   a	   polymerogenic	   intermediate	   ensemble	   in	   the	   pathway,	   often	  denoted	  as	  M*,	  is	  supported	  from	  the	  kinetics	  of	  polymerisation	  of	  serpins81;	  156;	  210.	   Structural	   data	   and	   studies	   with	   the	   α1-­‐antitrypsin	   polymer	   specific	  monoclonal	  antibody	  2C1	  support	  the	  population	  of	  multiple	  intermediate	  states	  in	   a	   condition-­‐dependent	   manner77	   93;208	   97;	   99	   115	   189.	   In	   vitro	   polymerisation	  therefore	  appears	  not	  to	  be	  a	  single	  phenomenon,	  but	  to	  proceed	  over	  a	  complex	  energy	  landscape	  incorporating	  a	  range	  of	  ensemble	  conformations	  and	  multiple	  possible	   end	   products.	   This	   landscape	   also	   relates	   to	   a	   physiological	   folding	  pathway	   that	   avoids	   populating	   the	   hyperstable	   polymeric	   and	   monomeric	  conformations	   in	   favour	   of	   the	   metastable	   and	   hence	   functional	   native	   state	  (outlined	  in	  simplified	  form	  in	  Fig.6.1.).	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NMR	   spectroscopy	   can	   report	   upon	   structural	   and	   dynamic	   solution	  behaviour	  over	  time	  scales	  covering	  6-­‐9	  orders	  of	  magnitude128;	  130.	  On	  the	  other	  hand,	  applying	  these	  methods	  to	  a	  protein	  of	  the	  size	  of	  the	  prototypic	  serpin	  α1-­‐antitrypsin	   is	   challenging	   even	   after	   the	   ‘first	   step’	   of	   assigning	   ~90%	   of	   its	  polypeptide	   chain	   residues	   in	   the	   backbone	  NH	   spectrum140.	   Nevertheless	   this	  breakthrough	  allows	  us	  to	  ask	  more	  sophisticated	  questions	  by	  a	  range	  of	  NMR	  techniques,	   to	   interrogate	   how	   the	   motions	   and	   dynamic	   proprieties	   of	  individual	   residues	  within	  α1-­‐antitrypsin	  may	   facilitate	   conformational	   change.	  The	   next	   steps	   that	   I	   have	   undertaken	   in	   this	   thesis,	   aided	   by	   complementary	  biophysical	  techniques,	  have	  primarily	  been	  to	  characterise:	  	   i)	   transitions	  observed	   in	  urea	  denaturing	  equilibrium	  studies	   to	   inform	  on	  folding	  	  and	  misfolding	  processes;	  	   ii)	  the	  dynamics	  of	  the	  natively	  folded	  metastable	  state	  in	  solution	  using	  HDXNMR	   (ms-­‐s	   timescale)	   in	   order	   to	   understand	   how	   potential	   lability	   is	  regulated;	  	  	   iii)	   Polymerogenic	   intermediate	   ensemble	   formation	   in	   physiological	  conditions	  in	  a	  novel	  variant	  associated	  with	  deficiency.	  	   Various	   biochemical	   and	   biophysical	   techniques	   have	   been	   used	   to	  separate	  and	  characterize	  proteins	  with	  different	  oligomerization	  states	  and/or	  conformations	  formed	  by	  perturbation	  of	  the	  native	  state211;	  212;	  213.	  Examples	  of	  such	  perturbations	  are	  those	  induced	  by	  changes	  in	  solution	  conditions,	  such	  as	  temperature	  or	  pH.	  Alternatively,	   denaturant	   studies	   are	  widely	  used	   to	  probe	  protein	   folding	   and	   unfolding	   pathways161.	   They	   have	   been	   considered	  particularly	  relevant	   in	  studying	  the	  relationship	  of	   these	  processes	   to	  disease-­‐associated	  polymerisation	   in	  systems,	  where	   low	  concentrations	  of	  denaturant,	  can	  induce	  the	  formation	  of	  polymeric	  states99;	  161.	  	  	   Over	   20	   years	   ago,	   the	   first	   published	   study	   of	   α1-­‐antitrypsin	   unfolding	  described	  equilibrium	  studies	  across	  a	  guanidinium	  hydrochloride	  titration	  165.	  It	  has	  since	  led	  to	  numbers	  of	  biochemical	  and	  biophysical	  unfolding	  studies	  using	  both	   urea	   and	   guanidine	   83;166;81;	   100;	   167.	   These	   have	   suggested	   that	   the	  folding/unfolding	   pathways	   of	   α1-­‐antitrypsin	   may	   involve	   three	   states:	   native	  
	   158	  
(N),	   intermediate	   (I),	   unfolded	   (U)	   83;166;81;	   100;	   167	   with	   	   intermediate	   states	  maximally	   populated	   around	   1.5	   M	   guanidine83	   or	   4.0	   M	   urea88.	   In	   order	   to	  obtain	   residue-­‐specific	   information	   on	   conformational	   change	   during	   such	  processes,	   I	   undertook	   a	   urea	   titration	   from	   0	   M	   to	   8.0	   M	   urea	   (100	   μM	   α1-­‐antitrypsin),	   and	   followed	   this	  by	  2D	   (1H-­‐15N	  TROSY-­‐HSQC)	  NMR	  spectroscopy	  experiments	   (Chapter	   III,	   Fig.6.1.	   blue	   pathway).	   This	   strategy	   was	   combined	  with	   1D	   (1H)	   NMR	   and	   CD	   spectroscopy,	   in	   order	   to	   track	   off-­‐pathway	  polymerisation	  at	  the	  high	  protein	  concentration	  and	  global	  unfolding	  when	  such	  polymerisation	  was	  minimized	  (0.1	  mg/ml	  α1-­‐antitrypsin),	  respectively.	  Spectra	  at	   0	   M	   and	   8.0	   M	   urea	   demonstrated	   the	   characteristic	   folded	   and	   unfolded	  fingerprints	   of	   α1-­‐antitrypsin,	   respectively.	   Surprisingly,	   at	   low-­‐urea	  concentration,	  1.0	  M	  urea,	  where	  the	  native	  conformation	  appears	  stable	  by	  CD	  spectroscopy	   conformational	   changes	   were	   already	   observed	   in	   the	   solution	  behaviour	  of	  α1-­‐antitrypsin.	  	  These	  may	  therefore	  predominantly	  reflect	  changes	  in	   dynamic	   behaviour	   rather	   than	   structural	   remodelling.	   Intriguingly,	   a	   few	  residues	  in	  β-­‐sheet	  C	  reported	  enhanced	   ‘native-­‐like’	  signal	   in	  these	  conditions.	  	  A	   possible	   explanation	   is	   that	   these	   α1-­‐antitrypsin	   residues	   are	   less	  conformationally	   labile	  at	  1.0	  M	  than	  at	  0	  M	  urea	  and	  could	  act	  as	  a	  more	  rigid	  scaffold	  during	  late	  folding/early	  unfolding.	  	  All	  dispersed	  resonance	  signals	  were	  lost	  during	  equilibriation	  of	  100	  µM	  α1-­‐antitrypsin	  at	  2.0	  M	  urea.	  	  Whilst	  the	  corresponding	  CD	  equilibrium	  studies	  at	  ~	   50-­‐fold	   lower	   α1-­‐antitrypsin	   concentration	   did	   not	   support	   extensive	  unfolding.	  Since	  unfolding	  is	  not	  likely	  to	  be	  concentration-­‐dependent	  this	  result	  indicates	   that	   the	   combination	   of	   denaturant	   and	   high	   α1-­‐antitrypsin	  concentration	   is	   causing	  urea-­‐induced	  polymerisation	  of	  most	  of	   the	   sample	   in	  the	   conditions	   used	   for	   the	   NMR	   studies	   Urea-­‐induced	   polymerisation	   was	  dominant	  in	  the	  2.0	  to	  6.0	  (maximal	  3.0-­‐4.0)	  M	  urea	  range.	  However,	  the	  data	  do	  not	   demonstrate	   clear	   evidence	   of	   a	   distinct	   urea-­‐induced	   intermediate.	  Unfolded	  resonances	  started	  appearing	  between	  3.0	  to	  7.6	  M	  urea.	  	  Unexpectedly,	   CD	   spectral	   studies	   strongly	   supported	   a	   two-­‐states	  equilibrium	  unfolding	  behaviour.	  The	  absence	  of	  an	  apparent	  intermediate	  state	  definable	   by	   a	   distinct	   secondary	   structure	   signature	   in	   urea	   is	   surprising.	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Previous	   studies	   of	   α1-­‐antitrypsin	   by	   single	   wavelength	   CD	   spectroscopy	  (ellipticity	  reported	  at	  222	  nm)	  supported	  the	  population	  of	  an	  extra	  state	  at	  2.5	  -­‐	   4.0	  M	   urea88;83.	   My	   studies	   suggest	   this	   ‘state’	   may	   have	   been	   an	   artefact	   of	  polymerisation	   induced	  by	  urea	  when	  α1-­‐antitrypsin	  was	  >	  0.25	  mg/ml.	  My	  CD	  studies	   were	   undertaken	   at	   0.1	   mg/ml	   α1-­‐antitrypsin,	   where	   polymerisation	  could	   not	   be	   detected	   by	   other	   methods.	   This	   low	   protein	   concentration	   was	  inevitably	  associated	  with	  noisier	  spectra	  than	  would	  be	  the	  case	  with	  higher	  α1-­‐antitrypsin	   concentrations.	   However,	   it	   effectively	   minimizes	   the	   effects	   of	  polymerisation	  that	  is	  otherwise	  favoured	  for	  this	  range	  of	  urea	  conditions.	  The	  findings	   presented	   in	   this	   thesis	   do	   not	   exclude	   the	   possibility	   that	   in	   other	  environmental	   conditions	   (e.g.	   low-­‐pH,	   guanidine,	   heat)	   unfolding	   pathways	  follow	   a	   three-­‐state	   process.	   They	   do	   however,	   constitute	   a	   useful	   comparator	  for	  further	  unfolding	  exploration.	  With	  the	  exception	  of	  guanidine,	  these	  could	  be	  investigated	   further	   at	   residue-­‐specific	   level	   and	   in	   solution,	   using	   NMR	  spectroscopy.	   They	   also	   indicate	   the	   importance	   of	   experimentally	   validating	  ‘intermediate’	  serpin	  states	  observed	  in	  denaturing	  conditions	  by	  assessing	  their	  apparent	  signal	  at	  a	  range	  of	  protein	  concentrations.	  	   Furthermore,	   the	   severe	  Z	  disease	  mutation	   (Glu342Lys)	   results	   in	  only	  mild	   reductions	   in	   thermodynamic	   stability	   relative	   to	   the	  effects	  of	   stabilizing	  mutations	   (Thr114Phe	   and	   Gly117Phe).	   This	   is	   important	   since,	   despite	   the	  larger	   thermodynamic	  effects,	   these	  phenylalanine	  mutations	   themselves	  cause	  no	   or	   minimal	   rescue	   of	   the	   disease	   phenotype	   when	   introduced	   on	   a	   Z	   α1-­‐antitrypsin	  background.	  	   The	  study	  of	  the	  dynamics	  of	  the	  metastable	  state	  presented	  in	  this	  work,	  started	   with	   exploration	   of	   the	   motions	   in	   the	   range	   of	   the	   milliseconds	   to	  seconds	   timescale	   using	   HDXNMR	   experiments	   (chapter	   IV).	   Indeed,	   HDXNMR	  was	   previously	   described	   to	   constitute	   a	   powerful	   tool	   providing	   insight	   into	  equilibrium	  populated	   intermediate214.	   	   The	   true	   challenge	  of	   this	   strategy	   lies	  on	   both	   the	   size	   of	   the	   protein,	   and	   the	   rapidity	   of	   exchange	   for	   many	   labile	  residues	   and	   the	   tendency	   to	   undergo	   acid-­‐induced	   polymerisation	   below	   pH	  6.0.	   These	   were	   addressed	   by	   optimizing	   the	   system	   (protein	   concentration,	  temperature,	   type	   of	   NMR	   experiment,	   method	   of	   exchange,	   length	   of	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experiment),	  working	   at	   high	   concentrations	   of	   α1-­‐antitrypsin	   (250	   μM),	   using	  SOFAST	   Heteronuclear	   Multiple	   Quantum	   Correlation138	   (HMQC)	   NMR	  experiments	   that	   allow	   rapid	  monitoring	   of	   fast	   exchange215,	   and	   by	   assessing	  the	  sample	  for	  polymerisation	  during	  and	  after	  the	  experiments.	  When	  assessed	  by	  HDXNMR,	  the	  data	  demonstrated	  groupings	  of	  residues	  with	  high	  rigidity	  or	  high	  lability.	  Relatively	  few	  residues	  reporting	  intermediate	  levels	  of	  protection	  on	   this	   scale.	   Globally,	   the	   lability	   ranged	   between	   0.4	   kcal.mol-­‐1	   ≥	   ΔGapp	   ≤	   9	  kcal.mol-­‐1.	   	  This	  range	  and	  the	  distribution	  of	  values	  is	  consistent	  with	  previous	  data	  on	  global	  ΔG	  values81	  and	  earlier	  lower	  resolution,	  higher	  coverage	  HDXMS	  data92	  to	  which	  it	  is	  complementary.	  More	  specifically,	  the	  data	  define	  a	  region	  of	  high	   protection	   extending	   from	   β-­‐sheet	   C	   through	   the	   core	   (β-­‐sheet	   B	   and	   B-­‐helix)	  through	  to	  the	  middle	  of	  β-­‐sheet	  A	  that	  can	  be	  divided	  into	  2	  hydrophobic	  clusters.	   Cluster	   1	   locks	   closed	   the	   centre	   of	   β-­‐sheet	   A	   (strands	   3	   and	   5)	   by	  interaction	  with	  the	  B-­‐helix	  and	  the	  lower,	  buried	  strand	  residues	  in	  β-­‐sheet	  B.	  It	  corresponds	   to	   the	   shutter	   region,	   and	   boundaries	   of	   the	   s4A/reactive	   loop	  insertion	  site77;	   140.	  The	  second	  cluster	  affects	  hydrophobic	  residues	   interacting	  in	  a	  β-­‐barrel	  region	  between	  β-­‐sheets	  B	  and	  C.	  Destabilisation	  of	  this	  region	  by	  ‘latch	   mutations’	   was	   recently	   described	   as	   a	   pathogenic	   mechanism	   in	   mild	  deficiency	   variants	   of	   α1-­‐antitrypsin191	   and	   this	   region	   is	   also	   proposed	   as	   a	  nucleation	   site	   for	   protein	   folding90.	   The	   minimally-­‐protected,	   flexible	   regions	  include	   the	   RCL	   and	   an	   area	   around	   the	   interface	   between	   the	   F-­‐helix	   and	  β-­‐sheet	   A.	   This	   suggests	   that	   the	   dominant	   regulation	   of	   opening	   is	   by	   cluster	   1	  interactions	   rather	   than	   conformational	   stability	   of	   the	   RCL	   or	   F-­‐helix.	   The	  effects	  of	  disease	  mutations	  support	   this.	  Whilst	  mutations	  shown	  or	  predicted	  to	   destabilize	   these	   regions	   do	   cause	   polymerisation	   and	   circulating	  deficiency192;	  193;	  194	  the	  effects	  of	  destabilizing	  s5A	  and	  shutter	  region	  mutations	  are	   much	   greater	   95;	   173;	   195.	   Moreover,	   I	   have	   conducted	   spin	   relaxation	  experiments216;	  217	  whose	  data	  are	  currently	  being	  analysed	  to	  inform	  upon	  fast	  (ps-­‐ns	  timescale)	  dynamics	  in	  α1-­‐antitrypsin.	  Building	  on	  these	  methods,	  the	  use	  of	   relaxation-­‐dispersion	   NMR	   218;	   219	   may	   allow	   analysis	   of	   low-­‐populated	  intermediate	   species	   in	   solution,	   e.g.	   during	   folding	   or	   pathophysiological	  conditions	  in	  the	  context	  of	  disease	  mutations.	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Studying	  key	  native	  to	  intermediate	  transitions	  can	  elucidate	  mechanisms	  of	  the	  conformational	  diseases	  and	  aid	  targeting	  of	  novel	  therapeutic	  strategies.	  However	   the	   intrinsic	   tendency	   of	   intermediates	   to	   adopt	   more	   stable,	  polydisperse,	   multimeric	   conformations	   renders	   this	   inherently	   challenging.	  Exploring	  the	  native	  to	  polymer	  transition	  (Chapter	  V,	  Fig.6.1.,	  red	  pathway),	  this	  thesis	   presents	   a	   newly	   characterised	   forme	   fruste	   deficiency	   variant	   of	   α1-­‐antitrypsin	   (Lys154Asn)	   that	   forms	   polymer	   recapitulating	   the	   conformer-­‐specific	  neoepitope	  observed	   in	  polymers	   that	   form	   in	  vivo	  (2C1).	   In	   this	  work,	  NMR	   spectroscopy	   was	   used	   to	   provide	   new	   insights	   on	   the	   structural	   and	  dynamic	   changes,	   and	   potential	   formation	   of	   M*,	   associated	   with	   polymer	  formation.	   The	   Lys154Asn	   mutant	   of	   α1-­‐antitrypsin	   (so-­‐called	   α1-­‐antitrypsin	  Queen’s)	  was	  identified	  in	  an	  individual	  with	  deficiency	  of	  the	  plasma	  protein.	  It	  adopted	   the	   native	   conformation	   at	   25	   °C	   but	   this	   thesis	   shows	   that	   it	   readily	  populated	   a	   polymerogenic	   intermediate	   ensemble	   at	   pathophysiological	  temperatures	   (characterised	   by	   Native-­‐PAGE,	   CD	   spectroscopy	   and	   IM-­‐MS	  studies).	   It	   was	   shown	   however	   to	   form	   polymers	   far	  more	   slowly	   than	   Z	   α1-­‐antitrypsin.	  The	  combination	  explains	  the	  low	  level	  of	  polymerisation	  within	  the	  cell	  model	   and	   the	   relatively	  mild	   deficiency	   of	   circulating	   protein	   and	   lack	   of	  clinical	  disease	  in	  the	  index	  case	  (Queen’s/Z	  compound	  heterozygote).	  	  The	   ‘molten	   globule’	   state	   as	   a	   general	   term	  was	   introduced	   in	   section	  1.1.1.3,	   describing	   for	   the	   first	   time	   the	   existence	   of	   a	   third	   (intermediate)	  equilibrium.	  This	  was	  defined	  as	  a	  thermodynamic	  state	  that	  conserves	  a	  native-­‐like	   secondary	   structure	   content	   without	   the	   tightly	   packed	   protein	   interior	  (lacking	   a	   specific	   tertiary	   structure).	   	   The	   results	   presented	   in	   this	   thesis	  provide	   evidence	   for	   different	   conformational	   behaviour	   along	   pathways	   of	  polymerisation	  induced	  by	  denaturants	  and	  by	  disease	  mutations.	  	  This	  indicates	  they	  cause	  the	  polypeptide	  chain	  to	  explore	  different	  paths	  through	  the	   folding	  landscape	  (Fig.	  6.2)	  leading	  to	  different	  stabilized	  polymer	  states.	  	   The	   same	   combination	   of	   characteristics	   rendered	   the	   polymerogenic	  intermediate	   ensemble	   unusually	   amenable	   to	   biophysical	   and	   biochemical	  characterization,	  including	  the	  use	  of	  NMR	  spectroscopy.	  These	  studies	  report	  at	  the	  level	  of	  multiple	  specific	  residues	  located	  all	  around	  the	  protein,	  representing	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>	  30	  %	  of	  the	  entire	  sequence.	  Thus	  they	  allow	  the	  first	  detailed	  characterization	  of	   the	   structural	   and/or	   dynamic	   solution	   behaviour	   of	   α1-­‐antitrypsin	   during	  formation	   of	   a	   disease-­‐relevant	   polymerogenic	   intermediate	   ensemble.	  Intermediate	   formation	  was	   therefore	   assessed	   by	   comparing	   spectra	   of	   wild-­‐type	  and	  Lys154Asn	  α1-­‐antitrypsin	  at	  both	  25	  °C	  and	  37	  °C.	  The	  residue-­‐specific	  changes	   in	   intensity	   that	  are	  observed	  by	  this	  approach	  therefore	  solely	  report	  structural	   and/or	   dynamic	   changes	   affecting	   individual	   residues	   due	   to	   the	  population	  of	  the	  polymerogenic	  intermediate	  ensemble.	  	  The	  data	  support	  high	  stability	   in	   the	   hI-­‐s5A	   region	   proposed	   to	   unfold	   in	   the	   β-­‐hairpin	   model	   of	  polymerisation97.	   Instead	   intermediate	   ensemble	   formation	   was	   characterized	  by	   highly	   localized	   changes	   in	   structural	   and/or	   dynamic	   behaviour.	   These	  changes	   affected	   residues	   in	   regions	   associated	   with	   remodelling	   during	  intermediate	  ensemble	  formation	  in	  the	  single	  strand	  models	  of	  polymerisation	  (top	   of	   F-­‐helix,	   upper	   s3A).	   Moreover,	   a	   major	   loss	   of	   relative	   intensities	   was	  noted	   at	   the	   C-­‐terminal	   end	   of	   the	   A-­‐helix.	   The	   F-­‐helix	   and	   linker	   region	  may	  therefore	   constitute	   a	   ‘clasp’	   motif,	   sealing	   a	   network	   of	   interactions	   that	  regulate	   conformational	   change.	   Similar	   clasp	   unlocking	   likely	   underlies	   the	  polymerogenic	   effects	   of	   antithrombin	  Rouen-­‐VI	   (Asn158Asp	   by	   α1-­‐antitrypsin	  template	   numbering)	  mutation	   in	   the	   related	   serpin	   antithrombin	   that	   is	   also	  associated	  with	  deficiency200.	  On	  the	  other	  hand,	  a	  linker	  mutation	  that	  promotes	  polar	   interactions	  within	   the	   clasp	   (Asn171His,	   template	  numbering)	   stabilises	  the	   native	   serpin	   plasminogen	   activator	   inhibitor-­‐1	   (PAI-­‐1)	   against	   loop	  insertion	  and	  conformational	  change203.	  Based	  upon	  recent	  experience	  with	  the	  serpinopathies,	   it	   seems	   reasonable	   to	   propose	   that	   the	   use	   of	   powerful	  techniques	  that	  are	  non-­‐perturbing	  to	  solution	  equilibria	  of	  forme	  fruste	  disease	  variants	  is	  an	  optimal	  strategy	  for	  the	  study	  of	  conformational	  disease	  processes.	  Data	   from	   this	   particular	  α1-­‐antitrypsin	   variant	   are	  most	   readily	   reconciled	   to	  the	   classical	   single-­‐strand	   polymerisation	   model77.	   However,	   further	   NMR	  studies	   are	   required	   for	   definitive	   characterisation	   of	   which	   polymerisation	  model(s)	  is/are	  most	  relevant	  to	  disease	  in	  vivo.	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   Overall,	  my	  studies	  support	  the	  use	  of	  NMR	  spectroscopy	  to	  obtain	  unique	  residue-­‐specific	   structural	   and	   dynamical	   information	   of	   the	   different	   folding	  and	  misfolding/polymerisation	   pathways	   available	   to	   α1-­‐antitrypsin.	   They	   also	  illustrate	  the	  importance	  of	  corroborating	  observations	  from	  this	  technique	  with	  those	   from	   complementary	   methods	   to	   avoid	   misinterpretation	   of	   potentially	  complex	  data.	   	  This	  opens	  the	  way	  to	  future	  studies	  including	  those	  that	  can	  be	  applied	   to	   aid	   the	   development	   of	   new	   therapeutic	   strategies	   to	   treat	   α1-­‐antitrypsin	   deficiency	   by	   affecting	   structural	   and	   dynamic	   behaviour	   of	   the	  protein	  in	  solution.	  The	  dynamics	  data	  obtained	  on	  the	  native	  state	  of	  wild-­‐type	  α1-­‐antitrypsin	   using	   HDXNMR	   and	   relaxation	   experiments	   allow	   future	  comparison	  with	  the	  behaviour	  of	  disease	  mutants	  such	  as	  Lys154Asn	  over	  slow	  and	   fast	   timescales.	   Furthermore,	   the	  NMR	  spectroscopic	   characteristics	   of	   the	  native	   protein	   described	   in	   this	   thesis	   provide	   the	   basis	   for	   assessing	   its	  interactions	   with	   ligands	   in	   drug	   discovery.	   To	   these	   ends	   I	   undertook	  preliminary	   drug–binding	   experiments;	   findings	   are	   presented	   in	   the	  supplementary	  material	  B	  (Appendix	  B	  Fig.	  1,	  Fig.2).	  In	  this	  study,	  the	  binding	  of	  the	  tetrapeptide	  lead	  compound	  Ac-­‐TTAI-­‐NH2	  to	  α1-­‐antitrypsin	  was	  assessed	  by	  NMR	   spectroscopy	   and	   IM-­‐MS.	   The	   data	   confirm	   widespread	   conformational	  changes	  upon	  binding	  and	  a	  2:1	  stoichiometry,	  respectively.	  This	  method	  can	  be	  used	   to	   screen	   compounds	   identified	   as	   potential	   ligands,	   to	   shed	   light	   on	   the	  binding	  interactions	  with	  the	  ligands	  at	  atomic	  resolution.	  	  Furthermore,	   the	   work	   presented	   in	   this	   thesis	   opens	   ways	   to	   explore	  whether	   misfolding	   processes	   occur	   co-­‐translationally	   on	   the	   ribosome	   in	  disease	   variants	   of	   α1-­‐antitrypsin	   using	   NMR	   spectroscopy	   of	   the	   ribosome-­‐nascent	   chain	   (RNC)	   complex.	   This	   has	   the	   potential	   to	   transform	   our	  understanding	  of	  the	  formation	  of	  intermediate	  ensembles	  in	  health	  and	  disease	  
in	  vivo	  and	  it	  has	  been	  very	  exciting	  being	  part	  of	  the	  development	  of	  this	  work.	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Figure	  6.2.	  	   Energy	   free-­energy	   landscape	   α1-­antitrypsin	   revised	   from	   the	  
findings	  of	   this	   thesis.	   Energy	   landscape	   shown	   in	  Fig.6.1.	  modified	   in	   line	  with	   the	   finding	   from	   this	   thesis,	   notably	   the	   absence	   of	   an	   identifiable,	  thermodynamically-­‐stabilised	   intermediate	   state	   along	   the	   urea-­‐induced	  folding/unfolding	   pathway.	   In	   contrast	   the	   Lys154Asn	   mutation	   appears	   to	  strongly	   enrich	   population	   of	   an	   intermediate	   ensemble	   in	   pathophysiological	  conditions	  along	  a	  pathway	  that	  results	  in	  polymers	  recapitulating	  the	  2C1	  neo-­‐epitope.	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Appendix	  A:	  Fast	  Timescale	  Dynamics	  from	  NMR	  relaxation	  
experiments	  of	  α1-­antitrypsin	  	  
[work	   carried	   out	   in	   collaboration	   with	   Dr	   Chris	   Waudby	   (Institute	   of	   Structural	   and	  
Molecular	  Biology,	  University	  College	  of	  London)]	  
	  
A.1.	  Introduction	  to	  R1,	  R2,	  and	  the	  15N-­{1H}	  NOE	  	  	   The	  relaxation	  processes	  of	  a	  perturbed	  NMR	  system	  back	  to	  equilibrium	  occurs	   through	   three	   main	   mechanisms,	   longitudinal	   relaxation	   (spin-­‐lattice	  relaxation),	   transverse	   relaxation	   (spin-­‐spin	   relaxation)	  and	   longitudinal	   cross-­‐relaxation	   (the	   Overhauser	   effect)	   220.	   These	   rates	   are	   dependent	   on	   the	  fluctuating	  magnetic	  environment	  within	  the	  molecule	  and,	  in	  the	  particular	  case	  of	  15N	  nuclear	  spin	  relaxation,	  by	  the	  motion	  of	  the	  N–H	  amide	  bond	  vector.	  Their	  measurement	   therefore	   provides	   important	   information	   on	   the	   rotational	  diffusion	   of	   the	  molecule,	   and	   the	   extent	   of	   local	  mobility	   and	   conformational	  exchange.	  	  	   Longitudinal	   relaxation	   rates	   may	   be	   recorded	   via	   inversion	   recovery	  experiments	   (or	   similar)221.	   These	   experiments	   involves	   flipping	   the	   bulk	  magnetisation	  on	  to	  the	  -­‐z	  axis	  and	  allowing	  the	  system	  to	  evolve	  for	  a	  defined	  period	  of	  time	  during	  which	  the	  system	  relaxes	  towards	  its	  equilibrium	  position;	  rotating	   the	   remaining	   magnetisation	   into	   the	   x-­‐y	   plane	   then	   permits	   the	  detection	  of	   the	  magnetisation	  as	  a	   function	  of	   the	   time	  allowed	   for	   relaxation,	  allowing	   the	  determination	  of	   the	   longitudinal	   relaxation	   rate,	  R1,	   that	   governs	  this	   process.	  As	   longitudinal	   relaxation	   is	   driven	  by	   spin	   flips,	   the	   observed	  R1	  rate	  depends	  on	  fluctuations	  at	  the	  Larmor	  frequencies	  of	  1H	  and	  15N	  nuclei	  and	  therefore	   is	   highly	   sensitive	   to	   the	   rotational	   correlation	   time	   of	   the	  molecule	  and	  to	  molecular	  motion	  on	  ps–ns	  timescales.	  221	  	   Transverse	  relaxation	  rates	  can	  be	  recorded	  using	  a	  CPMG	  experiment.	  In	  this	   type	   of	   experiment,	   the	  magnetisation	   is	   flipped	   to	   the	   -­‐y	   axis	  with	   a	   90ox	  pulse.	  The	  system	  is	  then	  allowed	  to	  relax	  for	  a	  period	  (τ)	  prior	  to	  180oy	  pulse.	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The	   system	   then	   relaxes	   for	   a	   time	   (2τ),	   followed	  by	   another	   180oy	   pulse,	   and	  allowed	   to	   relax	   for	   a	   time	   (τ)	   prior	   to	   acquisition.	   In	   practice	   the	   CPMG	  sequence	  (τ	  -­‐	  180oy	  -­‐	  2τ	  -­‐	  180oy	  -­‐	  τ)	  is	  often	  repeated	  several	  times.	  Varying	  the	  time	  for	  which	  the	  system	  relaxes	  allows	  quantification	  of	  the	  rate	  of	  relaxation	  delay	  and	  hence	  the	  transverse	  relaxation	  rate	  R2.	  This	  rate,	  like	  R1,	  depends	  on	  the	   overall	   rotational	   correlation	   time	   of	   the	   molecule,	   but	   importantly	   the	  transverse	  relaxation	  rate	  is	  also	  uniquely	  sensitive	  to	  chemical	  exchange	  on	  ms	  timescales.	   Alternatively,	   R2	   relaxation	   rates	   may	   be	   deduced	   from	   rotating	  frame	   R1ρ	   relaxation	   rates	   measuring	   during	   application	   of	   a	   spin-­‐lock,	   after	  correction	  for	  longitudinal	  relaxation	  in	  the	  tilted	  frame:	  	  
R2 = R1! / sin2" ! R1 / tan2" 	  
where	  
! 
tan" =#1 /$ 	  is	  the	  angle	  of	  the	  tilted	  frame	  relative	  to	  the	  static	  field,	  
! 
"	  is	  
the	  resonance	  offset	  and	  !1 	  is	  the	  spin-­lock	  field	  strength.	  	   The	   15N-­‐{1H}	   heteronuclear	   NOE	   experiment	   involves	   the	   interleaved	  recording	  of	  1H-­‐15N	  correlation	  spectra	  with	  and	  without	  irradiation	  of	  1H	  nuclei	  222;	  223.	  Irradiation	  of	  the	  1H	  spins	  equalises	  the	  1H	  spin	  population	  between	  the	  higher	   and	   lower	   energy	   states,	   and	   dipolar	   cross-­‐relaxation	   (a	   through-­‐space	  interaction	   also	   known	   as	   the	   nuclear	   Overhauser	   effect)	   between	   1H	   and	   its	  attached	  15N	  then	  may	  result	  in	  a	  difference	  in	  the	  intensity	  of	  the	  15N	  resonance	  relative	  to	  the	  experiment	  conducted	  without	  irradiation.	  The	  observed	  intensity	  difference,	   termed	   the	   steady-­‐state	   NOE,	   arises	   from	   competition	   between	   the	  cross-­‐relaxation	   and	   longitudinal	   relaxation	   rates,	   and	   is	   most	   sensitive	   to	  fluctuations	  at	  the	  proton	  Larmor	  frequency	  (of	  the	  order	  of	  picoseconds).	  Thus,	  the	   steady-­‐state	   NOE	   is	   an	   excellent	   probe	   of	   local	   flexibility	   on	   the	   fastest	  timescales.	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A.2.	  Data	  acquired	  and	  analysis	  to	  date:	  
A.2.2.	  Methods	  	   To	  investigate	  the	  dynamic	  properties	  of	  α1-­‐antitrypsin,	  a	  series	  of	  15N	  R1,	  
R1ρ	   and	   NOE	   nuclear	   spin	   relaxation	   experiments	   were	   recorded	   by	   Dr	   Chris	  Waudby	  on	  a	  150	  µM	  sample	  of	  perdeuterated,	   amide-­‐protonated,	   15N-­‐labelled	  α1-­‐antitrypsin.	  TROSY	  R1,	  R1ρ	  	  and	  NOE	  experiments	  were	  carried	  out	  with	  pulse	  sequences	  as	  described	   in	  Lakomek	  et	  al224.	  Spectra	  were	  recorded	  at	  298	  K	  at	  700	  MHz	   (see	  Chapter	   II	   of	  main	   thesis)	  Bruker	  Avance	   III	  NMR	  spectrometer,	  equipped	  with	  a	  TXI	  cryogenic	  probehead	  and	  a	  z-­‐gradient	  accessory.	  15N	  and	  1H	  spectral	  widths	  were	  2128	  Hz	  and	  10504	  Hz,	  with	  1024	  and	  160	  complex	  points	  in	   each	   dimension	   respectively.	   For	   each	   relaxation	   time	   measurement,	   the	  relaxation	  decay	  was	  sampled	  for	  10	  different	  delay	  durations,	  interleaved	  at	  the	  level	  of	  single	  scans.	  Longitudinal	  (R1)	  relaxation	  rates	  were	  measured	  using	  ten	  points	  with	  delays	  of	   0,	   0.4,	   0.8,	   1.2,	   1.6,	   2.0,	   2.4,	   2.8,	   3.2	   and	  3.6	   sec.	  Rotating	  frame	   (R1ρ)	   relaxation	   rates	  were	  measured	   in	   a	   2.05	   kHz	   spin-­‐lock	   field	  with	  relaxation	  delays	  of	  1,	  5,	  10,	  15,	  20,	  25,	  30,	  40,	  60	  and	  80	  ms.	  The	  spin-­‐lock	  field	  strength	  was	  measured	  directly	  by	  a	  nutation	  experiment,	  and	  the	  observed	  B1-­‐field	   inhomogeneity	  was	   approximately	   50	  Hz.	   For	   temperature	   compensation	  purposes	   an	   off-­‐resonance	   spin-­‐lock	   pulse	   was	   applied	   such	   that	   the	   total	  duration	   of	   the	   spin-­‐lock	   was	   80	   ms,	   in	   each	   scan,	   for	   all	   relaxation	  measurements.	  RF	  carriers	  were	  at	  4.79	  ppm	  for	   1H	  and	  at	  118	  ppm	  for	   15N.	  A	  recycle	  delay	  of	  2.5	  s	  was	  used	  in	  both	  R1	  and	  R1ρ	  measurements,	  chosen	  relative	  to	  the	  measured	  average	  1H	  T1	  value	  of	  1.6	  s.	  Heteronuclear	  NOE	  measurements	  were	  performed	  with	  a	  saturation	  period	  of	  5	  s	   following	  a	  recycle	  delay	  of	  1	  s	  (or	   6	   s	   in	   the	   absence	   of	   the	   saturation	   pulse	   chain),	   with	   saturation	   pulses	  applied	  to	  the	  centre	  of	  the	  amide	  region	  at	  8.5	  ppm.	  Data	  were	  processed	  with	  Lorentz-­‐to-­‐Gauss	  window	  functions	  and	  were	  fitted	  using	  nmrPipe144	  .	  	   A	  relaxation	  analysis	  (by	  Dr.	  Chris	  Waudby,	  UCL)	  was	  performed	  for	  247	  residues	  out	  of	  a	  possible	  394	  residues.	  A	  preliminary	  analysis	  of	   these	  data	   is	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presented	  here	  and	  an	  analysis	  including	  additional	  data	  recorded	  by	  Dr	  Waudby	  at	  900	  MHz	  is	  currently	  underway.	  This	  will	  include	  a	  ‘Model	  Free’	  analysis	  225	  226	  and	  a	  detailed	  definition	  of	  the	  spectral	  density	  function	  for	  α1-­‐antitrypsin.	  The	  parameters	   determined	   within	   the	   ‘model-­‐free’	   analysis	   include	   the	   diffusion	  tensor,	   describing	   the	   rotational	   correlation	   time(s)	   (τc),	   generalised	   order	  parameters	   (S2)	   and	   chemical	   exchange	   terms	   (Rex),	   and	   in	   favourable	   cases	  order	  parameters	  can	  also	  be	  determined	  for	  molecular	  motion	  on	  two	  different	  time-­‐scales	  (Sf2	  and	  Ss2).	  227	  Of	  particular	  relevance	  here	  is	  the	  Rex	  term	  since	  this	  is	   essentially	   part	   of	   the	   measured	   R2	   term,	   describing	   the	   additional	  contribution	  to	  R2	  arising	  from	  ‘chemical	  exchange’.	  The	  careful	  analysis	  of	  such	  exchange	   terms,	   using	   so-­‐called	   ‘relaxation	   dispersion’	   CPMG	   or	   R1ρ	  measurements,	  is	  forming	  a	  very	  important	  part	  of	  the	  use	  of	  NMR	  in	  biology	  as	  it	   provides	   a	   route	   to	   the	   high-­‐resolution	   characterisation	   of	   intermediate	  states122	   228	   	   229	   that	   are	   weakly	   populated	   at	   equilibrium,	   but	   that	   are	   in	  exchange	  with	  the	  ground	  state	  on	  ms	  timescales.	  This	  is	  of	  particular	  interest	  in	  the	  case	  of	  α1-­‐antitrypsin	  as	  sparsely	  populated	   intermediate	  states	   that	  are	   to	  date	   very	   poorly	   understood	  may	   be	   of	   relevance	   to	   the	  misfolding	   processes	  that	  occur	  in	  disease	  230.	  However,	  this	  type	  of	  analysis	  is	  unfortunately	  beyond	  the	  scope	  of	  this	  thesis	  as	  it	  requires	  a	  very	  carefully	  defined	  system	  with	  excited	  state	  populations	  between	  0.5–5	  %	  and	  with	  exchange	  rates	  of	  102–103	  s-­‐1.	  	  Figure	   A.1.	   plots	   the	   relaxation	   rates	   determined	   in	   this	   study;	   these	   are	   also	  projected	  onto	  the	  crystal	  structure	  of	  α1-­‐antitrypsin	  in	  Figure	  	  A.2.	  While	  some	  variation	  in	  relaxation	  rates	  is	  observed	  across	  the	  protein,	  given	  the	  asymmetric	  diffusion	   tensor	   expected	   given	   the	   α1-­‐antitrypsin	   structure,	   a	   complete	  interpretation	   of	   these	   variations	   must	   necessarily	   wait	   for	   the	   model-­‐free	  analysis	   to	   be	   completed	   using	   relaxation	   data	   obtained	   at	   multiple	   field	  strengths.	  Nevertheless,	  increased	  mobility	  is	  clearly	  discernible	  in	  loop	  regions	  (as	  increased	  R1,	  decreased	  R2	  and	  decreased	  NOE	  values),	  and	  in	  particular	  we	  observe	   that	   the	   reactive	   center	   loop	   exhibits	   large	   changes	   in	   its	   internal	  mobility	  across	  its	  sequence.	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Appendix	  A	  Fig.	  1:	  	   15N	   R1	   and	   R2	   relaxation	   rates,	   and	   15N-­{1H}	   NOE	   for	   α1-­
antitrypsin,	  recorded	  at	  700	  MHz,	  298	  K.	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Appendix	  A	  Fig.	  2	  	   15N	  relaxation	  rates,	  R1,	  R2,	  and	  15N-­{1H}	  NOE	  depicted	  on	  the	  
x-­ray	   crystal	   structure	   of	   α1-­antitrypsin	   (PDB:	   3	   NE4).	  
Colours	  schemes	  are	  from	  blue	  to	  red,	  depicting	  from	  x-­y	  s-­1	  
(R1),	  a-­b	  s-­1	  (R2)	  and	  0	  -­	  1	  (15N-­{1H}	  NOE).	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Appendix	  B:	  Therapeutic	  strategies	  for	  blocking	  α1-­Antitrypsin	  
polymerisation:	  TTAI	  peptide	  binding	  	  	  
	  	  
Appendix	  B	  Fig.	  1.	  	   1H-­15N	   HSQC	   spectra	   of	  α1-­antitrypsin	   before	   (orange)	   and	  
after	   (black)	   binding	   of	   the	   TTAI	   peptide	   (10:1	   molar	  
equivalence	   peptide:protein	   37	   °C)	   demonstrates	   some	  
major	  conformational	  changes	  upon	  binding.	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Appendix	  B	  Fig.	  2.	  	   Ion	   Mobility	   Mass	   Spectrometry	   titration	   of	   α1-­antitrypsin	  
binding	   increasing	   concentrations	   of	   TTAI	   peptide.	   A-­‐	   Stack	  plot	  of	   the	  +12,	  +13,	  +14	  monomeric	  states	  signal	  obtained	  from	  0.5:1	  to	   1:1	   molar	   equivalent	   into	   32.5	   μM	   of	   α1-­‐antitrypsin.	   The	   charge	  states	   of	   α1-­‐antitrypsin	   monomer	   appear	   as	   well-­‐resolved	   triplet	  corresponding	   to	   the	   apo	   α1-­‐antitrypsin,	   singly-­‐bound	   α1-­‐antitrypsin,	  and	  doubly-­‐bound	  α1-­‐antitrypsin.	  B-­‐	  Illustrates	  fractional	  occupancy	  of	  
α1-­‐antitrypsin	   with	   increasing	   concentrations	   of	   ligand.	   Our	   data,	  suggests	   a	   cooperative	   binding,	   stoechiometry	   2:1,	   for	   the	   binding	   of	  the	  TTAI	  peptide	  on	  α1-­‐antitrypsin.	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Appendix	  C:	  Fast	  Timescale	  Dynamics	  from	  HDXNMR	  experiments	  of	  
α1-­antitrypsin	  	  	   Plot	  of	  the	  raw	  intensity	  decay	  at	  a	  residue	  specific	  level	  for	  the	  HDXNMR	  analysis	  at	  pH	  8.0,	  pH	  7.0,	  pH	  6.5,	  pH	  6.0.	  Selected	  residues	  were	  subsequently	  selected	  for	  exponential	  fitting	  and	  free	  energy	  determination.	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